Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3023323	s-fsh	IU/l (iu/l)	11108	14248	0.00%
3023323	s-fsh	U/l (iu/l)	10778	13737	0.65%
3023323	s-fsh	— (—)	5565	7245	100.00%	Distribution not available
3023323	s-fsh	IU/l______ (iu/l)	491	618	0.00%
3023323	s-fsh	U/L (iu/l)	475	565	0.00%
3023323	p-follikkeliastimuloivahormoni	U/l (iu/l)	454	511	0.00%
3023323	s-follikkeliastimuloivahormoni	IU/l______ (iu/l)	225	256	0.00%
3023323	s-follikkeliastimuloivahormoni	IU/l (iu/l)	151	160	0.00%
3023323	follikkeliastimuloivahormoni	U/l (iu/l)	131	138	0.00%
3023323	s-follikkeliastimuloivahormoni	U/l_______ (iu/l)	47	48	0.00%
3023323	s-follikkeliastimuloivahormoni	U/l (iu/l)	31	32	0.00%
3023323	s-follikkeliastimuloivahormoni(ko)	U/l (iu/l)	25	27	0.00%
3023323	p-follikkeliastimuloivahormoni(pi)	U/l (iu/l)	9	9	0.00%	Distribution not available
3023323	s-follikkeliastimuloivahormoni	— (—)	6	7	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Mood [affective] disorders

5508

20155

1.82

319.74

1.5

1.4

23.17

26.43

iu/l

10.80

4509

17452

Mood disorders

5513

20156

1.82

318.93

1.5

1.4

23.13

26.44

iu/l

11.12

4513

17453

Neurotic, stress-related and somatoform disorders

5220

20386

1.84

317.62

1.5

1.4

23.17

26.58

iu/l

11.11

4284

17598

Anxiety disorders

5230

20379

1.84

315.81

1.5

1.4

23.23

26.56

iu/l

10.59

4292

17591

Benign neoplasm: Pituitary gland, craniopharyngeal duct

614

1213

6.67

313.51

2.0

1.4

19.77

25.07

iu/l

3.44

502

1034

Insomnia

5428

19359

2.05

307.65

1.4

24.12

26.24

iu/l

4.74

4653

16552

Exclusions for E4_PCOS_BROAD

1780

4671

4.57

307.65

2.0

1.4

17.44

25.38

iu/l

21.69

1448

3898

Amenorrhoea

947

2095

5.90

307.65

1.9

1.3

12.94

20.27

iu/l

13.03

774

1783

Behavioural syndromes associated with physiological disturbances and physical factors

5465

19044

2.04

307.65

1.4

23.69

26.35

iu/l

7.17

4645

16220

Noninflammatory disorders of female genital tract

2603

5295

2.65

307.65

1.4

1.3

20.22

25.22

iu/l

10.80

2203

4486

Female infertility

3133

4929

4.50

307.65

1.3

16.81

26.06

iu/l

41.47

2680

4195

Testicular dysfunction

304

202

18.11

307.65

2.1

1.5

13.32

7.92

iu/l

4.02

232

148

Testicular hypofunction

281

181

18.89

307.65

2.1

1.5

13.94

7.69

iu/l

4.62

213

134

Irregular menses

4837

18108

2.22

307.65

1.5

1.3

21.64

28.49

iu/l

41.35

4160

15739

Recurrent or chronic depression

2634

7026

2.79

307.65

1.5

1.3

23.41

28.77

iu/l

12.45

2226

6122

Sleep disorders

5329

18835

2.04

307.65

1.4

24.16

26.49

iu/l

5.51

4558

16091

Pain and other conditions associated with female genital organs and menstrual cycle

1752

5134

3.18

307.65

1.4

1.3

19.93

24.92

iu/l

9.01

1506

4356

Hypogonadotropic hypogonadism

357

265

18.38

307.65

2.0

1.5

5.40

12.25

iu/l

7.81

275

213

Disorders of other endocrine glands

3328

11664

3.09

307.65

1.8

1.3

17.56

25.07

iu/l

37.33

2734

9945

Depression

5451

20118

1.89

307.65

1.5

1.4

22.86

26.45

iu/l

12.91

4461

17422

Hypopituitarism

868

1210

9.48

307.65

2.1

1.5

12.84

21.69

iu/l

12.65

686

964

Other menopausal disorders

2035

3806

3.32

307.65

1.4

1.3

31.72

31.70

iu/l

0.01

1803

3287

Female infertility, cervical, vaginal, other or unspecified origin

2876

4865

4.47

307.65

1.3

17.78

26.30

iu/l

33.03

2442

4145

Female infertility, associated with anovulation

1192

3074

5.08

307.65

1.4

1.3

10.25

20.55

iu/l

40.67

1019

2619

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2194

9693

2.44

293.43

1.8

1.4

22.47

28.27

iu/l

13.37

1822

8296

Polycystic ovarian syndrome, consortium definition

5442

18282

1.81

292.05

1.5

1.3

21.28

28.67

iu/l

52.72

4665

15889

Anxiety disorders, excluding more controls

4548

16166

1.87

288.96

1.5

1.3

24.14

27.34

iu/l

8.26

3738

14097

Hypothyroidism, other/unspecified

5016

19056

1.80

282.91

1.5

1.3

24.25

26.15

iu/l

3.74

4310

16395

Hypothyreosis and Thyroxine purchase for inclusion criteria

5154

19810

1.77

275.02

1.5

1.3

24.46

26.36

iu/l

3.83

4436

17040

Disorders of the thyroid gland

5089

19372

1.77

270.04

1.5

1.3

24.17

25.90

iu/l

3.19

4350

16635

Male infertility

315

341

10.70

269.45

1.7

11.68

7.29

iu/l

4.97

220

270

Excessive, frequent and irregular menstruation

2270

5273

2.45

268.24

1.4

1.3

20.39

25.26

iu/l

9.90

1959

4472

Procreative management

2211

8253

2.37

267.11

1.6

1.5

23.32

28.20

iu/l

9.04

1761

6864

Endometriosis

1984

4934

2.50

249.94

1.3

24.18

26.48

iu/l

2.16

1764

4205

Mood disorders, excluding more controls

4721

16203

1.77

248.60

1.5

1.3

23.58

27.31

iu/l

11.75

3864

14136

Hypothyroidism (congenital or acquired)

2086

5129

2.46

247.85

1.5

1.3

19.59

24.50

iu/l

9.16

1750

4517

Hypothyroidism, levothyroxine purchases

2080

5122

2.46

247.02

1.5

1.3

19.61

24.51

iu/l

9.13

1743

4513

Hypothyroidism and >3 levothyroxin purchases

2080

5122

2.46

247.02

1.5

1.3

19.61

24.51

iu/l

9.13

1743

4513

Polycystic ovarian syndrome, broad definition

1538

6621

2.84

237.32

1.4

1.3

10.19

21.06

iu/l

70.14

1313

5707

Anxiety (asthma-related co-morbidities)

4055

17905

1.81

233.71

1.5

1.4

20.67

26.71

iu/l

27.77

3246

15591

Migraine

3772

17007

1.82

222.43

1.4

23.52

25.79

iu/l

4.04

3251

14600

Exclusions for E4_PCOS_CONSORTIUM

4973

19155

1.70

221.52

1.6

1.3

23.57

26.60

iu/l

8.54

4214

16484

Dysplasia of cervi uteri

1601

4765

2.56

219.12

1.4

1.3

23.41

26.47

iu/l

3.10

1395

4066

Genitourinary diseases

2001

4444

2.33

217.20

1.5

18.25

20.17

iu/l

1.87

1615

3561

Endocrine, nutritional and metabolic diseases

4562

13763

1.73

214.42

1.6

1.3

20.62

26.45

iu/l

27.51

3801

11844

Ovarian cyst

1933

5062

2.31

207.17

1.3

25.29

25.99

iu/l

0.38

1671

4309

All anxiety disorders

4162

19574

1.73

206.14

1.5

1.4

20.30

26.21

iu/l

28.22

3333

16926

Depression or dysthymia

2619

7360

2.00

200.39

1.4

1.3

24.39

28.26

iu/l

6.57

2205

6375

Ovarian dysfunction

1057

4135

3.18

199.90

1.6

1.3

16.78

20.11

iu/l

3.14

899

3548

Headache

3791

17431

1.75

198.37

1.5

1.3

23.71

25.96

iu/l

4.18

3231

14993

Other antidepressants

4495

13940

1.69

196.87

1.4

23.73

26.68

iu/l

6.83

3761

12068

Malignant neoplasm of testis

163

105

20.33

195.87

3.6

1.4

16.25

7.46

iu/l

5.37

124

Endometriosis of pelvic peritoneum

1173

4247

2.76

195.45

1.3

25.58

28.20

iu/l

1.75

1051

3639

Malignant neoplasm of testis, including Hilmo

167

113

18.75

194.85

3.6

1.4

16.09

7.33

iu/l

5.62

126

Hypothyroidism, strict autoimmune

4024

15989

1.71

191.25

1.4

1.3

24.48

26.20

iu/l

2.67

3480

13778

Sleep disorders (combined)

4996

16533

1.62

186.44

1.4

22.68

26.39

iu/l

12.56

4254

14121

Triptan medication for migraine, single purchase ok

4411

18767

1.65

183.45

1.4

25.35

26.17

iu/l

0.86

3821

15953

Migraine, single triptan purchase ok & required. ICD-code if available is included

4411

18767

1.65

183.45

1.4

25.35

26.17

iu/l

0.86

3821

15953

Benign neoplasm of other and unspecified endocrine glands

754

2512

3.30

178.18

1.9

1.4

22.43

30.48

iu/l

9.10

622

2165

Triptan medication for migraine, min. 3 purchases

4276

20313

1.66

176.55

1.4

24.82

26.35

iu/l

2.23

3734

17481

Medical treatment for female infertility

2577

14797

1.96

172.58

1.4

1.3

18.00

25.41

iu/l

34.12

2294

12851

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

4871

20327

1.58

169.45

1.4

23.63

26.42

iu/l

7.40

4113

17361

Polycystic ovarian syndrome

812

3064

3.36

165.89

1.4

1.3

8.91

18.71

iu/l

39.16

694

2623

Unspecified/other endometriosis

856

3231

2.95

157.87

1.4

1.3

21.00

23.11

iu/l

1.17

751

2763

Menorrhagia

1726

4692

2.16

157.00

1.4

1.3

25.05

27.46

iu/l

2.06

1497

4006

Selective serotonin reuptake inhibitors

4260

14088

1.61

155.73

1.4

22.71

26.54

iu/l

11.14

3547

12150

L02BG Aromatase inhibitors

1151

4962

2.41

154.85

1.5

1.3

41.66

37.33

iu/l

3.55

954

4311

Caries of enamel

4719

20388

1.56

154.79

1.4

25.89

26.18

iu/l

0.22

3882

17596

Cystitis

4350

16927

1.57

146.58

1.4

26.70

26.26

iu/l

0.35

3707

14619

Medicines for HER+ breast cancer

1704

8278

2.01

143.52

1.5

1.3

36.85

35.43

iu/l

0.90

1417

7254

Endometriosis of ovary

1013

4113

2.50

141.79

1.3

27.78

28.79

iu/l

0.40

891

3531

Dentofacial anomalies [including malocclusion]

4132

21422

1.56

139.59

1.4

24.11

26.25

iu/l

3.98

3548

18305

Depression medications

1968

5245

1.98

138.88

1.5

1.3

19.32

24.20

iu/l

8.89

1639

4594

Polyp of the female genital tract

1496

4142

2.15

135.78

1.4

1.3

27.36

29.98

iu/l

2.10

1323

3564

Other nutritional deficiencies

3662

21875

1.58

134.08

1.4

19.48

26.91

iu/l

52.05

3074

18824

Personal history of malignant neoplasm

627

2236

3.16

133.58

2.0

1.4

30.31

33.51

iu/l

1.31

445

1945

Neoplasms

4260

14793

1.56

132.77

1.6

1.3

21.48

21.85

iu/l

0.30

3530

12597

Uterine polyps

1402

3974

2.17

131.08

1.4

1.3

28.78

30.77

iu/l

1.28

1235

3427

Pain in joint

2634

9664

1.72

128.93

1.4

24.67

25.55

iu/l

0.66

2255

8185

Persons encountering health services in circumstances related to reproduction

2373

9312

1.76

127.41

1.5

27.02

28.07

iu/l

0.73

1912

7711

Other anxiety disorders

3141

17267

1.61

122.07

1.5

1.4

19.41

24.35

iu/l

16.20

2469

14910

Panhypopituitarism

169

236

9.20

120.40

2.3

1.5

9.55

21.76

iu/l

6.39

120

196

Seminoma of testis, including Hilmo

23.37

112.36

3.8

1.4

16.96

7.93

iu/l

2.41

Hyperfunction of pituitary gland

489

1705

3.43

111.89

2.0

1.3

15.68

25.15

iu/l

10.77

402

1448

Hypothyroidism, strict autoimmune, 3 medication purchases required

4195

19471

1.49

111.25

1.4

1.3

25.29

26.70

iu/l

2.00

3629

16786

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3718

19693

1.52

110.45

1.4

1.3

25.30

27.44

iu/l

3.57

3200

17106

Oligomenorrhoea

326

882

4.40

110.17

1.6

1.3

14.89

21.79

iu/l

4.45

269

738

Non-seminoma of testis, including Hilmo

29.31

107.49

3.9

1.5

18.33

9.71

iu/l

1.50

Intestinal infectious diseases, including avohilmo, including avohilmo

4990

19906

1.42

103.37

1.4

24.76

26.49

iu/l

3.13

4199

17024

Episodal and paroxysmal disorders

4965

18007

1.43

102.22

1.4

22.84

25.26

iu/l

5.82

4213

15302

Disorders of conjunctiva

4124

22446

1.46

102.11

1.4

25.50

25.44

iu/l

0.04

3507

19128

Adenomyosis (Endometriosis of uterus)

676

2834

2.55

101.18

1.4

1.3

23.37

30.03

iu/l

6.49

602

2431

Psychiatric diseases

3839

13153

1.49

99.59

1.4

1.3

24.86

27.48

iu/l

4.87

3214

11395

Conjunctivitis

3943

22265

1.46

99.45

1.4

25.10

25.56

iu/l

0.37

3341

18982

Obesity and other hyperalimentation

3387

21833

1.50

99.11

1.4

19.66

26.93

iu/l

47.85

2835

18811

Anaemias

1429

4999

1.93

98.32

1.5

1.3

22.91

24.99

iu/l

1.44

1174

4393

Seminoma of testis

24.21

98.32

3.9

1.3

16.50

8.96

iu/l

1.42

General symptoms and signs

4910

17676

1.42

98.02

1.5

1.3

24.27

25.75

iu/l

2.33

4127

15173

Dental pulpitis, including avohilmo

4613

21230

1.42

97.48

1.4

24.26

25.59

iu/l

1.96

3856

18214

Used for control exclusion in common control thyroid runs

4642

16680

1.43

97.17

1.5

1.4

21.68

25.12

iu/l

10.30

3900

14167

Other soft tissue disorders, not elsewhere classified

4372

17630

1.44

97.02

1.4

24.81

24.25

iu/l

0.52

3687

14922

Obesity

3365

21813

1.50

96.41

1.4

19.55

26.93

iu/l

49.13

2813

18792

Other diseases of urinary system

4400

17547

1.44

96.09

1.4

25.55

25.71

iu/l

0.11

3771

15078

Opioids

4685

17342

1.42

95.76

1.4

1.3

22.15

25.26

iu/l

9.12

3939

14936

Acute upper respiratory infections

4563

19619

1.42

95.17

1.4

25.70

26.59

iu/l

1.00

3946

16705

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4700

17998

1.41

93.10

1.5

1.4

24.37

26.49

iu/l

4.19

3914

15498

Non-small cell lung cancer

171

302

5.76

90.95

1.3

28.88

31.98

iu/l

0.50

136

257

Conjunctivitis (acute, non atopic), including avohilmo

4299

18583

1.42

90.95

1.4

25.64

25.58

iu/l

0.04

3588

15907

Codeine

4405

17137

1.42

88.76

1.4

1.3

22.89

25.47

iu/l

6.08

3713

14776

Disorders of puberty

170

330

6.66

88.45

3.2

1.7

8.40

10.30

iu/l

0.54

129

237

Asthma (mode)

3555

12947

1.48

87.76

1.4

23.74

26.86

iu/l

6.73

3004

11053

Any mental disorder

4493

16268

1.41

86.30

1.5

1.3

24.71

27.27

iu/l

5.37

3745

14166

Other endocrine disorders

335

1019

3.53

86.14

2.4

1.6

12.49

18.26

iu/l

3.20

230

781

Nonorganic sleeping disorders, excluding more controls

1272

7226

1.86

84.03

1.5

1.3

22.04

25.17

iu/l

3.07

1051

6306

Chronic diseases of tonsils and adenoids

3759

16870

1.44

83.80

1.4

24.33

26.06

iu/l

2.56

3225

14278

Sleep apnoea, including avohilmo

4253

18678

1.40

82.83

1.4

26.37

28.13

iu/l

2.94

3624

16116

Abnormal findings in secretions and smears from cervix uteri vagina vulva

3646

19278

1.45

82.61

1.4

1.3

25.31

27.73

iu/l

4.39

3147

16783

Asthma, including avohilmo

5132

21090

1.36

82.42

1.4

23.60

25.57

iu/l

4.21

4357

17954

Codeine or tramadol medication

4952

20001

1.37

81.40

1.4

23.72

25.83

iu/l

4.66

4190

17192

Persons encountering health services in other circumstances, wide

4742

17999

1.38

80.37

1.5

1.4

24.57

26.49

iu/l

3.47

3930

15498

Asthma

3545

12878

1.45

80.09

1.4

23.61

26.86

iu/l

7.27

2995

10995

Other headache syndromes

2231

14698

1.56

79.25

1.5

1.3

25.89

27.75

iu/l

1.90

1905

12749

Acute upper respiratory infections of multiple and unspecified sites

3686

19377

1.42

78.14

1.5

1.4

22.76

26.47

iu/l

10.19

3151

16517

Postmenopausal bleeding

939

2460

2.07

77.82

1.4

1.3

41.93

42.22

iu/l

0.08

806

2134

Asthma, excluding more controls

3517

12806

1.44

76.56

1.4

23.45

26.85

iu/l

7.85

2970

10935

Hyperprolactinaemia

373

1402

3.23

75.56

1.7

1.3

16.16

26.00

iu/l

8.85

309

1214

Gender identity disorders

170

382

5.81

75.31

2.2

1.5

4.74

12.99

iu/l

9.99

142

299

Disorders of puberty, all

197

497

5.09

75.27

3.4

1.8

9.02

9.83

iu/l

0.22

151

354

Fenamates

639

1952

2.33

74.86

1.4

1.3

23.61

26.27

iu/l

1.18

556

1677

Neurological diseases

4041

14806

1.40

74.03

1.5

1.4

22.09

24.71

iu/l

5.68

3438

12515

Follow-up examination after treatment for conditions other than malignant neoplasms

2070

8953

1.58

73.93

1.4

1.3

26.21

27.06

iu/l

0.54

1786

7595

Examination and observation for other reasons

2470

9333

1.53

73.50

1.4

1.3

23.96

26.41

iu/l

3.19

2123

7854

Any event in cancer register

4437

19316

1.37

73.44

1.6

1.3

30.35

25.29

iu/l

17.58

3673

16759

Other noninflammatory disorders of vulva and perineum

536

2358

2.44

72.72

1.4

1.3

23.13

27.14

iu/l

2.17

465

2004

Personality disorders, excluding more controls

1514

9362

1.69

72.12

1.5

1.3

20.77

23.74

iu/l

3.15

1171

8199

Dermatitis and eczema

4753

21244

1.35

71.64

1.4

25.01

25.66

iu/l

0.67

4075

18066

Lower back pain or/and sciatica

4637

21720

1.35

71.46

1.4

25.75

25.47

iu/l

0.22

3969

18582

Pain in limb

3732

17358

1.39

70.16

1.4

26.52

24.45

iu/l

3.33

3167

14732

Low back pain

3530

17317

1.40

70.13

1.4

25.12

25.04

iu/l

0.05

3023

14770

Diseases of male genital organs

730

1722

2.16

69.15

1.7

1.8

10.13

7.91

iu/l

3.99

531

1243

Asthma (only as main-diagnosis)

3229

12878

1.43

69.10

1.4

23.61

26.86

iu/l

6.87

2752

10995

Female genital prolapse

1165

3675

1.83

67.70

1.4

1.3

31.75

32.56

iu/l

0.31

1020

3172

Other disorders of adrenal gland

280

931

3.36

67.45

1.8

1.4

23.35

26.38

iu/l

0.77

230

772

Benign neoplasms

4396

18015

1.35

66.61

1.5

1.4

22.20

23.88

iu/l

2.91

3744

15292

Hypothyroidism, drug reimbursement

980

3790

1.91

66.55

1.4

1.3

30.23

29.84

iu/l

0.12

844

3429

Delayed puberty

128

9.58

66.33

3.0

1.8

7.87

7.94

iu/l

0.01

L02BA Anti-estrogens

889

4879

1.93

66.28

1.5

1.3

31.34

35.99

iu/l

4.54

734

4288

Asthma (only as main-diagnosis), excluding more controls

3224

12806

1.42

66.27

1.4

23.57

26.85

iu/l

6.92

2747

10935

Use of cabergoline

154

356

5.63

65.96

1.9

1.4

13.16

22.02

iu/l

3.63

122

309

Medical observation and evaluation for suspected diseases and conditions

2642

9344

1.47

65.27

1.5

1.3

22.44

26.40

iu/l

7.87

2239

7859

Other maternal disorders predominantly related to pregnancy

3667

17054

1.39

65.01

1.3

26.22

28.91

iu/l

5.06

3209

14753

Non-small cell lung cancer, including Hilmo

222

593

3.59

64.56

1.3

31.48

33.51

iu/l

0.35

177

503

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3023

21071

1.41

63.91

1.4

25.49

26.33

iu/l

0.71

2588

18082

Inflammatory diseases of female pelvic organs

3883

20000

1.37

63.69

1.4

1.3

25.62

27.29

iu/l

2.40

3331

17369

Short stature, not elsewhere classified

182

441

4.54

63.35

2.7

1.9

6.77

7.22

iu/l

0.13

119

284

Disorders of adult personality and behaviour

1702

11198

1.59

63.03

1.5

1.4

19.21

22.94

iu/l

5.62

1322

9643

First line medication for Crohn's disease

4835

20017

1.32

62.56

1.5

1.4

24.80

24.63

iu/l

0.13

4088

17017

Parasetamol

3331

12253

1.40

62.10

1.4

21.89

24.41

iu/l

4.58

2821

10418

Benzodiazepine use

4249

21843

1.33

61.67

1.5

1.4

23.86

26.09

iu/l

4.43

3489

18842

Other specific joint derangements/joint disorders

3720

17318

1.37

61.66

1.4

24.46

23.94

iu/l

0.44

3221

14652

Allergic conjunctivitis

3111

22061

1.39

60.75

1.4

25.59

26.25

iu/l

0.53

2663

18918

Premenstrual syndrome

178

489

4.63

60.61

1.6

1.3

12.97

19.07

iu/l

2.75

159

419

Malignant neoplasm, wide definition

3994

17557

1.35

60.55

1.6

1.3

33.37

27.17

iu/l

21.89

3271

15295

Dorsalgia

4361

17614

1.33

60.40

1.4

23.43

24.78

iu/l

1.95

3714

14983

Malignant neoplasm, including Hilmo

3996

17589

1.35

60.28

1.6

1.3

33.21

27.12

iu/l

21.33

3275

15325

Non-small cell lung cancer, adenocarcinoma

114

209

5.65

59.53

1.4

1.3

32.41

34.38

iu/l

0.21

178

Other diseases of intestines

4898

21210

1.31

59.35

1.4

24.44

24.91

iu/l

0.45

4160

18047

Abdominal and pelvic pain

3811

14346

1.35

58.26

1.4

23.63

25.83

iu/l

3.82

3232

12147

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

517

2351

2.18

57.62

1.7

1.3

32.62

32.90

iu/l

0.06

425

2044

Hyperkinetic disorders, excluding more controls

984

5412

1.80

57.56

1.5

1.4

12.37

15.91

iu/l

5.64

797

4588

Habitual aborter

235

796

3.61

57.46

1.3

18.74

20.75

iu/l

0.41

184

673

Irritable bowel syndrome

1423

9176

1.61

57.08

1.4

1.3

22.97

27.08

iu/l

5.27

1216

7926

Other dorsopathies, not elsewhere classified

4416

17656

1.32

56.77

1.4

23.17

24.75

iu/l

2.57

3789

15008

Obesity related asthma

1417

9129

1.60

56.40

1.5

1.4

22.92

30.24

iu/l

17.57

1166

7870

KRA_PSY_EATING, excluding more controls

732

3996

1.98

55.72

1.6

1.3

14.96

17.91

iu/l

2.38

596

3446

Nonorganic sleeping disorders

1272

8070

1.65

55.54

1.5

1.4

22.04

24.28

iu/l

1.80

1051

6901

Neurological diseases, wide definition

1717

5675

1.57

55.14

1.5

1.4

18.62

23.55

iu/l

8.87

1443

4703

Other reaction to severe stress, and adjustment disorders

2177

15408

1.46

55.02

1.5

1.4

23.01

25.10

iu/l

2.42

1807

13373

Complications associated with artificial fertilization

200

632

3.91

54.94

1.3

13.04

20.09

iu/l

3.64

175

539

Symptoms and signs involving the digestive system and abdomen

3788

14346

1.34

54.82

1.5

1.4

23.85

25.83

iu/l

3.13

3197

12147

GASTRO-related operations

3800

14466

1.34

54.00

1.5

1.3

22.37

24.79

iu/l

4.80

3204

12274

Any gastric operation

3800

14466

1.34

54.00

1.5

1.3

22.37

24.79

iu/l

4.80

3204

12274

Malignant neoplasm

3791

16921

1.34

53.99

1.6

1.3

33.68

27.79

iu/l

19.09

3106

14759

Mycoses, including avohilmo

3901

22843

1.32

53.86

1.4

24.14

25.56

iu/l

1.89

3243

19552

Malignant neoplasm

3789

16924

1.33

53.71

1.6

1.3

33.73

27.81

iu/l

19.24

3101

14756

Atopic dermatitis

3379

20382

1.35

53.66

1.4

22.69

25.69

iu/l

6.55

2865

17374

Liquid cancers

605

2916

2.00

53.64

1.9

1.4

24.01

28.32

iu/l

2.54

477

2483

Acetic acid derivatives and related substances

876

2505

1.85

53.51

1.4

18.59

22.79

iu/l

3.41

740

2083

Bronchitis

4616

21698

1.29

52.99

1.4

23.26

26.15

iu/l

7.85

3934

18515

Disorders of thyroid, IBD co-morbidities

1108

4630

1.71

52.74

1.4

1.3

27.91

26.46

iu/l

0.70

942

3959

Adrenocortical insufficiency

217

720

3.36

52.60

1.8

1.4

25.69

27.84

iu/l

0.40

188

612

Use of hypnotics and sedatives

4412

19692

1.30

51.73

1.4

27.10

26.84

iu/l

0.20

3713

16987

Coxibs

881

2592

1.82

51.72

1.4

18.15

22.30

iu/l

3.60

741

2151

Endometriosis diagnosis and infertility diagnosis occurring together

972

5975

1.78

51.58

1.3

23.37

26.66

iu/l

2.58

871

5212

Symptoms and signs involving the circulatory and respiratory systems

4661

18345

1.29

51.15

1.4

22.94

25.14

iu/l

4.60

3938

15640

Primary_lymphoid and hematopoietic malignant neoplasms

498

2418

2.11

51.10

2.1

1.4

23.58

27.48

iu/l

1.79

385

2025

Contraceptive management

1731

8222

1.51

50.69

1.4

29.08

29.85

iu/l

0.41

1491

6928

Solid cancers, including Hilmo

3816

17126

1.32

50.30

1.6

1.3

34.30

27.56

iu/l

24.28

3134

14954

Hirsutism in women

249

952

3.32

50.24

1.5

1.4

12.53

21.76

iu/l

7.76

213

818

Any reimbursement code in KELA

3359

12712

1.35

50.20

1.5

1.3

22.31

23.48

iu/l

1.28

2813

10962

Other abnormal products of conception

2851

14034

1.40

50.05

1.4

1.3

23.62

26.96

iu/l

6.43

2488

12240

General examination and investigation of persons without complaint and reported diagnosis

2499

9344

1.41

49.82

1.5

1.3

23.70

26.40

iu/l

3.76

2202

7859

Hypertrichosis

267

1058

3.13

49.78

1.5

1.4

12.64

22.09

iu/l

8.53

231

908

Antihypertensive medication - note that there are other indications

3728

14974

1.33

49.71

1.4

19.49

22.99

iu/l

10.20

3162

12666

Liquid cancers, including Hilmo

763

3772

1.82

49.63

1.9

1.4

26.39

28.64

iu/l

1.04

607

3231

Soft tissue disorders

4418

17726

1.29

49.53

1.4

22.83

24.17

iu/l

1.98

3784

14987

Migraine without aura

1573

10779

1.53

49.00

1.4

23.45

24.58

iu/l

0.69

1325

9284

803

4690

1.80

48.52

1.6

1.4

25.20

24.84

iu/l

0.11

630

4063

Malignant neoplasm of respiratory system and intrathoracic organs

280

880

2.68

48.42

1.4

1.3

31.78

31.64

iu/l

0.02

226

749

Malignant neoplasm of breast, HER-positive

1449

7170

1.55

48.30

1.5

1.3

40.95

36.41

iu/l

5.22

1208

6343

Malignant neoplasm of breast, ER-positive, including Hilmo

1453

7189

1.55

48.17

1.5

1.3

41.06

36.36

iu/l

5.49

1211

6361

Endometriosis of rectovaginal septum and vagina

371

1667

2.38

48.05

1.4

1.3

24.35

25.97

iu/l

0.42

324

1422

Female infertility, tubal origin

346

1527

2.50

47.93

1.3

24.13

30.85

iu/l

3.48

297

1317

Disease of hard tissues of teeth, NOS

1677

5914

1.51

47.63

1.4

1.3

27.02

27.65

iu/l

0.30

1425

5171

Urinary track infection

3820

14861

1.32

47.39

1.4

1.3

26.54

27.10

iu/l

0.45

3275

12933

Postmenopausal atrophic vaginitis

888

2818

1.77

47.03

1.3

44.79

38.69

iu/l

4.65

808

2444

Malignant neoplasm of bronchus and lung

230

667

2.93

47.03

1.3

32.49

33.86

iu/l

0.21

185

562

malignant neoplasm of male genital organs

237

476

3.03

46.96

3.0

1.4

13.98

9.21

iu/l

3.86

184

369

Symptoms and signs involving the nervous and musculoskeletal systems

2129

15384

1.41

46.47

1.5

1.4

26.25

26.84

iu/l

0.35

1853

13138

Special screening examination for infectious and parasitic diseases

1582

7890

1.51

46.11

1.4

1.3

19.63

23.76

iu/l

5.84

1236

6651

Non-selective monoamine reuptake inhibitors

1079

6533

1.62

46.05

1.4

1.3

30.04

34.47

iu/l

3.96

893

5762

malignant neoplasm of male genital organs, including Hilmo

244

504

2.94

45.90

3.0

1.4

13.83

9.22

iu/l

3.72

185

391

Complications of procedures, not elsewhere classified

3305

20505

1.32

45.69

1.4

26.73

26.92

iu/l

0.12

2838

17689

Excessive attrition of teeth

2952

22292

1.34

45.60

1.4

25.34

25.73

iu/l

0.25

2459

19146

Diabetes, insulin treatment (Kela reimbursement)

2415

19378

0.73

45.54

1.4

24.12

29.19

iu/l

14.36

2025

16691

Sleep apnoea

3611

17659

1.31

45.36

1.4

26.93

29.65

iu/l

5.52

3023

15297

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

354

1580

2.31

45.23

1.8

1.4

30.20

28.39

iu/l

0.39

278

1353

Migraine with aura

1673

11738

1.48

45.22

1.4

23.23

24.47

iu/l

0.85

1441

10115

Pain (limb, back, neck, head abdominally)

2628

9701

1.38

45.15

1.4

23.60

25.41

iu/l

2.01

2198

8185

Non-small cell lung cancer, adenocarcinoma, helper endpoint

114

266

4.43

44.91

1.4

1.3

32.41

36.28

iu/l

0.50

222

Personality disorders

1514

10442

1.50

44.55

1.5

1.4

20.77

23.10

iu/l

2.14

1171

8998

Fibromyalgia

663

3795

1.88

44.15

1.5

1.3

28.27

30.83

iu/l

1.17

565

3299

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

308

1053

2.44

43.98

1.4

1.3

31.69

31.49

iu/l

0.03

250

900

Malignant neoplasm of bronchus and lung, including Hilmo

249

787

2.68

43.13

1.3

32.07

33.54

iu/l

0.24

200

666

Rare circulating lymphoid malignancy, including Hilmo

103

232

4.77

43.02

3.3

1.7

11.52

15.11

iu/l

0.78

179

Obesity due to excess calories

2409

18048

1.37

42.81

1.4

19.00

26.56

iu/l

39.13

2015

15548

Malaise and fatigue

1809

10085

1.44

42.80

1.5

1.3

24.67

26.82

iu/l

1.95

1530

8694

Pregnancy examination and test

1449

6188

1.55

42.23

1.3

1.4

23.06

28.85

iu/l

9.30

1270

5275

Asthma (diagnoses ohter than nonallergic)

3613

22969

1.29

42.15

1.5

1.4

23.88

25.71

iu/l

2.95

3033

19609

Solid cancers

3591

16469

1.30

42.11

1.6

1.3

34.88

28.25

iu/l

22.38

2945

14394

Obesity, other/unspecified

1917

13938

1.42

41.81

1.4

20.20

27.58

iu/l

28.04

1565

12096

Other abnormal uterine and vaginal bleeding

812

3484

1.72

41.65

1.4

1.3

26.51

29.43

iu/l

1.56

687

2988

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

3743

23086

1.28

41.15

1.4

25.04

25.37

iu/l

0.24

3168

19671

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2276

16619

1.37

41.06

1.5

1.4

27.19

28.40

iu/l

0.99

1952

14361

Acute lymphocytic leukaemia

153

6.86

40.68

3.3

1.8

9.16

13.43

iu/l

1.09

124

Acute lymphocytic leukaemia, including Hilmo

153

6.86

40.68

3.3

1.8

9.16

13.43

iu/l

1.09

124

Acute lymphocytic leukaemia, helper endpoint

153

6.86

40.68

3.3

1.8

9.16

13.43

iu/l

1.09

124

Supervision of high-risk pregnancy

1611

6825

1.49

40.57

1.3

1.4

27.41

31.35

iu/l

4.69

1430

5831

Isolated growth hormone deficiency

213

6.18

40.52

3.2

2.5

7.00

9.67

iu/l

0.82

134

Migraine without aura and triptan purchases

1331

9195

1.53

40.39

1.4

23.71

24.26

iu/l

0.24

1121

7887

Dorsopathies

4374

17769

1.26

40.22

1.4

22.77

24.66

iu/l

3.48

3740

15083

Migraine with aura and triptan purchases

1232

8390

1.55

40.08

1.4

22.96

23.70

iu/l

0.34

1059

7199

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2100

15477

1.38

40.07

1.5

1.4

27.17

28.39

iu/l

0.94

1807

13352

Chronic sinusitis

1839

13309

1.41

40.03

1.4

25.87

28.52

iu/l

3.15

1599

11463

Specific personality disorders

1338

9217

1.51

39.82

1.5

1.4

20.18

23.33

iu/l

3.23

1017

7961

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1669

5843

1.46

39.78

1.4

1.3

22.56

25.41

iu/l

2.94

1381

4997

Generalized anxiety disorder

1063

6989

1.59

39.76

1.5

1.4

17.96

20.72

iu/l

2.43

841

6017

Temporomandibular joint disorders, including avohilmo

2726

20363

1.33

39.71

1.4

23.56

25.16

iu/l

1.85

2354

17508

Spontaneous abortion

2811

14504

1.34

39.46

1.3

25.14

27.30

iu/l

2.80

2409

12633

Malignant neoplasm of urinary organs

150

465

3.30

39.13

1.7

1.4

32.14

26.96

iu/l

0.83

109

388

Other special examinations and investigations of persons without complaint or reported diagnosis

2470

9344

1.36

39.13

1.5

1.3

23.13

26.40

iu/l

5.43

2124

7859

Asthma-related infections

2311

16961

1.35

38.75

1.5

1.4

22.15

25.83

iu/l

7.34

1933

14442

Asthma, hospital admission 2, infections

2311

16961

1.35

38.75

1.5

1.4

22.15

25.83

iu/l

7.34

1933

14442

Hodgkin lymphoma, hilmo

154

500

3.41

38.74

1.9

1.4

23.12

20.01

iu/l

0.52

121

421

Chronic lower respiratory diseases

5001

21540

1.24

38.68

1.4

24.06

25.39

iu/l

2.12

4247

18344

Pain, not elsewhere classified

1225

8310

1.51

38.48

1.5

1.3

24.93

26.31

iu/l

0.78

1033

7185

Chronic rhinitis, nasopharyngitis and pharyngitis

1478

10403

1.46

38.34

1.5

1.4

25.06

28.21

iu/l

3.33

1243

8880

Malignant neoplasm of urinary organs, including Hilmo

166

556

3.05

37.97

1.7

1.3

31.85

28.55

iu/l

0.50

122

463

1949

14271

1.38

37.76

1.5

1.4

21.79

24.88

iu/l

4.58

1623

12150

Disturbance of activity and attention

968

6180

1.61

37.72

1.5

12.13

15.00

iu/l

4.00

781

5106

Eating disorder

736

4538

1.75

37.67

1.6

1.4

14.95

17.61

iu/l

2.06

598

3826

Lung cancer and mesothelioma

252

875

2.48

37.56

1.3

1.4

31.85

36.02

iu/l

0.99

203

744

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2396

18636

0.75

37.18

1.4

24.21

29.34

iu/l

14.47

2008

16057

Hyperkinetic disorders

1000

6454

1.59

36.87

1.5

12.32

14.85

iu/l

3.31

801

5307

Cardiovascular diseases

3784

16075

1.27

36.85

1.5

1.4

21.00

22.84

iu/l

3.10

3214

13643

Asthma, hospital admissions , main diagnosis only

3363

23258

1.27

36.52

1.4

23.30

25.74

iu/l

4.71

2851

19821

Abnormalities of breathing

3973

18316

1.26

36.02

1.5

1.4

24.54

25.16

iu/l

0.57

3405

15621

Thyrotropin deficiency

112

321

4.37

35.96

2.0

1.3

19.56

23.99

iu/l

0.86

102

277

Dental caries

795

4680

1.64

35.77

1.7

1.4

21.85

25.85

iu/l

3.01

618

4061

Anorexia (incl.atypical)

407

2136

2.06

35.75

1.7

1.4

13.22

18.90

iu/l

5.26

335

1795

Nausea and vomiting

935

5921

1.57

35.66

1.6

1.4

21.57

25.16

iu/l

2.85

784

4936

Other general symptoms and signs

332

1607

2.21

35.40

1.6

1.4

20.93

24.15

iu/l

1.10

268

1344

Eating disorders

771

4866

1.68

35.39

1.6

1.4

15.39

18.12

iu/l

2.25

627

4105

Emotionally unstable personality disorder

847

5470

1.64

35.25

1.5

1.4

18.00

21.74

iu/l

3.28

627

4693

Molar incisor enamel hypoplasia, with caries

242

5.06

35.04

3.8

2.4

7.90

7.76

iu/l

0.03

136

Malignant neoplasm of kidney, except renal pelvis

140

447

3.21

34.86

1.8

1.4

32.18

26.83

iu/l

0.80

100

375

Corticotropin deficiency

191

5.41

34.68

2.2

1.3

26.39

25.80

iu/l

0.05

160

Hyperhidrosis

222

931

2.63

34.60

1.7

1.4

19.25

22.98

iu/l

1.18

198

796

Other extrapyramidal and movement disorders in other diseases

762

4778

1.63

34.10

1.4

26.43

29.39

iu/l

1.65

651

4105

Fever of other and unknown origin

2088

13651

1.34

33.84

1.6

1.4

24.23

25.57

iu/l

1.11

1728

11731

Other joint disorders

4115

17458

1.25

33.79

1.4

22.80

23.84

iu/l

1.25

3547

14740

Primary amenorrhea

273

4.90

33.75

2.4

1.4

7.41

15.66

iu/l

5.10

223

Other diseases of hard tissues of teeth

1601

5922

1.42

33.46

1.4

1.3

26.62

27.66

iu/l

0.57

1332

5175

Certain infectious and parasitic diseases, including avohilmo

2852

11133

1.30

33.42

1.4

25.93

26.74

iu/l

0.61

2401

9615

Other symptoms and signs involving the nervous and musculoskeletal systems

1644

12075

1.39

32.95

1.5

1.4

26.66

26.80

iu/l

0.06

1464

10304

Other disorders of urethra and urinary system

2978

16392

1.28

32.90

1.4

1.3

27.60

26.79

iu/l

0.64

2564

14207

Oxycodone

863

4757

1.57

32.89

1.5

1.4

28.41

33.28

iu/l

4.03

709

4132

Other sleep disorders

439

2399

1.90

32.83

1.5

1.4

21.53

26.42

iu/l

2.54

365

2028

Primary ovarian failure

204

867

2.83

32.75

2.2

1.3

46.20

26.32

iu/l

8.81

170

747

Malignant melanoma, including Hilmo

386

2013

1.96

32.71

1.3

27.70

31.30

iu/l

1.30

311

1761

Hypoplasia of dental enamel

280

4.61

32.65

3.9

2.6

7.00

5.80

iu/l

0.48

160

Gingivitis and periodontal diseases

3677

15305

1.25

32.56

1.4

26.83

26.23

iu/l

0.48

3116

13088

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1436

9043

1.43

32.51

1.6

1.5

12.21

15.35

iu/l

6.82

1147

7493

Persons encountering health services in other circumstances

1625

11806

1.39

32.48

1.5

1.4

22.35

24.59

iu/l

1.98

1303

10150

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

149

514

2.96

32.45

1.8

1.3

32.49

27.60

iu/l

0.75

107

427

Secondary and unspecified malignant neoplasm of lymph nodes

200

808

2.56

32.28

1.7

1.4

25.72

25.38

iu/l

0.04

151

688

Other functional intestinal disorders

1576

10441

1.39

32.25

1.5

1.4

26.08

27.83

iu/l

1.28

1328

8877

ILD medications: prednisolone, methylprednisolone, prednisone

4450

20403

1.23

32.06

1.4

25.68

25.11

iu/l

0.54

3825

17359

Hard cardiovascular diseases

1600

12859

0.73

32.02

1.4

32.45

33.55

iu/l

0.61

1351

11037

Nerve, nerve root and plexus disorders

4146

20425

1.23

31.97

1.4

26.94

26.37

iu/l

0.52

3618

17542

Persistent mood disorders

747

4749

1.62

31.88

1.5

1.4

22.47

26.60

iu/l

3.11

586

4098

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3113

22762

1.27

31.84

1.5

1.4

23.86

25.05

iu/l

1.24

2614

19434

Extrapyramidal and movement disorders

968

6495

1.52

31.61

1.4

27.02

29.99

iu/l

2.00

826

5583

Restless leg syndrome

553

3273

1.75

31.55

1.5

1.4

25.89

29.11

iu/l

1.46

471

2826

Disorders of skin appendages

2310

17845

1.31

31.53

1.4

21.73

24.50

iu/l

4.48

1964

15238

Non-invasive ventilation

1026

6022

1.51

31.20

1.5

1.3

28.70

29.96

iu/l

0.57

974

5284

Other/unspecified dorsalgia

1453

10429

1.40

30.99

1.4

26.21

27.45

iu/l

0.74

1230

8987

Bipolar affective disorders

987

6730

1.52

30.96

1.4

1.3

20.80

23.99

iu/l

2.73

785

5841

Malignant melanoma of skin, including Hilmo

331

1671

2.03

30.91

1.4

1.3

28.10

30.97

iu/l

0.81

269

1459

Complications of surgical and medical care, not elsewhere classified

3885

21241

1.23

30.79

1.5

1.4

26.80

26.33

iu/l

0.38

3329

18243

Disorders of tooth development and eruption

767

4004

1.61

30.66

1.4

20.47

23.22

iu/l

1.61

618

3500

Outcome of delivery

1419

6333

1.45

30.65

1.4

27.08

30.39

iu/l

2.98

1155

5412

Visual disturbances and blindness

1779

13368

1.35

30.26

1.5

1.4

26.04

26.57

iu/l

0.27

1480

11427

Visual disturbances

1700

12717

1.36

30.13

1.5

1.4

26.08

26.59

iu/l

0.25

1419

10881

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1914

14035

1.34

30.01

1.4

24.91

28.08

iu/l

4.28

1655

11985

Candidiasis, including avohilmo

1380

10035

1.41

29.91

1.4

25.21

24.12

iu/l

0.57

1118

8628

Other eating disorders

390

2150

1.97

29.88

1.6

1.4

13.70

17.62

iu/l

2.56

319

1784

Panic disorder

897

6059

1.54

29.83

1.5

1.4

19.63

21.83

iu/l

1.33

705

5224

Post-traumatic stress disorder

651

4122

1.68

29.81

1.5

1.4

16.25

20.60

iu/l

4.47

544

3534

Gastrointestinal diseases

2958

11790

1.28

29.79

1.5

1.4

21.92

24.40

iu/l

4.03

2508

10023

Malignant melanoma

339

1752

1.98

29.58

1.3

25.44

31.12

iu/l

2.70

270

1532

195

839

2.65

29.51

1.5

1.3

20.56

17.77

iu/l

0.64

177

718

ILD medications

4615

20752

1.21

29.38

1.5

1.4

24.67

24.84

iu/l

0.13

3925

17615

Secondary uncertain malignant neoplasm

242

1107

2.23

29.22

1.7

1.4

27.60

26.41

iu/l

0.20

185

945

Persons encountering health services for specific procedures, not carried out

385

2103

1.92

29.16

1.5

1.4

24.02

23.00

iu/l

0.21

265

1775

Clear cell adenocarcinoma of kidney

213

4.03

28.99

1.5

1.3

31.82

28.30

iu/l

0.31

180

Symptoms and signs involving the skin and subcutaneous tissue

2872

21819

1.26

28.62

1.4

26.30

26.69

iu/l

0.26

2492

18706

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1479

10830

1.38

28.45

1.4

1.3

20.76

24.17

iu/l

4.47

1211

9493

Other inflammation of eyelid, including avohilmo

2295

18065

1.30

28.45

1.4

25.13

25.30

iu/l

0.09

1947

15496

Disturbances of skin sensation

1419

10468

1.39

28.40

1.4

24.98

26.19

iu/l

0.73

1231

9019

Cardiovascular diseases (excluding rheumatic etc)

3835

18116

1.23

28.38

1.4

23.44

23.63

iu/l

0.13

3245

15470

Caries of dentine

664

4059

1.61

28.15

1.6

1.4

22.27

25.43

iu/l

1.77

518

3513

Autoimmune diseases

4410

18652

1.21

28.15

1.4

23.27

24.90

iu/l

2.65

3746

15795

Oxicams

571

1929

1.71

28.09

1.3

1.4

22.31

26.61

iu/l

2.44

490

1653

Factors influencing health status and contact with health services

695

2167

1.63

28.00

1.5

1.3

21.60

28.70

iu/l

6.83

575

1851

Tonsillectomy and adenotomy

3533

20252

1.24

27.95

1.4

19.79

24.72

iu/l

19.45

3035

17233

Inflammatory bowel disease treatment related agents

4623

21523

1.20

27.73

1.4

25.27

25.07

iu/l

0.16

3959

18289

Rheumatism, unspecified

504

3015

1.73

27.66

1.4

1.3

32.71

36.13

iu/l

1.43

436

2621

ILD differential diagnosis

3194

12947

1.25

27.42

1.4

25.96

26.86

iu/l

0.77

2713

11053

COPD differential diagnosis

3194

12949

1.25

27.40

1.4

25.96

26.86

iu/l

0.78

2714

11054

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1826

13953

1.33

26.87

1.5

1.4

21.94

22.33

iu/l

0.21

1451

12002

Other pulmonary diagnosis

3201

13008

1.25

26.86

1.4

26.01

26.92

iu/l

0.79

2724

11105

Sleep disorders, other/unspecified

238

1148

2.26

26.70

1.6

1.4

22.36

23.76

iu/l

0.27

182

969

Sciatica+with lumbago

2050

14143

1.30

26.66

1.4

1.3

27.71

28.41

iu/l

0.43

1769

12259

Cervical polyps

380

2127

1.86

26.52

1.3

32.20

35.14

iu/l

0.87

348

1831

Complications of medical and surgical care

2766

20081

1.25

26.36

1.5

1.4

26.77

27.97

iu/l

1.12

2380

17352

Excluding asthma or asthma-COPD overlap

3193

13008

1.24

26.19

1.4

25.95

26.92

iu/l

0.87

2713

11105

Endocrine disorders, other/unspecified

113

388

3.25

26.16

1.9

1.3

21.47

25.14

iu/l

0.52

336

Other diseases of upper respiratory tract

3937

17033

1.22

26.16

1.4

24.74

26.09

iu/l

1.77

3367

14407

4422

18812

1.20

26.14

1.4

25.76

26.62

iu/l

0.95

3812

16028

Other disorders of lacrimal gland

1348

9969

1.38

26.03

1.5

1.4

29.18

29.71

iu/l

0.23

1130

8644

Malignant melanoma of skin

271

1357

2.05

26.02

1.4

1.3

25.61

30.95

iu/l

1.96

218

1184

Asthma-related pneumonia or sepsis

999

6986

1.45

25.98

1.5

1.4

23.64

27.48

iu/l

3.51

820

5918

Asthma, hospital admissions 3, pneumonia

999

6986

1.45

25.98

1.5

1.4

23.64

27.48

iu/l

3.51

820

5918

Acromegaly and pituitary gigantism

116

5.78

25.97

2.4

1.3

19.33

23.83

iu/l

0.44

100

Routine general health check-up of defined subpopulation

173

744

2.60

25.95

2.3

1.3

23.80

32.36

iu/l

2.42

136

633

Major coronary heart disease event

1253

10246

0.72

25.88

1.4

32.65

35.12

iu/l

1.64

1073

8744

Asthma-related pneumonia

996

6968

1.45

25.85

1.5

1.4

23.70

27.53

iu/l

3.47

817

5904

Other obstetric conditions, not elsewhere classified

3150

16410

1.26

25.82

1.4

19.31

24.54

iu/l

19.54

2733

14225

Maternal care for known or suspected abnormality of pelvic organs

2184

11703

1.31

25.77

1.3

1.4

24.03

28.00

iu/l

6.84

1926

10064

Other noninflammatory disorders of vagina

324

1744

1.94

25.71

1.4

1.3

24.25

28.70

iu/l

1.66

278

1470

Myalgia

1104

7950

1.42

25.48

1.4

25.85

27.01

iu/l

0.55

925

6829

Intestinal infectious diseases

3672

22710

1.21

25.47

1.5

1.4

21.66

25.50

iu/l

11.37

3079

19335

Tramadol

3036

14859

1.24

25.43

1.4

1.3

26.46

27.98

iu/l

1.70

2536

12958

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3102

16136

1.26

25.38

1.4

18.99

24.20

iu/l

19.44

2692

13990

Care involving use of rehabilitation procedures

2327

16655

1.27

25.34

1.5

1.4

26.96

28.56

iu/l

1.56

2001

14300

Hypertrophy of breast in women and men

1084

7823

1.44

25.29

1.4

28.16

31.06

iu/l

2.13

943

6804

Endometriosis of intestine

147

600

2.83

25.15

1.4

1.3

17.76

19.31

iu/l

0.26

132

511

Mouth breathing

1128

8157

1.40

24.61

1.5

1.4

22.23

28.56

iu/l

10.39

947

6860

Enlarged lymph nodes

552

3475

1.63

24.59

1.5

1.4

26.79

26.93

iu/l

0.03

447

2949

Functional dyspepsia

1039

7450

1.43

24.41

1.4

26.63

28.91

iu/l

1.42

901

6419

False labour

2508

12599

1.28

24.40

1.4

24.70

28.26

iu/l

6.41

2252

10797

Disorders of lacrimal system

1598

12020

1.33

24.39

1.5

1.4

28.62

29.49

iu/l

0.47

1352

10416

Ischemic heart diseases

1427

11270

0.75

24.15

1.4

32.20

34.60

iu/l

1.76

1211

9643

Oral corticosteroids

4187

20701

1.20

24.12

1.4

26.41

25.69

iu/l

0.73

3612

17695

Persons with potential health hazards related to communicable diseases

2105

16605

1.28

24.09

1.5

1.4

20.09

21.75

iu/l

1.85

1805

14055

Other intervertebral disc disorders

3151

15461

1.23

23.73

1.4

1.3

28.35

26.96

iu/l

1.49

2734

13327

Monoamine oxidase A inhibitors

351

1980

1.83

23.65

1.5

1.3

24.99

32.09

iu/l

3.94

290

1723

Abnormalities of heart beat

1303

9421

1.36

23.64

1.4

23.96

26.85

iu/l

2.63

1127

8132

Sequelae with surgical and medical care as external cause

542

3428

1.62

23.53

1.5

1.4

26.89

28.82

iu/l

0.71

454

2932

Postprocedural endocrine and metabolic disorders, not elsewhere classified

626

4128

1.58

23.37

1.8

1.4

31.24

28.78

iu/l

0.96

511

3595

Emergency coronary revascularization (for ACS)

1202

9820

0.73

23.26

1.4

32.86

35.18

iu/l

1.42

1033

8366

Voice disturbances

985

7062

1.43

23.22

1.4

28.65

30.50

iu/l

0.98

843

6119

Lymphoid leukaemia

117

428

2.83

23.20

3.0

1.6

13.23

19.39

iu/l

2.18

342

Disorders of puberty, other/unspecified

6.92

23.13

3.7

1.9

10.31

14.63

iu/l

0.49

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2778

13338

1.25

23.11

1.3

1.4

28.42

29.23

iu/l

0.59

2444

11418

Non-small cell lung cancer, squamous

5.95

23.09

1.2

20.29

26.90

iu/l

0.58

Antenatal screening

1626

7009

1.34

23.04

1.3

1.4

31.14

31.00

iu/l

0.05

1418

5985

Other metabolic disorders

654

4371

1.55

22.86

1.8

1.4

30.72

28.65

iu/l

0.78

534

3795

Diabetes insipidus

159

4.51

22.71

2.4

1.3

14.38

22.21

iu/l

1.10

130

Diseases of the musculoskeletal system and connective tissue

2563

10379

1.25

22.69

1.4

20.79

22.89

iu/l

2.74

2149

8698

Symptoms and signs concerning food and fluid intake

314

1730

1.86

22.66

1.8

1.4

21.79

24.66

iu/l

0.84

273

1436

Coronary revascularization (ANGIO or CABG)

1182

9688

0.73

22.55

1.4

32.86

35.31

iu/l

1.53

1016

8258

Certain infectious and parasitic diseases

4053

17150

1.20

22.40

1.5

1.4

24.29

25.85

iu/l

2.28

3427

14732

Percutaneous Coronary Intervention

1181

9672

0.74

22.23

1.4

32.91

35.33

iu/l

1.50

1014

8244

Endometriosis ASRM stages 1,2

1189

8927

1.39

22.20

1.3

25.60

26.80

iu/l

0.62

1063

7766

Implicit viral Sepsis, including avohilmo

784

5416

1.47

22.04

1.5

1.4

24.26

26.41

iu/l

1.02

635

4571

Other diseases of blood and blood-forming organs, wide

635

4226

1.54

22.02

1.6

1.4

26.98

28.49

iu/l

0.52

526

3583

Precocious central puberty

143

4.91

21.96

3.5

1.5

11.15

13.56

iu/l

0.36

113

Diarrhoea and gastroenteritis of presumed infectious origin

2813

20726

1.23

21.92

1.5

1.4

21.66

24.16

iu/l

4.23

2381

17639

Somatoform disorder

732

5047

1.50

21.76

1.5

1.3

24.77

28.23

iu/l

2.16

617

4392

Non-Hodgkin lymphoma, all, including Hilmo

201

962

2.13

21.75

1.7

1.3

27.65

28.89

iu/l

0.19

163

822

Impotence

219

3.50

21.72

1.5

10.34

9.07

iu/l

0.27

179

Cervicalgia

722

4954

1.49

21.61

1.4

27.42

29.77

iu/l

1.12

616

4270

Diseases of the skin and subcutaneous tissue

3853

16311

1.20

21.57

1.4

24.15

25.97

iu/l

2.81

3267

13902

Covid-19 confirmed case

1092

8032

1.38

21.52

1.4

23.15

24.78

iu/l

0.92

905

6862

Symptoms and signs involving speech and voice

1105

8168

1.38

21.47

1.4

28.35

29.88

iu/l

0.82

945

7067

Diseases of oral cavity, salivary glands and jaws

1512

5922

1.33

21.42

1.4

1.3

26.57

27.66

iu/l

0.58

1268

5175

Erosion of teeth , including avohilmo

1369

10489

1.34

21.31

1.5

1.4

22.69

23.33

iu/l

0.32

1118

8970

Ovarian hyperstimulation (induction)

190

944

2.37

21.27

1.3

11.13

22.92

iu/l

11.73

166

814

Polyuria

488

3087

1.61

21.08

1.5

1.4

23.06

27.79

iu/l

2.41

405

2621

Diseases of the eye and adnexa

3759

15908

1.20

21.04

1.4

24.37

23.88

iu/l

0.39

3135

13582

Other medical care

1168

7301

1.36

20.68

1.7

1.4

27.43

28.32

iu/l

0.40

964

6212

Acne, including avohilmo

1414

8824

1.33

20.66

1.5

1.4

13.52

14.85

iu/l

1.36

1135

7383

Psychotic depression

229

1182

2.02

20.65

1.5

1.3

25.37

27.32

iu/l

0.35

187

1032

Sequelae of external causes of morbidity and mortality

720

4979

1.47

20.57

1.5

1.4

26.89

28.29

iu/l

0.54

598

4251

COPD/asthma/ILD related infections

4104

17519

1.18

20.48

1.4

25.77

26.63

iu/l

0.88

3520

14929

COPD/asthma related infections

4104

17519

1.18

20.48

1.4

25.77

26.63

iu/l

0.88

3520

14929

Supervision of normal pregnancy

1561

6939

1.33

20.46

1.3

1.4

31.18

31.10

iu/l

0.03

1365

5925

Disorders of pituitary gland, other and/or unspecified

5.60

20.42

2.1

1.2

23.42

26.92

iu/l

0.26

Abrasion of teeth

1425

11024

1.32

20.33

1.4

30.96

30.34

iu/l

0.26

1198

9563

Asthma and allergy

792

5554

1.46

20.24

1.5

1.4

20.55

23.31

iu/l

1.79

674

4704

Allergic asthma (mode)

1213

8975

1.35

20.18

1.5

1.4

21.47

24.55

iu/l

3.04

1038

7624

Congenital malformations, deformations and chromosomal abnormalities

2789

22031

1.22

20.14

1.5

1.4

23.99

24.39

iu/l

0.26

2342

18770

Appendectomy

2794

22156

1.22

20.10

1.4

25.26

26.27

iu/l

0.93

2401

19045

Persons encountering health services for specific procedures and health care

4349

22053

1.17

20.10

1.5

1.4

27.09

25.07

iu/l

3.51

3669

18830

899

6624

1.45

20.08

1.4

1.3

23.46

22.08

iu/l

0.61

694

5778

Herpesviral [herpes simplex] infections, including avohilmo

1339

10319

1.33

20.06

1.4

25.22

25.44

iu/l

0.09

1111

8910

Precocious puberty

109

5.34

20.01

3.4

1.8

7.26

8.60

iu/l

0.27

Allergic asthma (mode), excluding more controls

1212

8978

1.35

19.99

1.5

1.4

21.48

24.57

iu/l

3.05

1037

7627

Deviated nasal septum

797

5632

1.43

19.95

1.4

24.85

27.64

iu/l

1.80

685

4765

Asthma and allergy, excluding more controls

791

5563

1.45

19.94

1.5

1.4

20.57

23.35

iu/l

1.80

673

4715

Drug-induced adrenocortical insufficiency

101

381

2.92

19.73

1.7

1.4

30.35

27.94

iu/l

0.28

328

Hypertrophy of breast

1027

7669

1.39

19.69

1.4

1.3

29.17

31.43

iu/l

1.36

897

6686

Inflammatory disease of uterus

927

6835

1.41

19.51

1.4

1.3

22.62

25.48

iu/l

2.04

780

5943

Mixed and other personality disorders

412

2590

1.67

19.26

1.5

1.4

19.74

24.62

iu/l

2.78

323

2244

Arthropathies

4045

17503

1.18

19.19

1.4

22.53

23.82

iu/l

1.77

3473

14755

Dysphagia

602

4080

1.50

18.99

1.5

1.4

27.54

31.34

iu/l

2.06

514

3491

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

146

663

2.37

18.96

1.5

1.3

31.22

28.53

iu/l

0.37

127

571

Persons encountering health services for examination and investigation

2292

9344

1.24

18.96

1.4

1.3

23.83

26.40

iu/l

3.21

1941

7859

Asthma, unspecified (mode)

2080

12168

1.25

18.89

1.4

25.26

27.81

iu/l

3.07

1727

10452

Bulimia nervosa (incl. atypical)

278

1606

1.89

18.78

1.5

1.3

17.84

19.20

iu/l

0.32

217

1350

Oedema, not elsewhere classified

900

6416

1.39

18.73

1.5

1.3

28.14

29.24

iu/l

0.45

773

5551

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

8.25

18.70

2.9

1.6

25.70

6.89

iu/l

3.56

Other disorders of male genital organs

239

3.19

18.37

2.1

1.7

11.38

7.91

iu/l

1.21

184

Central nervous system disorder causing precocious puberty

6.91

18.34

4.2

2.2

6.31

6.73

iu/l

0.14

Brachial plexus disorders

527

3552

1.55

18.13

1.4

1.3

28.45

28.90

iu/l

0.11

454

3069

Oter anti-inflammatory and antirheumatic agents, non-steroids

410

1380

1.65

18.08

1.4

1.3

30.07

33.13

iu/l

0.97

358

1207

Other specified and unspecified personality disorders

434

2803

1.61

18.01

1.4

21.35

24.09

iu/l

1.00

318

2417

Asthma, unspecified (mode), excluding more controls

2077

12111

1.24

17.98

1.4

25.27

27.78

iu/l

2.99

1724

10403

Exposure to unspecified factor

3923

22985

1.17

17.94

1.4

24.47

25.41

iu/l

1.01

3204

19690

Diaphragmatic hernia

758

5417

1.42

17.93

1.4

30.35

33.86

iu/l

2.05

641

4660

Disorders of breast

2633

19441

1.21

17.89

1.4

1.3

28.85

28.42

iu/l

0.26

2307

16926

Personal history of other diseases and conditions

722

5157

1.45

17.84

1.6

1.4

21.12

21.86

iu/l

0.27

562

4355

Cervicocranial syndrome

410

2610

1.62

17.77

1.5

1.4

25.17

30.04

iu/l

2.29

353

2248

Other disorders starting during childhood or adolecense, excluding more controls

249

1329

1.88

17.72

1.8

1.5

9.21

11.26

iu/l

1.07

186

1046

Undetermined asthma

464

3038

1.56

17.54

1.5

1.4

24.79

29.04

iu/l

2.23

395

2588

Contact with and exposure to communicable diseases

1823

14760

1.26

17.53

1.4

20.18

21.27

iu/l

0.89

1599

12515

Benign neoplasm of meninges

277

1598

1.78

17.44

1.6

1.4

30.90

34.35

iu/l

0.93

246

1384

Undetermined asthma, excluding more controls

464

3044

1.56

17.39

1.5

1.4

24.79

29.05

iu/l

2.23

395

2591

Other bacterial intestinal infections, including avohilmo

703

4999

1.43

17.35

1.4

26.05

27.05

iu/l

0.32

562

4263

Viral Sepsis

483

3196

1.54

17.19

1.5

1.4

23.48

25.07

iu/l

0.48

389

2675

Other and unspecified mood [affective] disorders

400

2573

1.63

17.03

1.5

1.4

16.88

20.66

iu/l

2.12

317

2181

Implicit viral Sepsis

481

3188

1.53

17.00

1.5

1.4

23.56

25.05

iu/l

0.44

387

2669

Anogenital herpesviral [herpes simplex] infection, including avohilmo

742

5401

1.43

16.98

1.4

21.86

20.41

iu/l

0.61

617

4613

Other inflammation of eyelid

462

3053

1.55

16.84

1.4

28.32

29.38

iu/l

0.26

383

2594

Artificial joint operation, meniscal resection

1659

13183

0.80

16.81

1.3

1.4

29.87

32.67

iu/l

2.97

1461

11294

Subjective visual disturbances

897

6689

1.37

16.69

1.4

26.79

26.98

iu/l

0.06

750

5736

Phobic anxiety disorders

744

5403

1.42

16.60

1.5

1.4

19.46

20.72

iu/l

0.54

578

4593

Acute sinusitis

2409

18332

1.21

16.56

1.4

23.66

26.02

iu/l

3.36

2088

15646

Diseases of the respiratory system

2505

10453

1.21

16.46

1.4

25.85

26.91

iu/l

0.85

2134

8861

Cervicobrachial syndrome

865

6434

1.37

16.44

1.4

1.3

27.12

31.03

iu/l

2.97

759

5567

Fissure and fistula of anal and rectal regions

772

5633

1.39

16.42

1.4

26.86

28.59

iu/l

0.76

662

4817

Constitutional tall stature

100

4.90

16.28

2.8

1.6

6.16

8.58

iu/l

0.43

Cluster headache, wide

195

1044

1.98

16.24

1.6

1.4

26.78

26.86

iu/l

0.01

164

908

Autoimmune diseases related-to ILD

3200

22900

1.18

16.20

1.4

26.68

25.52

iu/l

1.18

2730

19569

Disorders of choroid and retina

1297

11537

0.78

16.17

1.4

30.38

29.98

iu/l

0.15

1103

9870

Dental operations

1569

6402

1.27

16.15

1.4

1.3

27.65

28.43

iu/l

0.38

1336

5487

Cervical disc disorders

986

7481

1.34

16.07

1.5

1.3

30.72

32.74

iu/l

1.09

860

6483

Other disorders of ear

2292

17720

0.83

16.01

1.4

28.96

29.14

iu/l

0.09

1956

15184

Brain meningioma

144

694

2.16

15.78

1.7

1.3

29.11

33.15

iu/l

0.75

131

606

Speech and linguistic disorders, excluding more controls

341

2004

1.65

15.76

2.0

1.5

11.17

14.21

iu/l

1.53

245

1605

Benign neoplasm: Cerebral meninges

253

1467

1.77

15.72

1.6

1.4

30.92

34.40

iu/l

0.91

223

1276

L01XE Protein kinase inhibitors

119

532

2.32

15.65

1.6

1.4

27.04

32.23

iu/l

0.87

457

Sexual dysfunction

312

2.82

15.61

1.6

1.4

14.71

21.04

iu/l

1.26

264

Drug-induced polyneuropathy

4.56

15.61

3.6

2.2

12.30

23.81

iu/l

1.77

Diseases of the ear and mastoid process

4722

20805

1.15

15.56

1.4

24.63

25.55

iu/l

1.13

4020

17749

Cluster headache, strict

188

1011

1.97

15.52

1.6

1.4

26.46

26.37

iu/l

0.01

158

878

Brain meningioma, including Hilmo

146

714

2.12

15.39

1.7

1.3

29.18

32.91

iu/l

0.68

133

621

Type 2 diabetes, wide definition

1485

11656

0.80

15.36

1.4

24.44

33.33

iu/l

24.13

1205

10112

Thyrotoxicosis, other and/or unspecified

800

5954

1.37

15.27

1.4

1.3

28.95

28.54

iu/l

0.13

677

5157

Non-small cell lung cancer, squamous, helper endpoint

101

4.12

15.18

1.2

1.3

20.29

26.09

iu/l

0.57

Benign paroxysmal vertigo

780

5775

1.37

15.10

1.4

28.75

32.16

iu/l

2.04

660

4993

Torsion of ovary, ovarian pedicle and fallopian tube

128

609

2.27

15.01

1.3

25.08

24.65

iu/l

0.05

112

525

Undescended testicle

161

3.62

14.99

3.1

2.3

12.78

6.34

iu/l

1.46

Endometriosis ASRM stages 3,4

1228

9746

1.29

14.95

1.3

27.04

26.73

iu/l

0.12

1088

8474

Any operation in hilmo

121

265

2.39

14.83

1.5

1.2

17.49

23.36

iu/l

1.10

220

Renal tubulo-interstitial diseases

2362

20466

0.84

14.76

1.5

1.4

26.91

25.96

iu/l

0.66

1962

17578

Vasomotor and allergic rhinitis

1789

14426

1.23

14.65

1.4

22.00

25.53

iu/l

5.24

1531

12200

Cough

1360

10146

1.27

14.63

1.5

1.4

24.95

28.54

iu/l

3.69

1151

8654

Cluster headache, wide,, including avohilmo

270

1642

1.73

14.63

1.5

1.4

25.15

25.00

iu/l

0.03

230

1405

Disorders of vestibular function (Vertigo)

1257

9699

1.28

14.63

1.4

28.85

31.50

iu/l

2.04

1054

8398

Infections with a predominantly sexual mode of transmission, including avohilmo

2307

17851

1.20

14.53

1.4

20.90

22.06

iu/l

1.03

1889

15324

Cushing syndrome

241

3.10

14.51

2.3

1.3

21.96

24.88

iu/l

0.32

203

Granulosa cell carcinoma of ovary

4.93

14.49

2.5

1.3

30.33

25.39

iu/l

0.47

Ovarian dysfunction, other/unspecified

220

3.47

14.46

2.1

1.3

31.68

20.17

iu/l

1.62

191

Other congenital malformations

432

2928

1.53

14.43

1.8

1.5

19.91

22.92

iu/l

1.20

347

2399

Convulsions, not elsewhere classified

717

5212

1.38

14.41

1.5

1.4

21.23

22.19

iu/l

0.35

557

4364

Malignant neoplasm of bladder, including Hilmo

270

2.73

14.30

1.4

1.3

32.29

23.35

iu/l

1.38

224

Other enthesopathies

1106

8671

1.30

14.30

1.4

1.3

30.33

32.11

iu/l

1.03

975

7489

Abnormal involuntary movements

405

2698

1.54

14.28

1.5

1.4

25.32

26.57

iu/l

0.32

344

2288

Other viral diseases, including avohilmo

1885

15542

1.22

14.17

1.5

1.4

21.90

23.33

iu/l

1.25

1594

13191

Other viral diseases, not elsewhere classified, including avohilmo

1305

10405

1.27

14.16

1.5

1.4

22.71

24.26

iu/l

1.03

1116

8811

Cluster headache, strict, including avohilmo

263

1604

1.73

14.15

1.5

1.4

24.89

24.63

iu/l

0.04

224

1375

Hernia

2445

19104

0.84

14.08

1.4

24.49

28.39

iu/l

8.14

2079

16380

Other diseases of lip and oral mucosa

1383

11148

1.26

14.07

1.5

1.4

26.95

28.48

iu/l

0.99

1177

9559

Other disorders of eye and adnexa

588

4231

1.43

14.00

1.5

1.4

29.72

25.75

iu/l

1.64

474

3598

Asthma/COPD (KELA code 203)

3686

21520

1.15

13.99

1.4

25.08

25.40

iu/l

0.25

3171

18329

Polyarthropathies

1897

14621

0.83

13.86

1.4

28.05

26.69

iu/l

0.98

1626

12493

Other congenital malformations, including avohilmo

627

4577

1.41

13.83

1.6

1.5

20.58

23.74

iu/l

1.72

507

3817

Emotional disorders starting during childhood or adolecense, excluding more controls

231

1321

1.77

13.81

1.8

1.5

7.69

10.41

iu/l

2.82

180

1049

Congenital malformations and deformations of the musculoskeletal system

438

2990

1.51

13.74

1.8

1.6

20.99

20.24

iu/l

0.20

348

2426

Other bacterial diseases, including avohilmo

2968

21425

0.86

13.72

1.6

1.4

26.60

26.83

iu/l

0.14

2444

18379

Pruritus

463

3203

1.49

13.72

1.5

1.4

21.56

26.96

iu/l

3.62

393

2743

Anti-inflammatory and antirheumatic products, non-steroids

785

2918

1.37

13.69

1.5

1.6

18.64

20.91

iu/l

1.23

646

2364

Lumbar disc prolapse

2331

14614

1.19

13.67

1.4

1.3

28.28

27.91

iu/l

0.21

2020

12637

Other and unspecified effects of external causes

1225

9811

1.27

13.48

1.4

21.71

23.72

iu/l

1.51

1037

8331

Propionic acid derivatives

783

2917

1.36

13.48

1.4

1.6

18.49

20.91

iu/l

1.38

652

2364

Anankastic personality disorder

224

1331

1.79

13.43

1.4

23.59

23.32

iu/l

0.04

189

1145

Postprocedural disorders of nervous system

439

3044

1.51

13.41

1.5

1.4

26.06

24.52

iu/l

0.44

391

2607

Disorders of lens

919

7390

0.77

13.40

1.4

36.71

35.97

iu/l

0.25

759

6355

Diseases of salivary glands

1144

9084

1.28

13.39

1.4

26.86

27.74

iu/l

0.39

977

7798

Faecal incontinence

224

1313

1.75

13.39

1.4

31.90

34.86

iu/l

0.62

189

1140

Thyroiditis, ILD-related definition

533

3817

1.44

13.22

1.5

1.4

25.18

26.61

iu/l

0.44

441

3269

Conductive and sensorineural hearing loss

1358

11133

0.80

13.17

1.5

1.4

30.46

31.56

iu/l

0.57

1163

9522

Non-allergic asthma (mode)

565

4029

1.41

13.12

1.5

1.4

23.33

27.47

iu/l

2.53

470

3388

Adverse effects, not elsewhere classified

904

7012

1.32

13.08

1.4

22.54

24.64

iu/l

1.23

770

5962

Urticaria and erythema

1611

13317

1.23

13.08

1.4

23.79

25.84

iu/l

1.90

1385

11377

Malignant neoplasm of bladder

108

3.73

13.05

1.2

1.3

35.93

24.33

iu/l

1.06

Non-allergic asthma (mode), excluding more controls

565

4033

1.41

13.05

1.5

1.4

23.33

27.51

iu/l

2.57

470

3390

Other CVD

262

1606

1.65

12.99

1.4

27.60

29.76

iu/l

0.47

223

1364

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

534

3816

1.43

12.97

1.7

1.5

20.73

21.27

iu/l

0.16

431

3131

Postviral fatigue syndrome

393

2.66

12.95

1.7

1.4

22.02

21.77

iu/l

0.03

342

Dermatographic urticaria

357

2388

1.56

12.91

1.4

21.95

25.83

iu/l

1.73

296

2050

Disorders of synovium and tendon

2067

14810

1.20

12.75

1.4

1.3

27.58

26.98

iu/l

0.36

1812

12747

Pain in throat and chest

3414

17667

1.15

12.73

1.4

27.28

25.76

iu/l

1.75

2854

15099

Other bacterial diseases

2285

17738

0.85

12.68

1.6

1.4

26.22

28.33

iu/l

2.42

1853

15206

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

269

1672

1.63

12.68

1.5

1.3

38.05

32.52

iu/l

1.59

231

1447

Other diseases of liver

563

4082

1.41

12.66

1.4

29.18

30.66

iu/l

0.52

477

3502

Disorders of ocular muscles, binocular movement, accommodation and refraction

2085

17530

1.19

12.64

1.5

1.4

25.10

25.34

iu/l

0.11

1712

14966

Hernia of abdominal wall, postoperative

503

3548

1.43

12.60

1.4

1.3

20.44

30.77

iu/l

14.56

418

3053

Maternal care for other conditions predominantly related to pregnancy

1601

13018

1.23

12.58

1.3

23.15

25.90

iu/l

2.98

1394

11233

Diabetes mellitus in pregnancy

2842

15724

1.18

12.56

1.3

20.70

27.32

iu/l

27.67

2479

13611

Other adrenocortical overactivity

136

3.77

12.55

2.1

1.6

14.78

16.16

iu/l

0.09

101

Radiculopathy

367

2458

1.52

12.53

1.4

29.74

32.31

iu/l

0.72

314

2117

Follow-up examination after treatment for malignant neoplasms

187

1060

1.79

12.50

1.5

1.3

39.92

36.47

iu/l

0.65

171

908

Chromosomal abnormalities, not elsewhere classified

135

706

2.08

12.44

2.5

1.7

17.01

17.53

iu/l

0.09

107

545

Viral hepatitis, IBD co-morbidity

221

1324

1.73

12.44

1.3

1.4

23.31

26.09

iu/l

0.61

159

1099

Gestational diabetes (for exclusion)

3083

18591

1.17

12.42

1.3

19.57

26.59

iu/l

36.32

2666

16154

Abnormalities of gait and mobility

211

1241

1.73

12.40

1.7

1.5

24.70

26.66

iu/l

0.38

160

1015

Recurrent aphthous stomatitis , including avohilmo

478

3386

1.44

12.38

1.6

1.4

25.39

24.57

iu/l

0.20

383

2846

Pain in thoracic spine

587

4310

1.39

12.32

1.5

1.4

26.88

29.00

iu/l

0.85

506

3688

Colonic or urogenital fistula

802

6153

1.32

12.32

1.4

26.78

28.16

iu/l

0.57

690

5263

Artrosis, including avohilmo

3282

15694

1.15

12.29

1.4

26.39

27.46

iu/l

1.07

2856

13555

Infections of the skin and subcutaneous tissue

2102

17580

1.19

12.24

1.5

1.4

21.88

24.39

iu/l

3.38

1765

14884

Dermatophytosis, including avohilmo

2305

19341

1.18

12.20

1.4

24.34

25.65

iu/l

1.17

1930

16532

Molar incisor enamel hypoplasia

227

1327

1.74

12.19

2.6

1.7

13.07

13.20

iu/l

0.02

158

1005

Need for other prophylactic measures

178

1009

1.83

12.19

1.7

1.6

19.45

25.48

iu/l

1.57

119

835

Deforming dorsopathies

881

6849

1.30

12.18

1.5

1.4

26.73

28.21

iu/l

0.69

763

5807

Dental caries, including avohilmo

2069

8918

1.20

12.13

1.4

26.49

27.10

iu/l

0.34

1731

7754

Agranulocytosis

317

2083

1.56

12.04

1.7

1.4

32.28

29.73

iu/l

0.58

267

1772

Visual field defects

213

1272

1.72

11.99

1.8

1.4

25.48

27.72

iu/l

0.42

167

1090

Haemorrhage in early pregnancy

1737

14219

1.21

11.91

1.3

24.97

27.75

iu/l

3.06

1506

12349

Soft tissue disorders related to use, overuse and pressure

718

5446

1.33

11.90

1.4

28.01

32.25

iu/l

3.01

611

4665

Diseases of pulp and periapical tissues, including avohilmo

3886

17772

1.14

11.88

1.4

23.62

24.59

iu/l

1.08

3243

15241

Atypical facial pain

215

1300

1.73

11.87

1.6

1.4

26.58

29.93

iu/l

0.77

183

1133

Periodontitis

2784

20382

0.86

11.85

1.4

31.34

27.27

iu/l

8.21

2346

17611

Melanocytic naevi

1263

10297

1.25

11.83

1.4

24.63

26.20

iu/l

0.97

1095

8839

Thyrotoxicosis

939

7404

1.29

11.82

1.4

29.76

28.85

iu/l

0.36

802

6391

Viral infections characterized by skin and mucous membrane lesions

1372

11254

1.23

11.80

1.5

1.4

23.10

25.28

iu/l

1.83

1158

9528

Hypoplasia of dental enamel , including avohilmo

218

1281

1.74

11.79

2.7

1.7

12.56

13.04

iu/l

0.08

154

968

Paracetamol or NSAID medication

535

1923

1.42

11.76

1.5

1.6

17.45

18.78

iu/l

0.47

433

1522

All kidney diseases

3017

23064

0.87

11.75

1.5

1.4

27.20

25.50

iu/l

1.90

2521

19771

Other noninflammatory disorders of uterus, except cervix

502

2384

1.42

11.74

1.4

1.3

30.83

37.84

iu/l

4.45

443

2060

Chronic periodontitis, including avohilmo

2776

20332

0.86

11.70

1.4

31.34

27.30

iu/l

8.07

2340

17571

Disorders of psychological development

525

3544

1.41

11.62

2.0

1.6

11.39

13.61

iu/l

1.45

393

2797

Biguanides

2682

18632

0.86

11.60

1.4

21.07

29.56

iu/l

48.20

2270

16159

Lack of expected normal physiological development

113

491

2.14

11.59

2.7

1.8

6.77

7.93

iu/l

0.49

345

Noninfective enteritis and colitis

1599

13331

1.21

11.57

1.5

1.4

24.41

25.37

iu/l

0.60

1392

11258

Viral and other specified intestinal infections, including avohilmo

1253

9840

1.24

11.55

1.5

1.4

16.76

19.15

iu/l

2.49

1032

8186

Non-Hodgkin lymphoma, all

138

3.24

11.53

1.7

1.4

29.51

25.95

iu/l

0.23

119

Urticaria

1379

11381

1.23

11.53

1.4

23.61

25.38

iu/l

1.34

1187

9708

Bilateral cryptorchidism (undescended testicles)

6.10

11.47

3.8

2.7

11.73

5.89

iu/l

0.73

Female infertility, uterine origin

125

3.87

11.42

1.2

1.3

16.57

25.41

iu/l

1.19

107

Nonalcoholic fatty liver disease

344

2330

1.52

11.42

1.4

27.80

29.78

iu/l

0.59

285

2003

Cerebral cysts

240

1507

1.65

11.39

1.7

1.4

18.89

22.14

iu/l

1.04

209

1268

Diseases of inner ear

1414

11165

1.22

11.34

1.4

29.51

30.98

iu/l

0.89

1194

9641

Varicose veins

1128

10527

0.80

11.31

1.3

35.28

35.90

iu/l

0.23

994

9189

Hypotension

185

1075

1.74

11.28

1.4

26.26

27.62

iu/l

0.21

158

909

Trochanteric bursitis

442

3139

1.43

11.28

1.4

1.3

29.47

35.69

iu/l

3.78

370

2706

Zoster [herpes zoster], including avohilmo

1341

10634

1.23

11.26

1.5

1.4

28.84

29.31

iu/l

0.20

1160

9115

Iron deficiency

224

1403

1.71

11.25

1.5

1.4

13.83

19.55

iu/l

2.86

195

1186

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1479

12330

1.22

11.24

1.4

20.76

23.08

iu/l

2.37

1211

10603

Viral warts, including avohilmo

898

7092

1.29

11.23

1.4

23.11

23.42

iu/l

0.10

764

5964

Other complications of surgical and medical care, not elsewhere classified

344

2339

1.51

11.21

1.4

23.18

28.13

iu/l

2.45

292

1997

Scar conditions and fibrosis of skin

200

1210

1.74

11.16

1.6

1.4

23.42

26.65

iu/l

0.79

162

1034

Malignant neoplasm of breast, HER2-negative, including Hilmo

1957

10654

1.19

11.16

1.5

1.3

41.63

34.46

iu/l

14.97

1627

9458

Malignant neoplasm of breast, including Hilmo

1957

10653

1.19

11.16

1.5

1.3

41.64

34.46

iu/l

15.04

1627

9457

Caries of dentine, including avohilmo

2399

10530

1.17

11.15

1.4

26.25

26.44

iu/l

0.09

2007

9083

Diabetic retinopathy, excluding more controls

363

2946

0.68

11.14

1.3

1.4

24.61

21.24

iu/l

1.08

301

2496

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

160

900

1.82

11.13

2.2

1.4

23.18

25.24

iu/l

0.37

132

760

Crossbite

312

1920

1.55

11.07

2.0

1.8

17.82

17.99

iu/l

0.03

235

1501

Tinnitus

632

4770

1.34

10.95

1.4

30.96

30.73

iu/l

0.05

544

4104

Single delivery by caesarean section

1320

6209

1.25

10.93

1.3

1.4

24.93

24.66

iu/l

0.11

1170

5128

Weight loss

244

1545

1.61

10.90

1.7

1.5

22.98

25.59

iu/l

0.62

212

1283

External causes of morbidity and mortality

2752

11995

1.16

10.90

1.4

23.88

25.64

iu/l

2.07

2338

10271

Injuries to the ankle and foot

3108

23404

1.14

10.88

1.4

22.79

25.43

iu/l

4.98

2642

19927

Maternal care for known or suspected fetal abnormality and damage

1325

9332

1.24

10.85

1.4

23.01

24.96

iu/l

1.42

1115

7983

Other disorders of breast

679

5216

1.34

10.83

1.4

1.3

27.48

28.40

iu/l

0.29

601

4517

Other and unspecified nerve root and plexus disorders, also in other diseases

677

5176

1.33

10.80

1.4

28.72

29.84

iu/l

0.38

602

4464

Malignant neoplasm of breast, HER2-negative

1869

10235

1.19

10.79

1.5

1.3

41.84

34.89

iu/l

13.81

1560

9087

Malignant neoplasm of breast

1874

10263

1.19

10.79

1.5

1.3

41.94

34.88

iu/l

14.14

1564

9111

Carpal tunnel syndrome

2152

16031

1.17

10.78

1.4

1.3

28.60

30.43

iu/l

1.90

1918

13910

Haemorrhoids and perianal venous thrombosis

792

6128

1.30

10.70

1.3

24.84

28.83

iu/l

3.16

690

5261

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3031

22867

0.88

10.62

1.5

1.4

24.67

25.95

iu/l

1.36

2511

19560

Melanocytic naevi of trunk

451

3257

1.42

10.62

1.5

1.4

24.20

25.86

iu/l

0.53

390

2775

Neuralgia and neuritis, unspecified

191

1152

1.72

10.60

1.6

1.4

24.87

28.40

iu/l

0.84

165

990

Other external causes of accidental injury

3300

14583

1.14

10.59

1.4

24.63

25.79

iu/l

1.22

2820

12507

Obsessive-compulsive disorder

375

2635

1.47

10.56

1.5

1.4

16.55

17.77

iu/l

0.39

307

2227

Disorders of refraction and accommodation

1256

10324

1.23

10.54

1.5

1.4

24.01

25.50

iu/l

0.87

1027

8773

Mental disorders, not otherwise specified

401

2853

1.45

10.53

1.5

1.4

23.83

23.04

iu/l

0.19

327

2443

Motor disorders, excluding more controls

311

2.43

10.48

3.1

2.1

5.98

6.38

iu/l

0.19

204

Diabetic retinopathy

383

3374

0.70

10.48

1.3

1.4

24.84

21.48

iu/l

1.14

319

2837

Other diseases of anus and rectum

710

5454

1.31

10.45

1.5

1.4

24.99

29.73

iu/l

3.70

605

4644

Specific development disorders of scholastic skills

232

1453

1.64

10.37

2.2

1.7

10.18

13.36

iu/l

1.68

162

1119

Atrophic disorders of skin

545

4068

1.37

10.37

1.5

1.4

26.72

30.85

iu/l

2.20

452

3503

Ectopic pregnancy

887

7089

1.28

10.36

1.3

26.73

29.73

iu/l

2.12

780

6184

Other disorders of bladder

199

1212

1.67

10.33

1.5

1.4

20.96

26.66

iu/l

1.96

167

1035

Plantar fascial fibromatosis

384

2713

1.45

10.31

1.4

1.3

31.03

33.90

iu/l

0.90

330

2353

Deep endometriosis

506

3763

1.39

10.30

1.4

22.53

24.04

iu/l

0.53

448

3263

Medical abortion

3130

14964

1.14

10.27

1.4

1.3

26.44

26.90

iu/l

0.33

2674

12998

Agoraphobia

192

1180

1.72

10.26

1.5

1.4

19.64

21.86

iu/l

0.43

138

1009

Thyrotoxicosis with diffuse goitre

623

4760

1.34

10.25

1.4

1.3

28.55

29.29

iu/l

0.22

536

4147

Other symptoms and signs involving the urinary system

219

1371

1.63

10.25

1.5

21.85

25.21

iu/l

0.93

187

1161

Other inflammation of vagina/vulva

259

1716

1.60

10.23

1.4

25.41

22.24

iu/l

0.76

204

1502

Certain disorders involving the immune mechanism

565

4245

1.35

10.23

1.8

1.4

24.51

28.27

iu/l

1.97

470

3618

Malignant neoplasm of brain, including Hilmo

124

665

1.92

10.16

2.3

1.4

20.53

23.26

iu/l

0.46

103

564

Acne vulgaris

458

3351

1.41

10.10

1.5

14.13

14.32

iu/l

0.06

371

2786

Non-follicular lymphoma

130

706

1.87

10.09

1.8

1.4

27.86

29.06

iu/l

0.14

105

595

Sacrococcygeal disorders, not elsewhere classified

158

924

1.81

10.09

1.4

24.45

29.73

iu/l

1.28

137

807

Other disorders of fluid, electrolyte and acid-base balance

527

3682

1.36

10.04

1.6

1.4

28.62

31.55

iu/l

1.08

438

3153

Abnormal weight loss

208

1294

1.64

10.03

1.7

1.5

24.33

26.06

iu/l

0.31

180

1073

Redundant prepuce, phimosis and paraphimosis

213

1306

1.62

9.97

1.7

7.54

7.90

iu/l

0.20

165

953

Poisoning by drugs, medicaments and biological substances

1027

8358

1.25

9.95

1.5

1.4

21.24

24.00

iu/l

2.24

809

7137

Unspecified mental disorder

1489

12536

1.20

9.94

1.4

21.73

24.67

iu/l

3.17

1166

10746

Abnormal findings on diagnostic imaging of other body structures

401

2867

1.42

9.91

1.5

1.4

32.44

30.96

iu/l

0.35

339

2468

Fibroblastic disorders

493

3638

1.37

9.89

1.4

29.54

33.28

iu/l

1.69

427

3131

Hypertensive diseases (excluding secondary)

2718

13882

1.15

9.89

1.4

27.21

27.99

iu/l

0.58

2277

12071

Other and unspecified visual disturbances

319

2192

1.49

9.86

1.4

24.32

27.75

iu/l

1.17

271

1885

Osteoporosis

363

2330

1.44

9.85

1.6

1.4

35.30

36.34

iu/l

0.20

299

1993

Speech and linguistic disorders

362

2444

1.46

9.85

2.1

1.7

11.07

13.28

iu/l

1.00

261

1887

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

957

7726

1.25

9.81

1.4

21.02

33.27

iu/l

40.41

819

6716

Glucagon-like peptide-1 (GLP-1) analogues

957

7726

1.25

9.81

1.4

21.02

33.27

iu/l

40.41

819

6716

Ischaemic heart disease, wide definition

929

7124

0.80

9.81

1.4

31.50

35.74

iu/l

3.13

769

6086

Benign lipomatous neoplasm

761

5979

1.29

9.80

1.3

1.4

31.00

31.36

iu/l

0.11

662

5175

Candidiasis

530

3978

1.36

9.80

1.5

1.4

27.52

25.23

iu/l

0.76

428

3406

Abnormal serum enzyme levels

386

2637

1.42

9.79

1.4

21.37

24.69

iu/l

1.49

324

2206

Malignant neoplasm of endocrine gland

242

1576

1.58

9.78

1.6

1.4

30.00

27.86

iu/l

0.44

201

1380

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2641

20185

1.15

9.78

1.3

25.38

27.82

iu/l

3.62

2351

17515

Diseases of liver

852

6785

1.27

9.76

1.4

28.51

30.43

iu/l

1.00

710

5785

Use of pramipexole

454

3317

1.39

9.74

1.5

1.4

27.28

32.33

iu/l

2.43

389

2858

Other female pelvic inflammatory diseases

660

5123

1.32

9.68

1.4

1.3

27.92

29.88

iu/l

0.80

572

4467

Sensorineural hearing loss

1167

9441

0.82

9.68

1.5

1.4

30.59

32.52

iu/l

1.14

1003

8074

Gastro-oesophageal reflux disease

2254

16531

1.16

9.66

1.4

27.22

29.34

iu/l

2.28

1912

14241

Diseases of tongue

153

888

1.76

9.64

1.4

25.45

28.82

iu/l

0.64

126

782

Carbimazole or st.post thyroidectomy, condition for graves disease

857

6866

1.27

9.63

1.4

29.26

29.21

iu/l

0.01

731

5930

Disorders of mineral metabolism

216

1375

1.60

9.52

1.6

1.4

26.92

28.58

iu/l

0.27

183

1181

Ocular pain

364

2590

1.45

9.52

1.4

26.84

24.86

iu/l

0.49

305

2205

Paralytic ileus and intestinal obstruction

463

3401

1.37

9.48

1.5

1.4

29.72

31.99

iu/l

0.72

394

2907

Allergic rhinitis

1565

13146

1.19

9.47

1.4

21.24

23.87

iu/l

2.86

1325

11151

Inflammatory diseases of prostate (prostatitis)

474

2.02

9.43

1.5

11.47

9.27

iu/l

0.59

372

Other noninfective gastroenteritis and colitis

759

5992

1.28

9.41

1.5

23.52

25.94

iu/l

1.39

657

4987

Abnormal findings on examination of blood, without diagnosis

945

6905

1.25

9.36

1.5

1.4

22.48

26.57

iu/l

3.76

788

5818

Pain associated with micturition

349

2462

1.45

9.36

1.5

1.4

27.42

27.34

iu/l

0.02

292

2097

Complications predominantly related to the puerperium

1515

12900

1.20

9.35

1.3

23.88

24.64

iu/l

0.42

1294

11202

Ganglion

879

7082

1.26

9.35

1.4

1.3

27.21

28.60

iu/l

0.62

784

6092

Other diseases of intestine

289

1964

1.49

9.29

1.5

1.4

28.34

32.81

iu/l

1.67

235

1675

Diseases of appendix

2825

22372

1.14

9.27

1.4

25.56

26.22

iu/l

0.52

2435

19197

Malignant neoplasm of endocrine gland, including Hilmo

268

1805

1.52

9.26

1.6

1.4

29.46

27.89

iu/l

0.31

222

1579

Other diseases of blood and blood-forming organs

160

952

1.72

9.25

1.6

1.4

19.91

28.15

iu/l

3.54

134

817

Diseases of pulp and periapical tissues and dental caries

1809

7916

1.18

9.20

1.4

26.44

26.75

iu/l

0.14

1510

6878

Other specified and unspecified disorders of eye and adnexa

129

727

1.84

9.20

1.5

1.4

34.41

28.58

iu/l

0.89

103

628

Hypo-osmolality and hyponatraemia

251

1645

1.53

9.20

1.7

1.4

29.05

32.39

iu/l

0.79

210

1400

Pneumonia, organism unspecified

2663

20655

0.88

9.19

1.5

1.4

24.73

26.35

iu/l

1.80

2195

17659

Implicit fungal Sepsis, including avohilmo

172

1046

1.68

9.16

1.7

1.4

29.51

27.72

iu/l

0.25

136

893

Excessive vomiting in pregnancy

529

4043

1.36

9.15

1.4

1.3

21.63

25.11

iu/l

1.80

464

3474

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

276

1872

1.51

9.15

1.5

1.4

27.85

27.35

iu/l

0.09

231

1610

Benign thyroid growths and nodules

917

6895

1.25

9.10

1.4

1.3

32.56

32.98

iu/l

0.13

809

6019

Hypermobility syndrome

357

2575

1.46

9.08

1.4

23.02

24.52

iu/l

0.39

307

2206

Poisoning by medicine

938

7645

1.25

9.04

1.5

1.4

21.22

24.08

iu/l

2.19

740

6535

Drug-induced neutropenia

189

1183

1.64

9.03

1.7

1.4

34.89

30.97

iu/l

0.74

158

1022

Appendicitis, broad definition

2809

22357

1.14

9.03

1.4

25.50

26.22

iu/l

0.58

2422

19186

Accidents

3267

14583

1.13

8.99

1.4

24.43

25.79

iu/l

1.56

2787

12507

Other disorders of eyelid

822

6202

1.26

8.94

1.4

32.98

35.01

iu/l

0.96

719

5354

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1095

9100

1.23

8.92

1.4

1.3

20.37

23.84

iu/l

3.63

954

7882

Pneumonias (Asthma/COPD co-morbidities)

3170

23138

0.89

8.91

1.5

1.4

24.63

25.75

iu/l

1.15

2630

19775

Atopic dermatitis, strict definition with reimbursement

1661

13724

1.18

8.82

1.5

1.4

21.57

22.82

iu/l

0.93

1415

11665

Blepharochalasis

509

3843

1.34

8.80

1.4

1.3

34.97

38.70

iu/l

1.67

454

3340

Falls/tendency to fall

4383

19898

1.11

8.80

1.4

23.97

25.05

iu/l

1.37

3691

17029

Heart failure, not strict

1050

8564

0.82

8.77

1.5

1.4

28.31

32.64

iu/l

3.91

859

7308

Diffuse large B-cell lymphoma

258

2.37

8.74

1.6

1.3

27.75

27.80

iu/l

0.00

223

Diffuse large B-cell lymphoma, including Hilmo

258

2.37

8.74

1.6

1.3

27.75

27.80

iu/l

0.00

223

Diffuse large B-cell lymphoma, helper endpoint

258

2.37

8.74

1.6

1.3

27.75

27.80

iu/l

0.00

223

Klinefelter syndrome, karyotype 47 XXY

7.96

8.73

2.6

1.7

28.84

10.64

iu/l

2.31

Mycoses

852

6885

1.25

8.72

1.5

1.4

26.03

25.93

iu/l

0.03

694

5848

Invasive ventilation

163

991

1.68

8.70

1.6

1.5

25.14

25.51

iu/l

0.04

111

814

Nontoxic goitre/thyroid nodule

779

6233

1.26

8.70

1.4

32.33

32.95

iu/l

0.18

680

5434

Striae atrophicae

366

2.26

8.63

1.5

1.3

23.51

24.65

iu/l

0.10

316

Chronic gastritis

430

3175

1.37

8.61

1.4

28.84

33.75

iu/l

2.55

341

2729

Ehlers-Danlos syndrome, including avohilmo

113

643

1.97

8.58

2.0

1.4

19.67

22.40

iu/l

0.42

558

Other problems related to primary support group, including family circumstances

613

4673

1.31

8.52

1.8

1.5

20.83

21.84

iu/l

0.35

488

3894

Finngen Rheumatological endpoints

3992

20497

1.11

8.51

1.4

25.42

24.85

iu/l

0.52

3436

17496

Injuries to the neck

894

7294

1.24

8.49

1.4

21.69

23.42

iu/l

1.01

762

6228

Other systemic involvement of connective tissue

804

6481

1.26

8.44

1.4

28.76

29.46

iu/l

0.23

698

5591

Other shoulder lesions

347

2498

1.42

8.44

1.5

1.4

26.40

28.17

iu/l

0.47

298

2137

Other bacterial intestinal infections

408

3005

1.37

8.41

1.5

1.4

26.12

27.02

iu/l

0.20

328

2557

Acne

571

4419

1.32

8.37

1.5

14.67

15.08

iu/l

0.15

463

3665

Primary adrenocortical insufficiency

250

2.48

8.37

1.7

1.3

26.04

23.43

iu/l

0.22

215

Adrenogenital disorders

4.07

8.37

2.2

1.2

17.00

24.07

iu/l

0.46

Other superficial mycoses, including avohilmo

472

3576

1.35

8.36

1.4

19.45

21.35

iu/l

0.72

403

3012

Injuries to the abdomen, lower back, lumbar spine and pelvis

1088

8911

1.21

8.35

1.4

23.28

24.65

iu/l

0.75

890

7560

Other specified/unspecified inflammatory spondylopathies

221

1470

1.56

8.34

1.4

23.70

27.04

iu/l

0.82

184

1263

STROKE

1071

8681

0.82

8.34

1.4

33.06

33.41

iu/l

0.12

896

7512

Intussusception

413

2.09

8.33

1.5

1.4

30.32

29.89

iu/l

0.04

358

Fentanyl

139

815

1.72

8.32

1.4

26.74

32.61

iu/l

1.24

110

700

Disorders of parathyroid gland

345

2446

1.41

8.29

1.4

1.3

33.62

36.49

iu/l

0.74

293

2110

Exclusion endpoint for clefts

107

594

1.92

8.28

2.2

1.8

18.00

18.06

iu/l

0.01

467

Venous thromboembolism

1138

9145

1.21

8.25

1.4

30.21

30.53

iu/l

0.12

958

7892

Vulvovaginal ulceration/inflammation in other diseases

437

3303

1.37

8.20

1.4

1.3

23.74

23.63

iu/l

0.02

377

2853

Other systemic involvement of connective tissue (FG)

795

6302

1.25

8.19

1.4

28.84

29.59

iu/l

0.25

691

5414

Stomatitis and related lesions

683

5430

1.28

8.19

1.5

1.4

25.60

24.56

iu/l

0.34

550

4588

Cerebrovascular diseases

963

8111

0.82

8.17

1.5

1.4

30.64

31.84

iu/l

0.50

794

6965

Injuries to the head

3542

23244

0.90

8.13

1.4

23.53

25.59

iu/l

3.47

2958

19856

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

283

1948

1.47

8.09

1.7

12.30

14.87

iu/l

1.08

209

1542

Spondylosis

1421

9447

1.18

8.09

1.4

1.3

31.88

34.22

iu/l

1.66

1213

8216

Unspecified lump in breast

606

4766

1.30

8.07

1.4

1.3

29.73

31.49

iu/l

0.63

522

4147

Anomalies of dental arch relationship, including avohilmo

869

6426

1.24

8.06

1.6

1.4

22.56

23.21

iu/l

0.24

722

5370

Emotional disorders and disorders of social functioning with onset specific to childhood

256

1729

1.50

8.06

1.8

1.7

7.43

9.39

iu/l

2.15

197

1333

Other and/or unspecified nontoxic goitre

222

1481

1.53

8.05

1.4

1.3

35.04

34.51

iu/l

0.07

196

1294

Ehlers-Danlos syndrome

510

2.07

8.03

1.9

1.4

20.56

22.99

iu/l

0.30

442

Social phobias

426

3202

1.37

8.01

1.6

1.4

17.22

19.39

iu/l

0.91

330

2683

Unspecified privation

306

2174

1.44

7.99

1.4

20.51

24.70

iu/l

1.80

241

1850

Pregnancy with abortive outcome

3219

15064

1.12

7.99

1.3

26.23

26.77

iu/l

0.39

2792

13077

112

627

1.81

7.93

1.8

1.3

20.47

25.08

iu/l

0.82

540

All pneumoniae

3214

23161

0.90

7.93

1.5

1.4

24.65

25.72

iu/l

1.08

2669

19798

Diabetic nephropathy, excluding more controls

141

1870

0.61

7.93

1.3

1.4

21.96

19.17

iu/l

0.40

118

1590

Spondylolisthesis/Spondylolysis

465

3531

1.33

7.89

1.4

31.06

33.44

iu/l

0.81

413

3047

Fistulae involving female genital tract

248

2.38

7.87

1.4

1.3

28.01

30.58

iu/l

0.25

218

Pulmonary embolism

481

3662

1.32

7.87

1.5

1.4

28.50

31.22

iu/l

1.12

398

3150

Pulmonary heart disease

481

3663

1.32

7.85

1.5

1.3

28.50

31.23

iu/l

1.12

398

3150

Cramp and spasm

162

1016

1.65

7.85

1.5

1.4

25.30

25.79

iu/l

0.07

146

860

Inguinal hernia

831

6778

0.81

7.82

1.5

1.4

20.28

23.62

iu/l

2.75

692

5617

All influenza

636

5032

1.28

7.80

1.6

1.5

22.60

24.21

iu/l

0.65

534

4199

Other puerperal infections

605

4822

1.31

7.78

1.4

1.3

18.04

19.42

iu/l

0.60

503

4150

Polyneuropathies and other disorders of the peripheral nervous system

341

2471

1.39

7.76

1.7

1.4

29.10

29.18

iu/l

0.01

282

2107

Acute bronchitis

1141

9407

1.20

7.76

1.5

1.4

23.26

25.31

iu/l

1.44

940

7951

Dislocation, sprain and strain of joints and ligaments at neck level

708

5704

1.27

7.75

1.4

21.75

22.92

iu/l

0.50

605

4864

DVT of lower extremities and pulmonary embolism

749

6010

1.25

7.75

1.4

30.45

31.21

iu/l

0.25

629

5171

Senile cataract

639

4908

0.79

7.74

1.4

1.3

39.95

37.93

iu/l

0.67

514

4218

Hernia of abdominal wall

1124

9450

1.20

7.67

1.4

21.87

27.32

iu/l

8.75

962

8090

Malignant neoplasm of heart, mediastinum and pleura

3.71

7.66

1.9

1.4

24.95

20.83

iu/l

0.20

Other disorders starting during childhood or adolescence

251

1726

1.49

7.65

1.8

9.21

11.05

iu/l

0.92

186

1298

Schizophrenia or delusion, excluding more controls

961

7872

1.22

7.64

1.4

1.3

20.45

25.75

iu/l

6.21

721

6825

Family history of malignant neoplasm

566

4457

1.30

7.63

1.5

1.3

31.32

28.36

iu/l

1.31

498

3893

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

130

791

1.78

7.61

1.9

1.5

19.54

23.30

iu/l

0.73

107

675

Chronic apical periodontitis

4197

21459

1.10

7.61

1.4

26.88

25.02

iu/l

2.95

3442

18513

Delayed milestone in childhood

448

1.97

7.61

3.0

2.5

6.77

6.16

iu/l

0.19

275

Other follicular disorders

319

2313

1.42

7.59

1.4

20.46

24.07

iu/l

1.47

269

1971

Ulcer of vagina/vulva

134

813

1.73

7.59

1.4

25.59

23.41

iu/l

0.29

114

704

Dissociative [conversion] disorders

194

1285

1.57

7.58

1.6

1.4

22.64

21.10

iu/l

0.28

160

1102

Benign leiomyoma with endometriosis

496

3832

1.32

7.57

1.3

1.4

31.75

33.82

iu/l

0.68

441

3338

Other symptoms and signs involving cognitive functions and awareness

873

6344

1.23

7.56

1.4

30.10

30.50

iu/l

0.12

729

5415

Short stature starting before birth

143

3.13

7.52

2.9

2.7

5.26

7.95

iu/l

1.09

Insulin medication

1126

11058

0.84

7.43

1.4

20.50

25.98

iu/l

8.15

925

9351

Enthesopathies of lower limb, excluding foot

781

6374

1.24

7.41

1.4

27.49

30.78

iu/l

2.06

679

5480

Heterophoria

329

2409

1.40

7.37

1.4

1.5

22.29

23.21

iu/l

0.22

267

2004

Congenital malformations of the musculoskeletal system, not elsewhere classified

108

632

1.86

7.31

1.9

1.5

20.32

22.47

iu/l

0.29

540

Immunodeficiencies

171

1107

1.60

7.30

1.9

1.5

20.76

27.00

iu/l

2.03

150

926

Abnormal findings on diagnostic imaging of central nervous system

191

1267

1.56

7.30

1.5

1.4

21.72

24.71

iu/l

0.70

170

1063

Gonarthrosis,primary

1781

12291

0.87

7.29

1.4

1.3

32.41

35.88

iu/l

4.48

1564

10697

Internal derangement of knee

1209

10178

1.19

7.29

1.4

24.76

28.31

iu/l

3.73

1048

8690

Meniscus derangement

1188

9286

0.84

7.27

1.4

1.3

29.08

32.30

iu/l

2.83

1041

7984

Nontoxic multinodular goitre

454

3483

1.32

7.19

1.4

1.3

32.96

34.19

iu/l

0.29

396

3038

Mental and behavioural disorders due to sedatives or hypnotics

233

1612

1.48

7.17

1.5

1.4

19.27

23.00

iu/l

1.19

163

1369

Intestinal stricture

536

4198

1.29

7.15

1.5

1.4

29.78

31.08

iu/l

0.37

460

3587

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

3.78

7.11

2.1

1.3

18.08

19.89

iu/l

0.10

Trigeminal neuralgia

203

1370

1.52

7.10

1.4

31.48

30.70

iu/l

0.12

169

1186

Wilms' tumor, including Hilmo

6.23

7.09

3.8

1.9

29.23

14.04

iu/l

0.67

Systemic connective tissue disorders

988

8287

1.20

7.03

1.4

29.28

29.16

iu/l

0.04

850

7142

Anosmia

298

2.12

7.02

1.4

1.3

33.32

38.35

iu/l

0.46

263

Noninfectious colitis NAS

423

3231

1.33

7.01

1.5

1.4

23.05

25.84

iu/l

1.09

364

2718

Pulmonary heart disease, diseases of pulmonary circulation

503

3916

1.29

7.01

1.5

1.4

29.04

30.96

iu/l

0.69

415

3357

Graves disease, strict definition

481

3757

1.31

6.97

1.5

1.4

27.34

28.18

iu/l

0.23

414

3260

110

648

1.78

6.96

1.5

1.4

25.10

31.35

iu/l

1.27

554

Metatarsalgia

341

2531

1.38

6.95

1.4

29.95

31.46

iu/l

0.36

299

2167

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1186

10128

1.18

6.94

1.4

24.22

24.92

iu/l

0.33

1008

8598

Overexertion and strenuous or repetitive movements

298

2164

1.40

6.94

1.4

23.55

24.88

iu/l

0.26

233

1828

Other disorders of bone

700

5697

1.25

6.91

1.5

1.4

25.78

26.75

iu/l

0.35

605

4851

Localized swelling, mass and lump of skin and subcutaneous tissue

938

7845

1.21

6.91

1.5

1.4

26.43

27.87

iu/l

0.71

817

6684

Rash and other nonspecific skin eruption

291

2107

1.41

6.90

1.4

30.46

28.82

iu/l

0.33

251

1793

Injuries to the wrist and hand

3795

22974

1.10

6.89

1.4

23.56

25.63

iu/l

3.73

3218

19576

Atopic dermatitis, strict definition

1596

13649

1.16

6.89

1.5

1.4

21.59

22.35

iu/l

0.45

1351

11581

Injury of muscle and tendon at shoulder and upper arm level

596

4758

1.26

6.80

1.4

27.09

31.66

iu/l

2.91

513

4031

Benign neoplasm of other and ill-defined parts of digestive system

375

2824

1.34

6.80

1.4

31.68

32.82

iu/l

0.27

308

2445

Bacterial intestinal infections, IBD co-morbidities

402

3057

1.33

6.79

1.5

1.4

25.88

27.54

iu/l

0.43

328

2606

Muscle strain

129

796

1.68

6.77

1.4

24.75

23.53

iu/l

0.16

108

691

Symptoms and signs involving emotional state

126

774

1.69

6.77

1.6

1.5

20.78

22.92

iu/l

0.35

654

Specific developmental disorder of motor function

386

2.01

6.76

3.1

2.2

5.98

6.73

iu/l

0.39

246

Epilepsy

824

6797

1.22

6.76

1.5

1.4

26.27

26.21

iu/l

0.02

673

5699

Other enthesopathy of foot (+metatarsalgia)

373

2819

1.35

6.75

1.4

29.71

31.02

iu/l

0.32

326

2408

Hypermetropia

233

1629

1.46

6.75

1.9

1.6

24.06

23.14

iu/l

0.15

181

1302

Diplopia

327

2418

1.37

6.74

1.5

1.4

28.01

27.49

iu/l

0.10

268

2075

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

279

2015

1.41

6.74

1.5

1.4

24.69

26.91

iu/l

0.51

242

1725

Assault

501

3942

1.29

6.70

1.4

18.78

21.48

iu/l

1.29

378

3295

All dysplastic lesions of the cervix uteri, vagina or vulva

2073

18052

1.14

6.70

1.4

1.3

24.76

26.09

iu/l

1.10

1792

15738

Strabismus

961

8068

1.20

6.68

1.6

1.4

25.00

25.01

iu/l

0.00

780

6796

D07AA Corticosteroids, weak (group I)

649

5259

1.25

6.67

1.5

1.4

22.25

22.74

iu/l

0.16

544

4382

Cerebral palsy and other paralytic syndromes

323

2391

1.37

6.66

1.7

1.4

24.82

26.47

iu/l

0.39

261

2004

Provisional assignment of new diseases of uncertain etiology

1859

16283

1.14

6.66

1.4

23.18

24.18

iu/l

0.68

1516

13941

Benign mammary dysplasia

399

3051

1.33

6.61

1.3

1.4

34.80

32.36

iu/l

0.66

353

2640

Viral and other specified intestinal infections

805

6510

1.22

6.60

1.6

1.5

15.22

15.89

iu/l

0.31

667

5330

Other disorders of patella

749

6179

1.23

6.58

1.4

1.3

26.04

28.39

iu/l

1.19

653

5304

Erysipelas, including avohilmo

1434

12228

0.86

6.57

1.4

27.85

29.88

iu/l

1.52

1197

10512

Bleeding

1510

12147

0.87

6.57

1.5

1.4

27.00

28.70

iu/l

1.19

1262

10308

Cutaneous abscess, furuncle and carbuncle

861

7185

1.21

6.57

1.5

1.4

21.55

24.79

iu/l

2.45

720

6090

Codes for special purposes

1859

16299

1.14

6.55

1.4

23.18

24.18

iu/l

0.68

1516

13956

Disorders of muscles

306

2255

1.38

6.51

1.4

26.56

26.37

iu/l

0.03

260

1920

Perineal laceration during delivery

994

9410

0.83

6.49

1.3

1.4

18.75

20.07

iu/l

0.78

883

8015

Other and unspecified local infections of skin and subcutaneous tissue

275

1993

1.40

6.49

1.6

1.4

27.62

25.68

iu/l

0.37

222

1680

Congenital malformations of genital organs

561

4487

1.28

6.49

1.5

1.4

21.60

22.96

iu/l

0.47

453

3777

Injury, poisoning and certain other consequences of external causes

2253

10056

1.13

6.48

1.4

23.54

25.83

iu/l

2.71

1909

8580

Collagenous colitis

253

1809

1.42

6.47

1.5

1.4

28.10

28.40

iu/l

0.05

220

1547

Other local infections of skin and subcutaneous tissue

287

2096

1.39

6.46

1.6

1.4

28.15

26.18

iu/l

0.39

231

1764

Salpingitis and oophoritis

631

5124

1.25

6.45

1.4

1.3

33.41

34.56

iu/l

0.35

539

4487

Other strabismus

870

7261

1.21

6.44

1.5

1.4

24.87

24.63

iu/l

0.08

705

6134

Other CVD (FINNGEN)

182

922

1.52

6.43

1.4

25.88

30.27

iu/l

0.93

155

787

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

102

2.92

6.43

1.9

1.3

24.16

19.72

iu/l

0.28

Other disorders involving the immune mechanism, not elsewhere classified

100

585

1.77

6.41

3.0

1.5

19.01

22.58

iu/l

0.58

486

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1537

11676

1.15

6.38

1.5

1.4

30.11

30.05

iu/l

0.02

1305

10034

Wide developmental disorders, excluding more controls

148

936

1.60

6.37

1.9

1.6

11.24

13.31

iu/l

0.57

115

734

Disorders of adrenal gland, other and/or unspecified

3.17

6.34

1.7

1.3

23.03

25.12

iu/l

0.10

Suicide or other Intentional self-harm

943

7971

1.20

6.32

1.4

22.30

25.52

iu/l

2.57

750

6818

Substance use, excluding alcohol

650

5301

1.24

6.31

1.5

1.4

19.40

23.29

iu/l

2.75

473

4492

Other acute lower respiratory infections

1574

13137

1.15

6.31

1.5

1.4

21.71

23.78

iu/l

1.99

1296

11087

Coxarthrosis

744

5821

0.82

6.29

1.4

1.3

33.16

37.53

iu/l

2.99

640

5006

Other and unspecified rosacea

335

2523

1.36

6.29

1.4

26.84

30.05

iu/l

0.98

289

2185

Other and unspecified dermatitis

1754

15501

1.14

6.28

1.5

1.4

26.22

27.81

iu/l

1.30

1525

13281

Calculus of kidney and ureter

570

4575

1.26

6.28

1.4

27.84

26.86

iu/l

0.26

475

3901

Primary hyperparathyroidism

211

1467

1.46

6.25

1.4

31.97

36.28

iu/l

1.05

184

1269

Other symptoms and signs involving the digestive system and abdomen

533

4258

1.27

6.24

1.4

30.44

31.43

iu/l

0.26

459

3657

All dysplastic lesions of the cervix uteri

1910

16794

1.14

6.22

1.4

1.3

24.22

24.97

iu/l

0.48

1660

14623

Abnormal findings on diagnostic imaging of lung

717

5582

1.22

6.19

1.4

31.96

32.44

iu/l

0.14

601

4767

Complications of other internal prosthetic devices, implants and grafts

102

604

1.73

6.19

1.9

1.4

21.50

27.92

iu/l

1.34

512

Superficial injury of abdomen, lower back and pelvis

518

4131

1.27

6.18

1.5

1.4

22.23

22.83

iu/l

0.17

422

3478

Heartburn

334

2515

1.35

6.18

1.4

22.15

27.77

iu/l

2.99

282

2157

Autism spe, excluding more controls

114

699

1.70

6.18

1.8

1.5

11.59

14.44

iu/l

0.72

560

Urolithiasis

591

4771

1.25

6.17

1.4

27.98

26.84

iu/l

0.32

495

4068

Other specified congenital malformation syndromes affecting multiple systems

507

1.85

6.17

2.2

1.9

19.45

17.11

iu/l

0.24

389

Somnolence, stupor and coma

103

612

1.72

6.16

1.4

1.5

19.46

23.27

iu/l

0.60

525

Hypoparathyroidism

501

1.81

6.15

1.4

1.3

29.92

29.20

iu/l

0.06

428

Other and unspecified polyneuropathies, also in other diseases

269

1955

1.39

6.13

1.4

30.24

29.36

iu/l

0.15

226

1669

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

556

1.77

6.11

3.1

1.5

19.04

22.65

iu/l

0.57

461

Open bite

287

2133

1.39

6.09

1.7

1.6

17.54

19.23

iu/l

0.47

237

1723

Pregnancy hypertension

2481

20066

1.12

6.08

1.3

25.20

27.56

iu/l

3.28

2207

17412

Valvular heart disease excluding rheumatic fever

519

4642

0.79

6.08

1.5

1.4

28.88

29.78

iu/l

0.24

435

3876

Other and unspecified immunodeficiencies with predominantly antibody defects

286

2.13

6.07

2.4

1.5

25.45

24.49

iu/l

0.08

234

Non-rheumatic valve diseases

510

4559

0.79

5.99

1.5

1.4

29.28

30.04

iu/l

0.19

427

3818

Presbycusis

264

2.07

5.99

1.4

39.66

32.88

iu/l

0.71

215

Syncope and collapse

1024

7279

1.18

5.95

1.4

24.50

25.49

iu/l

0.42

843

6230

Injuries to the knee and lower leg

4437

22170

1.09

5.95

1.4

24.79

25.32

iu/l

0.51

3807

18850

Osteopathies and chondropathies

1510

12109

1.15

5.94

1.5

1.4

28.05

28.40

iu/l

0.15

1296

10321

Diverticular disease of intestine

1272

9134

0.86

5.93

1.4

1.3

33.22

35.50

iu/l

1.59

1109

7949

In situ neoplasms

1105

9499

1.17

5.93

1.3

26.54

27.37

iu/l

0.37

958

8212

Diseases of oesophagus, stomach and duodenum

3891

21136

1.09

5.92

1.4

27.02

26.28

iu/l

0.69

3307

18132

Other noninflammatory disorders of cervix uteri

105

634

1.69

5.92

1.2

1.3

32.00

37.14

iu/l

0.71

544

Stroke, including SAH

645

5650

0.82

5.92

1.4

31.49

32.77

iu/l

0.40

530

4828

Emotional disorders starting during childhood or adolescence

234

1671

1.43

5.92

1.8

1.7

7.65

9.31

iu/l

1.53

183

1266

Haemorrhage from respiratory passages

575

4107

1.25

5.91

1.5

1.4

25.39

29.43

iu/l

2.37

473

3445

Complications of labour and delivery

2992

15138

1.11

5.90

1.3

1.4

28.33

27.59

iu/l

0.57

2641

12976

Benign neoplasm of eye and adnexa

236

1695

1.41

5.88

1.5

1.4

29.63

31.00

iu/l

0.25

202

1461

Hallux rigidus

246

1779

1.40

5.83

1.3

35.17

37.83

iu/l

0.56

208

1521

Other viral diseases

1217

10530

1.16

5.83

1.5

1.4

20.97

23.25

iu/l

1.83

1018

8877

6-mercaptopurine

153

1022

1.55

5.80

2.0

1.4

21.67

20.59

iu/l

0.14

122

855

Rosacea

506

4065

1.27

5.79

1.4

26.14

29.04

iu/l

1.22

437

3513

Other (not insulin) diabetes medications

3018

19397

0.91

5.79

1.4

21.63

28.91

iu/l

39.20

2553

16822

Acute appendicitis

2629

22146

1.11

5.79

1.4

25.71

26.32

iu/l

0.44

2272

19019

Transplanted organ and tissue status

220

1569

1.42

5.72

2.2

1.5

27.30

25.81

iu/l

0.20

175

1286

Other and unspecified anaemias

684

5298

1.22

5.72

1.6

1.4

28.11

29.37

iu/l

0.40

548

4493

Poisoning by narcotics and psychodysleptics [hallucinogens]

362

1.95

5.71

1.6

1.5

21.74

14.92

iu/l

0.93

303

Diseases of the digestive system

974

8245

1.18

5.70

1.5

1.4

25.09

26.73

iu/l

0.84

821

6956

Other congenital malformations of male genital organs, including avohilmo

141

2.59

5.69

2.4

2.5

8.89

5.41

iu/l

0.74

Artificial opening status

595

1.69

5.67

1.7

1.4

25.27

27.08

iu/l

0.21

489

Other congenital malformations of nervous system

368

1.99

5.67

1.4

1.6

20.21

18.70

iu/l

0.14

304

Thyroiditis

278

2074

1.37

5.66

1.4

28.07

27.95

iu/l

0.02

230

1796

Orchitis and epididymitis

422

1.81

5.66

1.7

9.23

8.92

iu/l

0.09

332

Unspecified fall

1361

11688

1.15

5.66

1.5

1.4

24.93

25.56

iu/l

0.30

1117

9830

Coxarthrosis [arthrosis of hip](FG)

754

6211

0.83

5.65

1.4

1.3

33.40

37.51

iu/l

2.72

649

5336

Other septicaemia, including avohilmo

639

4928

1.22

5.60

1.9

1.4

22.42

27.87

iu/l

4.44

505

4126

Radial styloid tenosynovitis [de Quervain]

246

1806

1.40

5.58

1.3

25.80

29.27

iu/l

0.95

214

1552

Other and unspecified drugs and medicaments

250

1834

1.39

5.58

1.5

1.4

24.79

27.01

iu/l

0.47

218

1563

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

130

841

1.58

5.57

1.5

1.3

30.61

33.89

iu/l

0.52

118

727

Benign neoplasm of brain and other parts of central nervous system

165

1124

1.50

5.56

1.9

1.4

28.18

27.64

iu/l

0.07

142

941

Malignant neoplasm of thyroid gland

208

1482

1.43

5.55

1.4

31.15

28.07

iu/l

0.66

177

1305

Fracture of skull and facial bones

551

4476

1.24

5.55

1.5

1.4

23.33

24.58

iu/l

0.43

451

3735

Congenital malformations of the nervous system

116

740

1.65

5.55

1.6

1.7

19.62

19.69

iu/l

0.01

596

Pollen allergy

998

8467

1.18

5.54

1.5

18.69

21.71

iu/l

2.74

833

7099

Lateral epicondylitis

471

3770

1.27

5.54

1.4

1.3

30.98

33.76

iu/l

1.07

416

3269

Otitis media, unspecified

449

3289

1.28

5.53

1.8

1.6

12.96

17.28

iu/l

4.31

381

2638

Anogenital herpesviral [herpes simplex] infection

369

2886

1.32

5.52

1.4

21.29

21.63

iu/l

0.07

302

2463

Other and unspecified iron deficiency

954

8141

1.18

5.51

1.5

1.4

23.83

26.63

iu/l

1.72

774

6960

Dermatitis

2068

18188

1.12

5.51

1.4

25.72

27.54

iu/l

1.85

1796

15590

Pure hyperglyceridaemia

205

2.20

5.49

1.4

17.13

25.69

iu/l

1.08

175

Renal cell carcinoma of kidney

123

2.56

5.48

1.5

1.2

49.19

29.04

iu/l

1.65

105

Endometriosis of fallopian tube

190

2.34

5.43

1.5

1.4

24.85

25.11

iu/l

0.02

163

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

715

5993

1.21

5.42

1.5

1.4

21.38

24.04

iu/l

1.55

563

5098

Diabetes medication

3458

21914

0.92

5.41

1.4

21.54

26.90

iu/l

23.63

2918

18799

Hidradenitis suppurativa

193

1373

1.46

5.40

1.4

21.65

23.28

iu/l

0.35

165

1171

Complications of the puerperium, not elsewhere classified

302

2320

1.36

5.38

1.4

24.30

24.86

iu/l

0.12

257

2005

Other disorders of optic [2nd] nerve and visual pathways

184

1290

1.46

5.38

1.9

1.5

23.39

23.98

iu/l

0.08

151

1075

Hyperparathyroidism

270

1986

1.36

5.37

1.4

1.3

33.73

37.31

iu/l

0.87

234

1715

Other septicaemia

615

4769

1.22

5.36

1.9

1.4

22.32

27.74

iu/l

4.24

485

3993

Ptosis of eyelid

186

1302

1.45

5.36

1.5

1.4

32.45

32.83

iu/l

0.05

151

1113

Other specified/unspecified dorsopathies

102

631

1.66

5.34

1.4

33.15

30.97

iu/l

0.21

551

Malignant neoplasm of adrenal gland, including Hilmo

103

2.79

5.33

3.3

2.0

20.20

18.88

iu/l

0.07

Gingival hyperplasia

108

679

1.64

5.31

2.0

1.7

18.91

22.27

iu/l

0.60

543

Subacute thyroiditis

138

920

1.55

5.30

1.3

1.4

25.78

28.74

iu/l

0.48

116

797

Other anaemias

687

5350

1.21

5.30

1.6

1.4

28.20

29.33

iu/l

0.35

551

4539

Androgenic alopecia

282

2.08

5.28

1.4

1.3

20.23

25.28

iu/l

0.59

243

Early onset COPD, excluding more controls

303

2297

1.33

5.26

1.4

1.3

28.81

33.90

iu/l

2.05

246

1957

Astigmatism

222

1615

1.40

5.25

1.8

1.6

18.48

20.73

iu/l

0.56

170

1278

Viral hepatitis, including avohilmo

262

1960

1.37

5.23

1.4

24.45

21.89

iu/l

0.61

190

1648

Disorders of calcium metabolism

140

934

1.52

5.21

1.6

1.4

29.78

28.77

iu/l

0.12

115

808

Other facial nerve disorders

559

1.70

5.21

1.5

1.3

23.20

28.37

iu/l

0.85

484

Kela-code for severe mental illness

1192

10417

1.15

5.21

1.4

20.61

24.82

iu/l

5.20

916

8932

Other degenerative diseases of the nervous system

383

3549

0.78

5.20

1.4

1.3

31.24

28.93

iu/l

0.60

335

3071

Other abnormal findings of blood chemistry

138

921

1.54

5.20

1.6

1.4

22.95

26.08

iu/l

0.58

121

786

Other neurotic disorders

106

665

1.63

5.20

1.6

1.4

29.02

28.59

iu/l

0.05

574

Malignant neoplasm of brain

459

1.76

5.20

2.3

1.4

16.85

21.90

iu/l

0.96

387

Viral pneumonia

295

2240

1.33

5.18

1.5

1.4

24.01

24.39

iu/l

0.07

238

1856

Manic episode

105

661

1.64

5.18

1.3

1.4

22.00

24.60

iu/l

0.31

576

Memory loss

102

632

1.63

5.18

1.5

1.3

32.08

30.14

iu/l

0.21

527

Acute laryngitis and tracheitis

545

4401

1.24

5.17

1.6

1.5

16.25

18.93

iu/l

1.57

448

3593

Viral warts

345

2686

1.31

5.15

1.5

1.4

20.44

22.93

iu/l

0.89

296

2252

Congenital malformations of breast

122

808

1.62

5.15

1.5

1.4

20.41

23.12

iu/l

0.45

100

695

Other retinal disorders

879

7816

0.85

5.15

1.4

28.52

28.50

iu/l

0.00

732

6653

Disturbances of smell and taste

119

771

1.58

5.15

1.4

31.19

31.66

iu/l

0.05

673

Major coronary heart disease event excluding revascularizations

485

3964

0.80

5.14

1.3

1.4

31.39

34.28

iu/l

0.98

400

3332

Malignant neoplasm of eye, brain and central nervous system

567

1.67

5.11

2.2

1.4

19.32

22.80

iu/l

0.56

479

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

372

2924

1.29

5.10

1.4

29.96

30.89

iu/l

0.21

318

2532

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

249

1857

1.37

5.08

1.5

1.4

17.43

18.57

iu/l

0.26

166

1546

Follicular cysts of skin and subcutaneous tissue

495

4020

1.24

5.08

1.4

26.65

27.94

iu/l

0.40

418

3428

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

590

1.65

5.07

1.9

1.4

34.89

28.01

iu/l

0.86

508

Panniculitis affecting regions of neck and back

109

695

1.61

5.06

1.5

1.4

24.56

29.99

iu/l

1.02

603

Motor disorders

435

1.81

5.06

3.1

2.3

5.98

6.72

iu/l

0.39

267

All-cause Heart Failure

331

2974

0.77

5.05

1.5

1.4

25.90

31.41

iu/l

2.19

270

2497

Maternal care for known or suspected malpresentation of fetus

1648

10542

1.14

5.03

1.3

1.4

22.65

26.21

iu/l

4.85

1459

9049

Other viral diseases, not elsewhere classified

701

5883

1.20

5.03

1.6

1.5

21.69

25.15

iu/l

2.19

595

4905

Malignant neoplasm of thyroid gland, including Hilmo

221

1620

1.39

5.02

1.4

31.45

28.50

iu/l

0.62

188

1429

Other/unspecified enthesopathies of lower limb, excluding foot

253

1895

1.36

5.01

1.5

1.4

24.56

29.38

iu/l

1.72

222

1633

Abnormal results of function studies

259

1945

1.35

5.00

1.6

1.4

28.36

26.31

iu/l

0.45

223

1643

Other and unspecified diseases of blood and blood-forming organs

347

1.87

4.99

1.6

1.4

22.31

26.12

iu/l

0.51

301

Other nonscarring hair loss

375

1.89

4.99

1.6

1.3

18.33

23.57

iu/l

0.77

328

Malignant neoplasm of other connective and soft tissue

200

2.15

4.98

1.6

1.3

27.48

25.70

iu/l

0.11

166

Diseases of external ear

964

8322

1.17

4.98

1.5

1.4

23.72

26.34

iu/l

1.98

820

7026

Artificial joint re-operation

448

1.74

4.98

1.3

1.4

36.68

36.58

iu/l

0.01

378

Other specified/unspecified soft tissue disorders

118

768

1.57

4.97

1.4

29.46

28.97

iu/l

0.05

101

671

Inflammatory bowel disease

1062

9244

1.16

4.95

1.4

24.55

25.05

iu/l

0.20

933

7856

Abnormal blood-pressure reading, without diagnosis

140

948

1.51

4.94

1.4

26.43

29.04

iu/l

0.41

124

804

Injuries to the shoulder and upper arm

2100

17876

0.90

4.93

1.4

24.86

27.48

iu/l

3.43

1783

15181

Coronary atherosclerosis

605

4598

0.83

4.88

1.4

29.26

35.15

iu/l

3.65

501

3889

GI-bleeding

451

3633

1.25

4.87

1.5

1.4

24.64

26.61

iu/l

0.64

376

3033

Exposure to other specified factors

3006

23755

1.09

4.87

1.4

24.25

25.40

iu/l

1.19

2528

20246

Heart failure, strict

343

3050

0.78

4.87

1.5

1.4

25.73

31.31

iu/l

2.30

279

2562

Other erythematous conditions

100

631

1.63

4.87

1.4

25.79

28.17

iu/l

0.30

541

Zoster [herpes zoster]

346

2706

1.29

4.87

1.8

1.4

26.89

29.61

iu/l

0.86

298

2314

Shoulder lesions

2384

12986

1.10

4.86

1.4

1.3

30.04

29.46

iu/l

0.36

2081

11223

Chondrocostal junction syndrome [Tietze]

125

832

1.55

4.85

1.3

1.4

26.98

27.60

iu/l

0.07

105

710

Mental and behavioural disorders associated with the puerperium

495

1.78

4.84

1.3

24.02

25.01

iu/l

0.09

435

Other/unspecified disorders of vestibular function

584

1.65

4.84

1.4

28.10

28.84

iu/l

0.08

506

Personal history of medical treatment

198

2.18

4.84

2.3

1.4

16.99

22.32

iu/l

0.73

166

Other disorders of penis

542

1.65

4.82

1.6

1.8

8.15

8.25

iu/l

0.03

392

Secondary polycythaemia

265

1.98

4.82

1.8

1.4

13.22

24.69

iu/l

3.43

218

Diffuse brain injury

508

1.69

4.79

1.6

1.3

15.94

24.59

iu/l

2.66

437

Other disorders of white blood cells

136

921

1.51

4.79

1.5

1.4

23.05

26.47

iu/l

0.65

111

776

Other postsurgical states

175

1243

1.43

4.78

1.5

1.4

26.24

28.35

iu/l

0.37

152

1054

Viral hepatitis

243

1824

1.36

4.78

1.3

1.4

25.03

22.24

iu/l

0.63

175

1537

Stroke, excluding SAH

555

4848

0.82

4.77

1.4

31.32

32.44

iu/l

0.31

453

4132

Benign neoplasm: Colon, unspecified

299

2298

1.31

4.77

1.4

30.41

33.98

iu/l

1.00

252

1962

Any death

604

5073

0.83

4.77

1.4

30.26

32.98

iu/l

1.26

484

4293

Bicipital tendinitis

114

744

1.56

4.76

1.3

1.4

34.49

31.10

iu/l

0.49

102

641

Maternal care for other known or suspected fetal problems

2013

11463

1.12

4.76

1.3

1.4

20.88

26.28

iu/l

13.71

1783

9814

Immunodeficiency with predominantly antibody defects

102

654

1.62

4.75

2.0

1.5

23.20

26.09

iu/l

0.41

554

Hemiplegia

138

939

1.50

4.75

1.6

1.4

25.29

27.66

iu/l

0.34

110

802

Neuromuscular dysfunction of bladder

198

1437

1.40

4.73

1.7

1.4

25.97

28.93

iu/l

0.56

176

1243

Other disorders of kidney and ureter

220

1622

1.37

4.73

1.5

1.4

31.55

29.25

iu/l

0.41

178

1378

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

243

1828

1.36

4.73

1.5

1.4

22.73

21.68

iu/l

0.20

190

1523

Medial epicondylitis

129

869

1.53

4.73

1.4

1.3

35.78

33.72

iu/l

0.27

112

753

Diseases of arteries, arterioles and capillaries

799

6860

0.85

4.72

1.4

27.00

29.95

iu/l

1.69

665

5846

Other congenital malformations of skin, including avohilmo

315

2458

1.31

4.72

1.4

22.60

25.46

iu/l

0.88

262

2069

Condition for Implicit Sepsis (Organ dysfunction codes)

2114

16122

0.90

4.71

1.5

1.4

26.76

27.19

iu/l

0.23

1735

13789

Sequelae of injuries, of poisoning and of other consequences of external causes

666

5611

1.20

4.71

1.4

26.44

27.80

iu/l

0.49

561

4779

Antepartum haemorrhage, not elsewhere classified

667

5672

1.21

4.70

1.3

1.4

25.20

25.68

iu/l

0.14

586

4887

Malignant neoplasm of breast, ER-negative, including Hilmo

531

4096

1.22

4.67

1.4

1.3

44.20

35.18

iu/l

6.08

441

3629

Cellulitis

566

4702

1.21

4.65

1.5

1.4

22.37

25.43

iu/l

1.63

481

3950

Umbilical hernia

675

5699

1.19

4.63

1.4

19.28

25.19

iu/l

7.06

580

4847

Herpesviral [herpes simplex] infections

404

3252

1.26

4.62

1.5

1.4

27.80

26.99

iu/l

0.18

342

2779

Other specified/unspecified arthritis

813

6976

1.18

4.61

1.4

27.05

28.43

iu/l

0.57

706

5915

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

799

6844

1.18

4.61

1.4

24.55

26.42

iu/l

0.97

681

5785

Haemangioma, any site

270

2069

1.33

4.60

1.5

1.4

28.54

28.71

iu/l

0.03

237

1775

Injury of muscle and tendon at hip and thigh level

293

2268

1.31

4.59

1.4

28.35

29.41

iu/l

0.21

247

1933

Arnold-Chiari syndrome

327

1.92

4.57

1.4

1.6

20.39

19.07

iu/l

0.12

270

Superficial injury of lower leg

901

7801

1.17

4.57

1.4

24.09

25.39

iu/l

0.62

766

6569

Congenital malformations of breast, including avohilmo

126

863

1.55

4.56

1.5

1.4

19.86

23.07

iu/l

0.59

104

742

Tooth eruption problems

718

5910

1.19

4.55

1.7

1.5

14.85

14.41

iu/l

0.18

584

4852

Benign intracranial hypertension

410

1.82

4.55

1.5

1.4

12.57

17.48

iu/l

1.13

345

Sequelae of injuries of upper limb

265

2027

1.33

4.53

1.4

28.75

26.79

iu/l

0.43

232

1732

Assault by bodily force

292

2268

1.31

4.53

1.4

18.54

20.86

iu/l

0.70

220

1877

Other diseases of the digestive system

456

3713

1.23

4.51

1.5

1.4

25.15

26.85

iu/l

0.53

379

3110

Malignant neoplasm of mesothelium and soft tissue

292

1.88

4.50

2.0

1.3

28.93

25.10

iu/l

0.35

243

Other congenital malformations of male genital organs

132

2.43

4.48

2.5

2.6

9.28

5.54

iu/l

0.72

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

423

1.76

4.48

2.4

1.8

14.12

20.35

iu/l

1.20

323

Acute appendicitis, no complications

2215

20111

1.10

4.48

1.4

25.16

26.14

iu/l

0.75

1919

17273

Carcinoma in situ of breast, intraductal

218

1625

1.36

4.48

1.4

1.3

40.32

38.55

iu/l

0.32

189

1415

Acute nasopharyngitis (common cold)

254

1917

1.33

4.46

1.4

18.75

19.79

iu/l

0.24

221

1558

Mental and behavioural disorders due to opioids

146

1022

1.47

4.45

1.5

1.4

15.04

17.04

iu/l

0.42

103

862

595

1.64

4.45

1.5

1.6

6.58

10.55

iu/l

3.88

452

Melanocytic naevi of lower limb, including hip

162

1156

1.44

4.44

1.4

22.52

25.96

iu/l

0.73

138

991

Acute pharyngitis

608

5066

1.20

4.44

1.5

17.99

17.77

iu/l

0.07

506

4171

HSIL lesion of the cervix uteri

1325

11852

1.14

4.42

1.3

23.33

24.47

iu/l

0.69

1138

10351

Hypokalaemia

239

1806

1.34

4.41

1.5

1.4

25.53

31.04

iu/l

2.01

198

1564

Other surgical follow-up care

117

785

1.53

4.40

1.4

17.49

21.96

iu/l

0.90

654

Asthma mixed form (mode)

146

1020

1.46

4.40

1.5

1.4

22.40

26.54

iu/l

0.93

129

860

Striking against or struck by other objects

1075

9433

1.15

4.38

1.5

21.00

22.18

iu/l

0.65

884

7851

Galactorrhea

463

1.76

4.37

1.3

1.4

24.54

25.03

iu/l

0.04

407

Disorders of endocrine glands in diseases classified elsewhere

6.07

4.37

3.3

2.1

17.20

22.15

iu/l

0.14

Mental and behavioural disorders due to cannabinoids

112

747

1.55

4.36

1.5

12.17

13.27

iu/l

0.25

623

Dystonia

171

1234

1.42

4.36

1.5

1.4

30.74

29.42

iu/l

0.19

149

1066

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2605

19096

0.92

4.35

1.4

26.45

26.74

iu/l

0.16

2161

16372

Acute lymphadenitis

218

1637

1.36

4.35

1.5

1.4

22.86

22.87

iu/l

0.00

186

1373

Other symptoms and signs involving the circulatory and respiratory systems

171

1231

1.41

4.35

1.4

24.21

26.84

iu/l

0.54

149

1042

Adhesive capsulitis of shoulder

396

3197

1.25

4.34

1.4

1.3

33.03

34.62

iu/l

0.37

336

2762

Endometriosis in cutaneous scar

2.76

4.34

1.4

41.12

24.92

iu/l

0.75

Other and unspecified erythematous conditions

571

1.62

4.34

1.4

25.50

27.18

iu/l

0.18

486

Haemangioma and lymphangioma, any site

286

2228

1.31

4.33

1.5

1.4

28.48

28.36

iu/l

0.02

251

1900

Other and unspecified abdominal hernia

578

1.61

4.32

1.5

1.4

24.25

27.36

iu/l

0.38

495

Autoimmune thyroiditis

552

1.65

4.32

1.5

1.3

27.94

24.58

iu/l

0.39

475

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

511

1.71

4.32

1.3

24.02

24.05

iu/l

0.00

451

Accessory breast

307

1.96

4.30

1.4

1.3

23.49

24.90

iu/l

0.11

267

Asthma mixed form (mode), excluding more controls

146

1025

1.45

4.30

1.5

1.4

22.40

26.69

iu/l

0.98

129

862

Coagulation defects, purpura and other haemorrhagic conditions

576

4837

1.20

4.28

1.5

1.4

24.47

25.05

iu/l

0.17

476

4097

Bacterial infection, other or unspecified

1026

7573

1.15

4.28

1.6

1.4

27.35

28.75

iu/l

0.68

813

6452

Abscess of anal and rectal regions

226

1705

1.34

4.28

1.4

24.74

24.58

iu/l

0.03

185

1438

Statin medication

3177

16574

1.08

4.28

1.4

27.71

26.41

iu/l

1.36

2736

14356

Other and unspecified disorders of white blood cells

103

676

1.56

4.27

1.4

22.26

26.67

iu/l

0.82

574

Personal history of allergy to drugs, medicaments and biological substances

317

1.87

4.26

1.4

1.3

19.08

23.86

iu/l

0.62

276

Other or unspecified ileus, impaction or obstruction

263

2021

1.31

4.25

1.6

1.4

30.20

31.37

iu/l

0.22

228

1729

Disorders in reading

500

1.68

4.25

2.1

1.9

7.09

12.46

iu/l

3.22

377

Scoliosis

270

2093

1.31

4.24

1.6

1.5

21.44

19.30

iu/l

0.57

222

1711

Malignant neoplasm, without specification of site

108

2.43

4.23

1.3

38.00

26.66

iu/l

0.77

Type 2 diabetes, strict (exclude DM1)

3037

19063

0.92

4.22

1.4

21.88

29.09

iu/l

38.20

2565

16556

Other/unspecified enthesopathies, not elsewhere classified

193

1425

1.37

4.20

1.3

30.47

31.79

iu/l

0.21

168

1230

Papillary adenocarcinoma of thyroid gland

157

1124

1.43

4.20

1.4

31.37

27.80

iu/l

0.71

135

981

Gluteal tendinitis

142

999

1.46

4.20

1.4

33.87

34.21

iu/l

0.04

124

879

Otitis externa

732

6286

1.18

4.19

1.4

21.59

26.08

iu/l

4.38

629

5323

Benign neoplasm of mouth and pharynx

228

1727

1.34

4.18

1.4

30.13

29.73

iu/l

0.06

197

1481

Whooping cough, including avohilmo

606

1.61

4.18

1.4

21.66

22.40

iu/l

0.08

502

Pediculosis, acariasis and other infestations, including avohilmo

739

6360

1.18

4.18

1.5

1.4

21.34

22.40

iu/l

0.44

626

5371

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

129

895

1.48

4.15

1.5

1.4

27.07

24.88

iu/l

0.29

106

759

Disorders of continuity of bone

325

2586

1.28

4.15

1.5

1.4

25.29

28.45

iu/l

0.87

286

2200

Visual impairment including blindness (binocular or monocular)

130

898

1.47

4.14

2.1

1.5

24.84

26.37

iu/l

0.19

101

765

Episcleritis

213

1609

1.36

4.14

1.4

30.16

28.72

iu/l

0.23

182

1388

Inguinal or femoral hernia, bilateral

605

1.56

4.14

1.4

1.5

18.59

19.42

iu/l

0.10

481

Tongue abnormality

131

908

1.47

4.14

1.4

26.44

30.59

iu/l

0.75

109

773

Achilles tendinitis

264

2045

1.31

4.13

1.4

26.76

32.72

iu/l

2.38

237

1759

5-aminosalicylic acid

739

6359

1.17

4.13

1.4

25.23

25.11

iu/l

0.03

645

5414

Heart failure,strict

336

2941

0.79

4.12

1.5

1.4

25.43

31.56

iu/l

2.68

273

2474

Injuries to the elbow and forearm

2037

19090

0.91

4.11

1.4

26.35

26.18

iu/l

0.08

1691

16200

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

499

1.64

4.11

1.4

29.20

27.08

iu/l

0.22

418

Otalgia

280

2192

1.30

4.10

1.5

23.35

24.95

iu/l

0.39

236

1816

Other and unspecified injuries of abdomen, lower back and pelvis

312

1.83

4.09

1.5

23.37

20.14

iu/l

0.28

263

Bacterial pneumonia (organism specified)

903

7123

1.15

4.09

1.5

1.4

24.73

26.39

iu/l

0.86

758

6041

Other diseases of arteries and capillaries

183

1346

1.38

4.08

1.5

1.4

30.98

28.83

iu/l

0.37

155

1149

Aplastic and other anaemias

748

5879

1.17

4.08

1.6

1.4

27.57

29.10

iu/l

0.56

602

4987

HSIL lesion of the cervix uteri, vagina or vulva

1385

12476

1.13

4.08

1.3

23.84

24.80

iu/l

0.55

1191

10887

Other and unspecified nonscarring hair loss

287

1.92

4.07

1.6

1.3

18.95

21.89

iu/l

0.29

251

Other/unspecified synovitis and tenosynovitis

330

2635

1.27

4.06

1.4

27.30

28.94

iu/l

0.41

289

2263

Bell's palsy

306

2422

1.28

4.05

1.4

22.47

27.48

iu/l

2.04

252

2065

Meralgia paraesthetica

102

678

1.54

4.04

1.3

1.4

31.49

28.74

iu/l

0.34

594

Spermatocele

238

1.90

4.01

1.8

1.5

11.49

9.83

iu/l

0.26

196

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

3.24

4.01

2.1

2.3

17.03

22.54

iu/l

—

Bacterial, viral and other infectious agents, including avohilmo

268

2092

1.30

4.01

1.4

22.50

22.18

iu/l

0.06

212

1743

Lichen simplex chronicus and prurigo

141

997

1.44

4.01

1.4

30.34

30.30

iu/l

0.00

122

850

Disorders of sclera, cornea, iris and ciliary body

1761

16006

1.11

4.01

1.4

27.27

26.65

iu/l

0.33

1507

13696

Type 2 diabetes, definitions combined

3039

19031

0.92

4.00

1.4

21.89

29.06

iu/l

37.89

2566

16528

Other specified/unspecified necrotizing vasculopathies

151

2.19

3.99

1.3

34.18

26.39

iu/l

0.60

128

Myeloid leukaemia

247

1.90

3.99

2.3

1.4

23.58

24.04

iu/l

0.04

204

Small fibre neuropathy

350

1.75

3.98

1.6

1.4

28.83

26.90

iu/l

0.16

295

Ischaemic Stroke, excluding all haemorrhages

483

4276

0.83

3.98

1.4

31.40

32.86

iu/l

0.40

396

3655

Postpartum haemorrhage

1838

13854

1.11

3.97

1.3

1.4

24.54

26.62

iu/l

2.04

1658

11893

Single delivery by forceps and vacuum extractor

1113

5900

1.15

3.96

1.3

1.4

24.03

23.96

iu/l

0.02

973

4872

Malignant neoplasm of head and neck, including Hilmo

644

1.53

3.95

1.5

1.3

28.20

27.82

iu/l

0.03

551

Hydronephrosis

220

1672

1.33

3.95

1.6

1.4

34.09

26.53

iu/l

2.03

186

1420

Benign neoplasm of ovary

442

3653

1.22

3.94

1.3

1.4

34.77

34.65

iu/l

0.02

389

3151

Budesonide

474

3947

1.22

3.94

1.5

1.4

24.87

25.88

iu/l

0.30

419

3378

Postprocedural disorders of digestive system, not elsewhere classified

529

1.61

3.94

1.5

1.4

24.46

27.22

iu/l

0.31

448

Infections, IBD-co-morbidities

491

2868

1.21

3.92

1.6

1.4

25.86

30.63

iu/l

2.14

403

2419

Algoneurodystrophy

146

1051

1.44

3.92

1.5

1.4

31.64

27.52

iu/l

0.74

124

911

Congenital iodine-deficiency syndrome/hypothyroidism

539

1.60

3.91

1.4

31.40

28.67

iu/l

0.30

464

Conjunctivitis (acute, non atopic)

1018

8959

1.14

3.89

1.4

24.66

24.80

iu/l

0.05

835

7580

Other diseases of stomach and duodenum

116

795

1.48

3.88

1.4

28.23

31.68

iu/l

0.51

107

678

Enterocolitis due to Clostridium difficile

178

1314

1.37

3.88

1.5

1.4

29.07

26.84

iu/l

0.31

140

1123

Influenza and pneumonia

3525

23241

0.93

3.86

1.5

1.4

24.23

25.49

iu/l

1.50

2936

19840

Third [oculomotor] nerve palsy

201

2.00

3.85

2.1

1.4

24.03

29.02

iu/l

0.33

165

Keratitis

1101

9782

1.13

3.85

1.4

27.00

26.03

iu/l

0.43

934

8352

Chondropathies

497

4168

1.21

3.84

1.5

1.4

24.10

25.46

iu/l

0.46

434

3532

Undescended testis, unilateral

148

2.21

3.83

3.4

2.4

12.82

7.57

iu/l

0.71

Other osteochondrodysplasias

211

2.02

3.83

1.9

1.5

21.62

19.96

iu/l

0.13

166

Arthrosis

2477

12506

1.09

3.82

1.4

1.3

28.42

29.63

iu/l

1.02

2159

10800

Somnolence

283

1.85

3.80

1.5

1.4

14.48

21.20

iu/l

1.46

240

Childhood asthma (age<16)

699

4709

1.17

3.80

1.5

1.4

14.40

16.32

iu/l

1.29

568

3865

Other gastritis (incl. Duodenitis)

384

3137

1.23

3.79

1.4

30.52

30.46

iu/l

0.01

328

2682

Other heart diseases

1847

13138

0.91

3.79

1.4

27.20

28.00

iu/l

0.45

1545

11307

Sicca syndrome [Sjögren]

245

1907

1.31

3.78

1.5

1.4

34.13

32.42

iu/l

0.31

216

1659

Sulfonylureas

105

1223

0.68

3.77

1.5

1.4

27.47

33.77

iu/l

1.44

1025

Diagnoses used for exclusion with ILD

455

3782

1.21

3.77

1.4

29.31

29.92

iu/l

0.14

377

3242

Early lumbar disc prolapse, operated

485

4076

1.21

3.77

1.4

22.95

25.05

iu/l

0.78

422

3502

Childhood asthma (age<16), excluding more controls

699

4712

1.17

3.76

1.5

1.4

14.40

16.33

iu/l

1.29

568

3866

Intestinal adhesions without obstruction

142

1016

1.41

3.76

1.6

1.4

29.58

31.80

iu/l

0.29

117

868

Trigger finger

407

3354

1.23

3.76

1.4

1.3

32.24

33.52

iu/l

0.32

348

2892

Other peripheral vertigo

197

1487

1.34

3.76

1.4

28.81

30.57

iu/l

0.30

153

1288

Iron deficiency anaemia

1131

9880

1.13

3.75

1.4

24.08

27.03

iu/l

2.25

933

8486

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

114

784

1.47

3.74

1.4

29.11

29.75

iu/l

0.07

666

Vitamin D deficiency

444

1.66

3.74

1.7

1.5

16.58

23.14

iu/l

1.11

376

Other specified and unspecified strabismus

270

1.87

3.74

1.6

1.5

26.48

21.48

iu/l

0.37

218

Mixed disorders of conduct and emotions, excluding more controls

627

1.55

3.74

1.5

7.28

8.51

iu/l

0.56

495

Viral conjunctivitis, including avohilmo

166

1230

1.39

3.73

1.4

24.73

25.09

iu/l

0.06

142

1043

Benign neoplasm of bone and articular cartilage

278

2204

1.28

3.73

1.4

24.19

26.48

iu/l

0.57

242

1894

Helminthiases, including avohilmo

180

1351

1.37

3.72

1.4

1.5

19.96

19.44

iu/l

0.08

141

1114

Myocardial infarction

330

2861

0.80

3.72

1.3

1.4

32.08

33.07

iu/l

0.17

268

2392

Mixed specific developmental disorders

557

1.56

3.71

2.6

2.1

7.39

8.25

iu/l

0.34

369

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

196

1483

1.34

3.71

1.3

1.4

32.47

31.57

iu/l

0.14

173

1277

Acute bronchiolitis

199

1361

1.34

3.71

2.3

1.9

8.83

9.07

iu/l

0.08

149

976

Hyperplasia of prostate

179

738

1.37

3.70

1.4

9.47

9.63

iu/l

0.07

143

571

Autoimmune hyperthyroidism

260

2051

1.29

3.70

1.5

1.4

24.56

29.38

iu/l

1.90

222

1789

Other and unspecified disorders of autonomic nervous system

119

2.41

3.68

1.6

1.5

24.39

25.07

iu/l

0.04

103

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

110

2.34

3.68

2.6

1.4

20.21

26.90

iu/l

0.46

Intracranial injury

1654

14013

1.10

3.68

1.5

1.4

22.80

24.42

iu/l

1.32

1372

11823

Nasal polyp

371

3032

1.23

3.68

1.4

24.97

29.01

iu/l

1.64

313

2612

Complications of internal orthopaedic prosthetic devices, implants and grafts

274

2162

1.27

3.68

1.4

31.23

35.73

iu/l

1.52

234

1852

Other keratitis

367

3005

1.24

3.66

1.5

1.4

25.84

24.45

iu/l

0.34

305

2546

Other and unspecified types of non-Hodgkin lymphoma, hilmo

298

1.77

3.66

1.6

1.3

25.26

25.17

iu/l

0.01

250

Raynaud syndrome

359

2940

1.24

3.65

1.5

1.4

24.44

25.51

iu/l

0.25

302

2550

ILD, hospital admissions 1, main diag only

138

987

1.41

3.64

1.4

32.01

29.45

iu/l

0.36

106

835

Benign neoplasm: Rectum, anus and anal canal

260

2042

1.28

3.64

1.5

1.4

34.97

33.28

iu/l

0.32

218

1753

Crohn disease

447

3735

1.21

3.64

1.4

21.86

23.80

iu/l

0.77

398

3144

Infections with a predominantly sexual mode of transmission

1581

14365

1.11

3.63

1.4

22.21

22.36

iu/l

0.07

1290

12379

Other and unspecified coagulation defects

212

1635

1.33

3.62

1.4

24.70

24.34

iu/l

0.06

177

1395

ILD, hospital admission 2, with pulmonary infections

101

682

1.49

3.62

1.5

1.4

34.46

29.49

iu/l

0.66

571

Elevated blood glucose level

203

1549

1.33

3.62

1.4

1.5

19.16

26.09

iu/l

2.43

156

1303

Varicella [chickenpox]

126

893

1.44

3.61

1.8

1.6

12.71

19.71

iu/l

2.46

714

Postpartum care and examination

1025

5722

1.14

3.61

1.3

1.4

21.46

27.73

iu/l

9.30

932

4865

Other viral hepatitis, including avohilmo

230

1790

1.31

3.61

1.4

21.90

21.32

iu/l

0.10

164

1504

Malignant neoplasm of adrenal gland

2.80

3.60

2.7

2.2

20.31

19.69

iu/l

0.02

Other coagulation defects

276

2199

1.28

3.59

1.4

23.19

24.58

iu/l

0.33

231

1867

Varicose veins of other sites

108

742

1.47

3.59

1.7

1.4

14.91

22.26

iu/l

2.49

610

Postzoster neuralgia

124

2.23

3.59

1.6

1.4

34.67

29.23

iu/l

0.26

108

Other benign neoplasms of skin

904

7969

1.14

3.59

1.4

28.56

29.72

iu/l

0.48

776

6854

Concussion

1856

13164

1.10

3.59

1.4

23.14

25.41

iu/l

2.45

1551

11148

Septicaemia

706

5567

1.16

3.58

1.8

1.4

22.65

27.66

iu/l

4.26

558

4654

Diseases of middle ear and mastoid

2434

18407

1.09

3.58

1.4

19.22

21.61

iu/l

3.96

2060

15601

Nontoxic single thyroid nodule

203

1554

1.33

3.57

1.4

1.3

30.15

31.39

iu/l

0.19

178

1351

Other and unspecified trigeminal disorders

326

1.75

3.57

1.4

1.3

28.68

27.92

iu/l

0.05

285

Constipation

2841

17899

1.08

3.57

1.5

1.4

28.51

28.96

iu/l

0.29

2389

15365

Other necrotizing vasculopathies (FG)

597

1.53

3.55

1.4

31.06

30.31

iu/l

0.08

517

Obstructed labour due to malposition and malpresentation of fetus

1616

13681

1.11

3.55

1.3

1.4

28.32

27.79

iu/l

0.25

1444

11787

Rheumatoid arthritis

641

6576

0.86

3.55

1.4

1.3

32.65

31.53

iu/l

0.34

550

5632

Ulcerative colitis

781

6833

1.15

3.53

1.4

25.60

25.42

iu/l

0.06

685

5784

Procedures for purposes other than remedying health state

669

1.52

3.53

1.4

31.82

29.59

iu/l

0.29

571

Certain conditions originating in the perinatal period

343

2486

1.24

3.52

1.9

1.7

14.39

14.93

iu/l

0.13

270

1926

Thrombocytopenia, unspecified

141

1022

1.40

3.51

1.5

1.4

30.01

25.81

iu/l

0.65

111

858

Use of ropinirole

236

1.85

3.50

1.5

1.4

28.04

29.95

iu/l

0.17

198

LSIL lesion of the cervix uteri

770

6771

1.16

3.50

1.4

1.3

25.38

24.91

iu/l

0.15

671

5885

Heart failure and coronary heart disease

181

1679

0.75

3.49

1.5

1.4

24.26

30.46

iu/l

1.58

151

1379

Other benign neoplasms of connective and other soft tissue

261

2070

1.28

3.48

1.4

24.95

28.63

iu/l

1.20

235

1779

Acute myeloid leukaemia and myelodysplastic syndromes

106

2.30

3.47

2.7

1.2

15.77

23.58

iu/l

0.91

Benign neoplasm: Choroid

121

856

1.43

3.47

1.4

29.31

31.85

iu/l

0.38

107

739

Malnutrition

282

1.78

3.47

2.4

1.8

16.34

20.86

iu/l

0.47

218

Personal history of risk-factors, not elsewhere classified

345

1.72

3.46

1.6

1.4

22.04

16.72

iu/l

0.66

279

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3723

22101

1.07

3.45

1.6

1.4

26.97

25.63

iu/l

1.64

3072

18998

Inguinal hernia, bilateral

584

1.52

3.44

1.4

1.5

17.80

18.40

iu/l

0.07

462

Fracture of forearm

1379

13665

0.90

3.44

1.4

28.90

27.94

iu/l

0.45

1139

11609

Impingement syndrome of shoulder

461

3875

1.20

3.44

1.4

1.3

35.27

36.03

iu/l

0.17

406

3317

Unspecified misadventure during surgical and medical care

136

986

1.40

3.43

1.5

1.4

27.74

28.12

iu/l

0.04

122

842

Bacterial infection, other or unspecified, including avohilmo

1228

9037

1.12

3.42

1.5

1.4

26.88

28.08

iu/l

0.61

986

7700

Myopia

599

5167

1.18

3.42

1.5

1.4

21.54

23.86

iu/l

1.09

497

4397

Stenosis and insufficiency of lacrimal passages

213

1651

1.31

3.40

1.5

1.4

30.05

29.97

iu/l

0.01

189

1419

Anorexia

490

1.61

3.40

1.7

1.4

18.96

24.43

iu/l

1.00

422

Malignant neoplasm of bone and articular cartilage

108

2.31

3.40

2.8

1.8

17.55

22.37

iu/l

0.29

Maternal care for cervical incompetence

144

1061

1.39

3.38

1.2

1.3

20.95

22.45

iu/l

0.23

129

906

Other and unspecified urticaria

780

6856

1.15

3.37

1.4

23.28

25.82

iu/l

1.55

690

5820

512

0.48

3.37

1.3

1.4

33.17

25.18

iu/l

0.52

418

Insulin, combination of fast acting with intermediate-acting or long-acting

1126

11373

0.89

3.35

1.4

20.50

24.97

iu/l

5.69

925

9597

Erosion and ectropion of cervix uteri

330

1.70

3.35

1.3

1.4

27.89

32.60

iu/l

0.50

288

Cholecystectomy

2345

18461

1.08

3.35

1.4

27.94

30.04

iu/l

2.49

2045

16040

Other bursopathies

244

1926

1.28

3.34

1.3

1.4

28.52

31.75

iu/l

0.84

209

1639

Gout, FINNGEN

211

1620

1.30

3.34

1.5

1.4

24.09

26.56

iu/l

0.45

163

1344

Acute myeloid leukaemia, helper endpoint

2.47

3.34

3.0

1.2

14.52

23.77

iu/l

1.03

Acute myeloid leukaemia, including Hilmo

2.47

3.34

3.0

1.2

14.52

23.77

iu/l

1.03

Acute myeloid leukaemia

2.47

3.34

3.0

1.2

14.52

23.77

iu/l

1.03

Bacterial, viral and other infectious agents

235

1851

1.29

3.34

1.5

1.4

23.24

22.29

iu/l

0.18

186

1553

Other osteochondrodysplasias, including avohilmo

250

1.84

3.34

1.8

1.5

23.20

20.50

iu/l

0.24

203

Other skin changes

415

3467

1.21

3.34

1.4

26.95

28.85

iu/l

0.57

364

2932

Diabetic nephropathy

141

1886

0.73

3.34

1.3

1.4

21.96

19.12

iu/l

0.41

118

1593

Sarcoidosis

315

2564

1.24

3.33

1.4

28.39

30.09

iu/l

0.37

260

2204

Injury of eye and orbit

390

3243

1.21

3.33

1.4

23.53

22.89

iu/l

0.15

330

2696

Contact with other hot fluids

103

717

1.47

3.33

1.4

1.5

17.56

21.50

iu/l

0.65

587

Otitis externa, unspecified

390

3249

1.22

3.32

1.4

21.09

24.64

iu/l

1.72

333

2746

Type 1 diabetes, strict definition

233

2924

0.78

3.32

1.4

1.6

16.93

18.07

iu/l

0.25

188

2374

Giant cell arteritis with polymyalgia rheumatica

183

1.94

3.31

1.3

1.4

32.76

32.64

iu/l

0.01

154

Malignant neoplasm of other connective and soft tissue, including Hilmo

408

1.62

3.30

1.7

1.4

33.71

26.69

iu/l

0.64

352

Cauda equina syndrome

258

1.82

3.30

1.6

1.3

19.61

24.72

iu/l

0.62

213

All influenza (not pneumonia)

351

2890

1.22

3.30

1.7

1.5

19.40

22.19

iu/l

1.15

301

2375

Superficial injury of wrist and hand

791

6967

1.15

3.30

1.4

20.46

23.35

iu/l

2.10

673

5834

Cerebrovascular diseases (FINNGEN)

746

5966

0.87

3.30

1.4

31.71

33.79

iu/l

0.85

617

5189

Scleritis and episcleritis

234

1851

1.29

3.29

1.4

30.88

28.84

iu/l

0.38

201

1593

Convergence insufficiency and excess

438

1.63

3.29

1.5

1.4

33.43

21.51

iu/l

1.34

367

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

138

1015

1.40

3.29

1.5

1.4

21.55

24.31

iu/l

0.51

106

858

Malignant neoplasm of cervix uteri, including Hilmo

104

730

1.47

3.28

1.3

46.48

24.62

iu/l

4.84

639

Other embolism and thrombosis

264

2110

1.26

3.28

1.4

27.54

29.91

iu/l

0.63

224

1816

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

1160

0.66

3.28

1.4

30.91

30.18

iu/l

0.07

1000

Vitamin deficiency, wide

126

910

1.41

3.27

1.6

1.4

22.05

27.45

iu/l

1.07

103

772

Vitamin deficiency

126

910

1.41

3.27

1.6

1.4

22.05

27.45

iu/l

1.07

103

772

Benign neoplasm: Brain, supratentorial

304

1.74

3.26

2.6

1.4

24.02

23.14

iu/l

0.06

248

Other and unspecified injuries of wrist and hand

135

989

1.40

3.26

1.4

29.35

23.41

iu/l

1.11

110

808

Malignant neoplasm of breast, HER-negative

443

3582

1.20

3.26

1.4

1.3

45.68

35.66

iu/l

6.39

373

3169

Other disorders of glucose regulation and pancreatic internal secretion

212

1653

1.30

3.26

1.5

23.90

23.20

iu/l

0.11

176

1367

Temporal arteritis

184

1.93

3.26

1.3

32.76

33.15

iu/l

0.02

155

Ulcerative rectosigmoiditis

262

2100

1.27

3.25

1.4

25.27

25.39

iu/l

0.02

220

1789

Scabies, including avohilmo

661

5764

1.16

3.25

1.5

1.4

20.43

21.99

iu/l

0.70

558

4843

Hypersomnia

290

1.76

3.23

1.7

1.3

17.16

26.92

iu/l

1.75

251

Explicit Sepsis, including avohilmo

977

7889

1.13

3.23

1.7

1.4

22.76

25.96

iu/l

2.55

798

6671

Myocardial infarction, strict

286

2507

0.80

3.23

1.3

1.4

30.09

32.39

iu/l

0.47

231

2094

Cyst of kidney

643

1.48

3.23

1.5

1.3

29.38

29.74

iu/l

0.03

544

Disorders of lipoprotein metabolism and other lipidaemias

1802

11924

0.92

3.22

1.4

30.00

33.07

iu/l

3.15

1447

10344

Other congenital malformations of skin

140

1035

1.39

3.22

1.5

22.31

24.24

iu/l

0.31

119

860

Other viral hepatitis

212

1661

1.30

3.21

1.3

1.4

22.32

21.26

iu/l

0.18

149

1399

Mucosal proctocolitis

417

3507

1.20

3.20

1.4

24.87

23.57

iu/l

0.35

359

2963

Explicit Sepsis

947

7674

1.13

3.20

1.7

1.4

22.58

26.06

iu/l

2.85

774

6487

Osteoporosis with pathological fracture (FG)

474

1.55

3.19

1.5

1.3

42.25

40.98

iu/l

0.10

391

Hypoglycaemia, other or unspecified

179

1370

1.33

3.19

1.5

25.29

23.17

iu/l

0.36

150

1142

Nontoxic diffuse goitre

591

1.51

3.18

1.5

1.3

32.70

32.16

iu/l

0.05

522

Superficial injury of head

623

5400

1.16

3.17

1.4

24.83

26.36

iu/l

0.57

502

4509

Malignant neoplasm of bone and articular cartilage, including Hilmo

201

1.89

3.17

2.4

1.5

19.24

23.37

iu/l

0.37

170

Crohn's disease of small intestine

236

1876

1.28

3.17

1.4

23.09

23.29

iu/l

0.03

209

1566

Acute pancreatitis

342

2819

1.22

3.17

1.5

1.4

25.48

28.82

iu/l

1.13

285

2388

Later onset COPD, excluding more controls

298

1.61

3.17

1.3

1.4

28.94

36.81

iu/l

1.08

239

Unspecified haematuria

603

4237

1.16

3.16

1.5

1.4

30.05

27.58

iu/l

0.94

508

3549

Diabetic maculopathy

167

2062

0.76

3.15

1.3

1.4

20.36

17.24

iu/l

0.66

143

1751

Other chromosome abnormalities, not elsewhere classified

156

2.12

3.14

2.8

2.1

13.38

16.13

iu/l

0.30

117

Other mental disorders due to brain damage and dysfunction and to physical disease

124

896

1.39

3.14

1.5

1.4

28.57

28.86

iu/l

0.03

755

Dependence on enabling machines and devices, not elsewhere classified

152

2.03

3.14

2.3

1.8

6.31

17.62

iu/l

4.47

111

Benign neoplasm: Liver/bile ducts

108

770

1.45

3.14

1.5

1.3

26.57

26.74

iu/l

0.02

669

Crowding of teeth, including avohilmo

412

2871

1.21

3.13

1.9

1.6

15.61

15.16

iu/l

0.13

338

2266

Unspecified abortion

248

1995

1.28

3.13

1.4

1.3

35.15

37.86

iu/l

0.56

212

1754

Ulcerative colitis, NAS

442

3746

1.19

3.11

1.5

1.4

25.34

24.83

iu/l

0.12

388

3166

Family history of other conditions

500

1.57

3.11

1.6

1.4

17.21

21.61

iu/l

0.66

426

Other and unspecified disorders of vitreous body

723

6201

1.14

3.11

1.4

1.3

38.78

38.68

iu/l

0.03

624

5340

Presence of cardiac and vascular implants and grafts

240

2217

0.79

3.11

1.3

1.4

26.75

29.56

iu/l

0.57

194

1854

Misadventures to patients during surgical and medical care

365

3040

1.21

3.10

1.4

26.49

28.38

iu/l

0.52

322

2608

Pneumocystosis

153

2.00

3.09

1.9

1.5

39.75

26.80

iu/l

0.84

125

Pneumocystosis, including avohilmo

153

2.00

3.09

1.9

1.5

39.75

26.80

iu/l

0.84

125

Embedded teeth, including avohilmo

421

3564

1.20

3.09

1.5

16.47

16.71

iu/l

0.06

363

2972

Alcohol abuse, main dg, excluding more controls

340

2812

1.22

3.09

1.5

1.4

19.70

23.76

iu/l

1.87

264

2403

Other and unspecified injuries of ankle and foot

162

1233

1.34

3.08

1.3

1.5

19.61

22.20

iu/l

0.57

147

1007

Amblyopia ex anopsia

130

957

1.39

3.06

1.7

22.50

18.93

iu/l

0.64

107

765

Phlebitis and thrombophlebitis (not including DVT)

565

4885

1.16

3.06

1.4

28.82

30.20

iu/l

0.45

481

4223

Helminthiases

302

1.71

3.05

1.3

1.5

23.69

23.17

iu/l

0.04

251

Drug-induced osteoporosis with pathological fracture

161

1.97

3.05

1.5

1.4

32.83

27.69

iu/l

0.25

133

Other salmonella infections, including avohilmo

120

872

1.40

3.04

1.5

1.4

26.52

25.91

iu/l

0.07

755

Pervasive developmental disorders excl. Autism + Asperger

385

1.63

3.04

2.0

13.26

12.82

iu/l

0.04

260

Cyst of Bartholin Gland

189

1478

1.32

3.03

1.4

27.23

26.81

iu/l

0.06

165

1289

Pneumonia due to other infectious organisms, not elsewhere classified

475

1.54

3.01

1.6

1.4

23.45

26.60

iu/l

0.31

409

Speech therapy

576

4992

1.16

3.01

1.4

32.23

31.07

iu/l

0.36

512

4254

Other injuries of upper limb, level unspecified

191

1.90

3.01

1.6

1.5

25.35

18.37

iu/l

0.63

163

Type1 diabetes, definitions combined, early onset

195

2461

0.77

3.01

1.5

1.6

13.67

14.97

iu/l

0.31

159

1969

Implicit fungal Sepsis

507

1.52

3.01

1.7

1.4

32.31

27.01

iu/l

0.52

436

Cysts of oral region, not elsewhere classified

140

1044

1.36

3.00

1.6

1.5

28.21

25.12

iu/l

0.44

110

877

Hypertension, essential

3034

16088

1.07

3.00

1.4

29.11

30.04

iu/l

0.81

2545

14067

Type 1 diabetes, strict definition, subgroup 1

224

2788

0.79

3.00

1.5

1.6

17.19

17.61

iu/l

0.08

180

2269

Ventral hernia

501

4298

1.17

2.99

1.4

24.43

31.34

iu/l

6.15

422

3682

Specific development disorders of speech and language

178

1325

1.31

2.99

2.1

1.7

11.42

12.02

iu/l

0.11

130

993

Hyperprolactinaemia, drug-induced

173

2.01

2.99

1.4

1.3

18.63

28.68

iu/l

1.64

149

Long labour

1695

13266

1.10

2.98

1.3

1.4

24.03

26.32

iu/l

2.19

1502

11401

Other and unspecified follicular disorders

123

902

1.39

2.97

1.4

19.57

22.57

iu/l

0.53

102

774

Other arthritis (FG)

922

8249

1.12

2.97

1.4

26.83

28.29

iu/l

0.69

797

7053

Other heart diseases, wide

3358

21541

0.94

2.97

1.4

26.52

26.28

iu/l

0.16

2867

18405

Eustachian salpingitis and obstruction

399

3379

1.20

2.97

1.4

23.90

21.33

iu/l

0.81

331

2901

Other congenital malformations of circulatory system

519

1.52

2.97

1.8

1.4

29.73

26.77

iu/l

0.29

444

Intermittent heterotropia

223

1775

1.28

2.97

1.9

1.6

18.89

18.04

iu/l

0.17

168

1414

Special screening examination for other diseases and disorders

315

2596

1.22

2.96

1.4

1.3

22.31

25.98

iu/l

1.37

269

2152

Lesion of ulnar nerve

332

2753

1.22

2.96

1.4

27.87

30.17

iu/l

0.65

293

2365

Other and unspecified disorders of skin and subcutaneous tissue

1091

0.67

2.96

1.4

27.71

28.26

iu/l

0.04

942

Benign neoplasm: Rectum

220

1743

1.27

2.95

1.5

1.4

35.80

33.62

iu/l

0.39

182

1495

Hydrocephalus

656

1.45

2.94

2.2

1.5

24.34

27.95

iu/l

0.50

545

Protozoal diseases, including avohilmo

430

1.57

2.94

1.7

1.4

36.54

27.73

iu/l

0.95

361

Acute pancreatitis (for exclusion)

342

2844

1.21

2.93

1.5

1.4

25.48

28.64

iu/l

1.04

285

2412

Barrett oesophagus

397

1.58

2.93

1.4

29.53

28.80

iu/l

0.06

334

Mental and behavioural disorders of puerperium, not classified elsewhere

562

1.54

2.93

1.3

24.02

22.84

iu/l

0.12

495

Scissor bite

111

797

1.42

2.93

2.0

2.1

11.86

12.36

iu/l

0.08

582

Giant cell arteritis

228

1.77

2.92

1.3

30.48

32.67

iu/l

0.16

194

Other specified/unspecified hearing loss

142

1064

1.35

2.92

1.4

29.75

30.40

iu/l

0.08

116

904

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

315

1.68

2.92

1.3

1.4

27.24

21.56

iu/l

0.53

267

Benign neoplasm: Stomach

165

1264

1.32

2.92

1.4

33.80

34.21

iu/l

0.05

139

1092

Postpartum hemorraghe, all women as controls

1838

16639

1.09

2.91

1.3

24.54

24.48

iu/l

0.03

1658

14345

Mature T/NK-cell lymphomas, hilmo

2.30

2.90

1.9

1.4

32.94

27.24

iu/l

0.26

LSIL lesion of the cervix uteri, vagina or vulva

903

8117

1.13

2.90

1.4

1.3

26.17

26.37

iu/l

0.06

777

7075

Oral lichen planus, including avohilmo , including avohilmo

171

1320

1.31

2.90

1.4

32.31

33.28

iu/l

0.14

154

1141

Malignant neoplasm, without specification of site, including Hilmo

221

1.78

2.89

1.3

1.2

35.45

29.21

iu/l

0.54

191

Vocal cord dysfunction

487

3681

1.17

2.88

1.4

26.80

31.61

iu/l

2.59

424

3236

Lactose intolerance

104

747

1.43

2.88

1.4

25.20

23.43

iu/l

0.22

632

Superficial injury of ankle and foot

488

4203

1.17

2.88

1.5

21.94

21.62

iu/l

0.08

411

3488

Enterobiasis, including avohilmo

127

949

1.39

2.88

1.3

1.5

16.75

16.24

iu/l

0.07

103

782

ILD, hospital admissions 3, with pneumonia sepsis

535

1.49

2.87

1.4

34.67

29.64

iu/l

0.55

447

Melanocytic naevi of other and unspecified parts of face

199

1572

1.29

2.87

1.3

1.4

23.15

26.77

iu/l

0.90

176

1334

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

141

1076

1.37

2.86

1.4

1.3

23.06

24.90

iu/l

0.27

108

931

Fall on and from stairs and steps

696

6138

1.14

2.86

1.4

25.87

27.69

iu/l

0.82

566

5234

Disorders of eyelid, lacrimal system and orbit

2965

20420

1.07

2.85

1.5

1.4

28.70

27.42

iu/l

1.23

2505

17618

Injury of muscle and tendon at wrist and hand level

305

2520

1.22

2.84

1.3

1.4

27.28

26.62

iu/l

0.13

256

2121

Event of undetermined intent

195

1537

1.29

2.84

1.4

20.23

21.83

iu/l

0.33

144

1284

Benign neoplasm of male genital organs

2.43

2.81

2.3

1.3

9.55

11.20

iu/l

0.24

Other disorders of nervous system

120

883

1.37

2.80

1.7

1.4

25.30

30.55

iu/l

1.09

101

762

Social disorders starting during childhood or adolecense, excluding more controls

205

1.85

2.79

2.2

1.8

4.76

10.06

iu/l

3.56

148

Migraine without aura, drug-induced

344

1.65

2.79

1.4

19.68

27.04

iu/l

1.26

290

Intestinal malabsorption

126

938

1.37

2.78

1.7

1.4

21.33

25.85

iu/l

0.97

106

799

Total colectomy operation

109

793

1.40

2.78

1.5

1.4

23.02

24.79

iu/l

0.22

675

Total colectomy

109

793

1.40

2.78

1.5

1.4

23.02

24.79

iu/l

0.22

675

Other vitreous opacities

616

1.45

2.77

1.4

1.3

26.79

29.87

iu/l

0.45

522

Nail disorders

224

1800

1.26

2.76

1.4

23.94

25.29

iu/l

0.26

187

1520

conjunctival haemorrhage

121

894

1.37

2.75

1.5

1.4

31.47

31.26

iu/l

0.02

110

765

Congenital deformities of hip

554

1.49

2.75

1.7

21.20

19.32

iu/l

0.21

434

Lichen ruber planus, wide definition including periferal and oral lichen planus

474

4081

1.17

2.75

1.4

30.54

33.26

iu/l

1.08

421

3524

Campylobacter enteritis

545

1.48

2.73

1.5

1.3

25.66

26.69

iu/l

0.09

462

Malignant neoplasm of cervix uteri

633

1.46

2.73

1.3

46.14

23.66

iu/l

4.19

550

Other hearing loss

341

2763

1.20

2.72

1.4

28.62

31.43

iu/l

0.87

285

2366

Convalescence

162

1255

1.31

2.72

1.4

23.88

27.57

iu/l

0.83

142

1082

Cardiac murmurs and other cardiac sounds

301

2469

1.22

2.72

1.5

1.6

20.47

22.91

iu/l

0.71

250

1999

Hypertrophic disorders of skin

233

1890

1.26

2.72

1.4

24.39

24.31

iu/l

0.01

199

1605

Hypertension

3171

16860

1.06

2.71

1.4

28.64

29.27

iu/l

0.49

2659

14659

Tooth agenesis EXCLUDE clefts and syndromes

181

1426

1.30

2.71

1.9

1.6

16.35

15.57

iu/l

0.16

147

1134

Right bundle-branch block

287

1.66

2.71

1.4

1.5

24.21

24.37

iu/l

0.01

242

Other disorders of veins

1297

11681

1.10

2.69

1.4

29.60

32.00

iu/l

1.83

1121

10171

Urethritis and urethral syndrome

416

1.55

2.69

1.5

1.3

33.63

27.60

iu/l

0.45

359

Hallux valgus (acquired)

828

6616

0.89

2.69

1.4

1.3

35.50

35.86

iu/l

0.11

727

5752

Other congenital malformations, not elsewhere classified

246

1.76

2.69

2.1

1.9

15.97

19.13

iu/l

0.23

190

Calcific tendinitis of shoulder

175

1372

1.30

2.69

1.4

1.3

28.30

34.44

iu/l

1.74

158

1204

Nummular dermatitis

154

1184

1.31

2.69

1.4

21.63

27.14

iu/l

1.77

135

1000

Fracture of foot, except ankle

866

7778

1.12

2.68

1.4

25.77

25.31

iu/l

0.15

726

6594

Necrosis of pulp, including avohilmo

2258

20874

1.07

2.68

1.4

26.65

26.90

iu/l

0.14

1893

17963

Fungal Sepsis

529

1.48

2.67

1.7

1.4

31.90

26.62

iu/l

0.53

453

Benign neoplasm of other and unspecified sites

522

1.48

2.67

1.6

1.4

26.71

28.38

iu/l

0.15

449

Ménière disease

180

1414

1.29

2.67

1.4

28.98

32.02

iu/l

0.65

153

1227

Fall on same level involving ice and snow

1737

16088

1.08

2.66

1.4

28.22

27.87

iu/l

0.16

1468

13765

Separation of retinal layers (serosa)

571

1.46

2.66

1.3

1.4

28.55

26.91

iu/l

0.14

481

Any dementia

112

1052

0.73

2.66

1.4

38.75

32.70

iu/l

0.91

886

Other/unspecified soft tissue disorders related to use, overuse and pressure

699

1.42

2.66

1.4

25.30

27.95

iu/l

0.38

607

Secondary hypertension

170

1306

1.30

2.66

1.7

1.5

29.20

26.47

iu/l

0.35

142

1089

Glaucoma suspect

579

5064

1.15

2.66

1.4

32.36

33.89

iu/l

0.51

510

4375

Exposure to other and unspecified animate mechanical forces

130

984

1.36

2.65

1.4

27.20

23.58

iu/l

0.55

113

841

Autoimmune hepatitis, wide definition

123

920

1.36

2.65

1.6

1.5

22.86

27.76

iu/l

1.10

107

779

Hypertensive diseases

3171

16879

1.06

2.64

1.4

28.64

29.26

iu/l

0.47

2659

14668

Vasomotor rhinitis (mode)

194

1543

1.27

2.64

1.3

1.4

25.59

28.30

iu/l

0.61

173

1325

Hypothyroidism, autoimmune, DX-based

130

2.10

2.64

1.4

1.5

20.06

22.19

iu/l

0.13

110

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

135

1026

1.35

2.64

1.9

1.7

19.93

18.37

iu/l

0.21

106

814

Status epilepticus

449

1.51

2.64

1.6

1.5

25.28

27.35

iu/l

0.17

372

Viral pneumonia (unknown virus, not influenza)

159

1233

1.31

2.63

1.4

20.58

22.51

iu/l

0.34

124

1041

Certolizumab pegol

620

1.45

2.62

1.2

1.4

24.66

18.91

iu/l

0.79

525

Other disorders of breast and lactation associated with childbirth

112

837

1.40

2.62

1.2

1.3

14.58

16.40

iu/l

0.40

101

716

Lichen planopilaris

2.89

2.62

1.5

1.3

46.62

30.51

iu/l

0.58

Lichen simplex chronicus

566

1.46

2.61

1.4

29.09

30.19

iu/l

0.12

491

Dementia

145

1294

0.76

2.61

1.5

1.4

35.61

32.17

iu/l

0.49

121

1081

Other congenital malformations of intestine

172

1.89

2.61

1.8

1.9

19.97

19.51

iu/l

0.03

134

Disorders of optic nerve and visual pathways

329

2770

1.20

2.61

1.7

1.4

23.96

24.86

iu/l

0.19

278

2345

Other specified/unspecified bacterial intestinal infections

138

1051

1.33

2.61

1.5

1.4

21.10

27.95

iu/l

2.37

118

901

Other other unspecified disorders of the circulatory system

533

1.47

2.60

1.5

1.4

30.86

32.47

iu/l

0.17

447

Disorder of lipoprotein metabolism, unspecified

125

936

1.34

2.60

1.5

1.4

29.92

30.51

iu/l

0.07

101

803

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

240

1.74

2.59

1.9

2.0

15.20

14.09

iu/l

0.10

186

Other maltreatment syndromes

711

1.41

2.59

1.4

21.03

22.27

iu/l

0.15

600

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1757

16114

1.08

2.59

1.4

21.62

23.12

iu/l

1.32

1495

13647

Autism

115

858

1.38

2.59

1.7

1.6

11.51

13.09

iu/l

0.35

680

Heart failure and antihypertensive medication

257

2035

0.82

2.58

1.5

1.4

24.82

35.92

iu/l

5.44

207

1722

Benign neoplasm of middle ear and respiratory system

127

956

1.34

2.58

1.4

28.37

28.45

iu/l

0.01

810

Insulin, fast-acting (human)

347

4089

0.84

2.57

1.4

20.03

21.70

iu/l

0.49

304

3465

Other and unspecified nonorganic psychotic disorders

706

6289

1.13

2.56

1.4

19.03

23.32

iu/l

3.46

521

5339

Autism spe

114

852

1.37

2.55

1.8

1.6

11.59

13.10

iu/l

0.32

678

Deep bite

397

2982

1.18

2.55

1.9

1.6

22.51

21.11

iu/l

0.37

320

2399

ILD, hospital admissions

147

1130

1.31

2.55

1.4

33.95

29.32

iu/l

0.80

114

961

Disorders of lacrimal system and orbit in diseases classified elsewhere

571

1.46

2.55

1.4

26.23

30.06

iu/l

0.51

499

Other sexually transmitted chlamydial diseases, including avohilmo

511

4468

1.16

2.54

1.4

14.78

13.87

iu/l

0.34

390

3723

Injuries to unspecified part of trunk, limb or body region

250

2052

1.23

2.54

1.5

24.39

23.45

iu/l

0.17

206

1710

Purpura and other haemorrhagic conditions

308

2578

1.20

2.54

1.5

1.4

25.57

25.55

iu/l

0.00

251

2167

Enteropathic arthropathies

639

1.43

2.54

1.4

25.80

27.48

iu/l

0.21

541

Myeloproliferative diseases

120

898

1.35

2.54

1.4

1.3

26.85

29.93

iu/l

0.57

105

764

Assault by other specified means

265

1.70

2.54

1.4

17.65

20.32

iu/l

0.21

220

Transitory endocrine and metabolic disorders specific to fetus and newborn

392

1.56

2.53

2.5

2.4

5.66

6.29

iu/l

0.23

246

Diabetic retinopathy, strict definition

261

2800

0.82

2.53

1.3

1.4

21.95

19.32

iu/l

0.62

222

2360

Ulcerative ileocolitis

133

1016

1.34

2.53

1.5

1.4

20.40

24.47

iu/l

0.97

119

868

Drug-induced hypopituitarism

3.96

2.52

3.0

1.9

11.11

17.98

iu/l

—

Congenital malformations of the circulatory system

431

3609

1.17

2.52

1.9

1.6

22.48

22.38

iu/l

0.02

354

2925

667

1.41

2.51

2.5

2.3

8.01

6.82

iu/l

0.38

443

Substance abuse, excluding more controls

1478

11390

1.09

2.51

1.4

1.3

20.76

25.82

iu/l

8.98

1137

9869

Localized adiposity

154

1.96

2.50

1.8

1.3

25.47

29.03

iu/l

0.27

130

Streptococcal septicaemia, including avohilmo

142

1091

1.31

2.50

1.6

1.5

24.94

26.22

iu/l

0.19

110

902

Nutritional anaemias

1235

10784

1.10

2.50

1.4

24.88

27.44

iu/l

1.90

1022

9269

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1900

12837

0.93

2.50

1.4

31.72

29.02

iu/l

2.68

1646

11244

Other congenital malformations of female genitalia

364

1.60

2.50

1.5

24.82

17.70

iu/l

0.68

308

Impacted maxillary molar

296

2484

1.21

2.49

1.4

11.92

13.69

iu/l

0.81

253

2045

Benign neoplasm: Liver

100

736

1.40

2.49

1.5

1.3

25.78

26.12

iu/l

0.04

639

Other peripheral vascular diseases

236

1933

1.24

2.49

1.4

23.77

26.96

iu/l

0.81

201

1659

Previous suicide attempt

290

1.65

2.49

1.6

1.5

20.45

18.35

iu/l

0.20

239

Other necrotizing vasculopathies

102

747

1.38

2.49

1.5

1.4

31.32

29.89

iu/l

0.16

641

Abnormal reflex

125

2.05

2.49

1.9

1.5

19.43

24.37

iu/l

0.40

107

Bacterial pneumoniae

851

6718

1.12

2.48

1.5

1.4

24.63

26.64

iu/l

1.10

715

5713

Problems related to lifestyle

315

2652

1.20

2.48

1.5

1.4

20.34

21.76

iu/l

0.38

248

2263

Interstitial lung disease

147

1135

1.30

2.48

1.4

33.95

29.40

iu/l

0.78

114

965

Other interstitial pulmonary diseases

147

1135

1.30

2.48

1.4

33.95

29.38

iu/l

0.78

114

966

Interstitial lung disease endpoints

147

1135

1.30

2.48

1.4

33.95

29.40

iu/l

0.78

114

965

Other diseases caused by chlamydiae

522

1.50

2.47

1.3

1.4

32.77

32.57

iu/l

0.02

465

Perioral dermatitis

112

841

1.37

2.47

1.3

1.4

25.49

25.72

iu/l

0.03

725

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

379

1.56

2.47

2.3

2.4

5.69

6.34

iu/l

0.23

240

Other papulosquamous disorders

182

1.82

2.47

1.3

1.5

28.90

25.50

iu/l

0.18

142

Volume depletion

111

824

1.36

2.47

1.6

1.5

21.17

25.36

iu/l

0.75

679

Anisometropia and aniseikonia

607

1.43

2.46

1.7

1.5

22.65

26.05

iu/l

0.47

494

Hypothyroidism due to medicaments and other exogenous substances

220

1.74

2.46

1.7

1.4

25.35

26.04

iu/l

0.04

190

Other immunodeficiencies

315

1.63

2.46

1.7

1.4

23.59

24.44

iu/l

0.07

258

Congenital malformations of eyelid, lacrimal apparatus and orbit

198

1.80

2.46

1.8

2.1

14.33

13.53

iu/l

0.06

157

Superficial injury of hip and thigh

283

2356

1.21

2.46

1.4

26.60

24.37

iu/l

0.49

244

1984

Carcinoma in situ of other and unspecified sites

130

1.94

2.46

1.3

25.19

23.41

iu/l

0.12

108

Car occupant injured in other and unspecified transport accidents

679

6052

1.13

2.45

1.5

1.4

20.21

23.22

iu/l

2.15

601

5134

Other and unspecified disease of Bartholin gland

592

1.44

2.45

1.3

19.76

27.64

iu/l

1.93

526

Non-ischemic cardiomyopathy

203

1995

0.80

2.44

1.5

1.4

27.23

31.27

iu/l

0.98

168

1669

Early onset COPD

303

2540

1.20

2.44

1.4

28.81

32.94

iu/l

1.50

246

2150

Congenital malformations of the respiratory system, including avohilmo

394

1.54

2.44

1.6

1.8

35.00

23.11

iu/l

1.61

304

Disorders of vitreous body

919

7904

1.11

2.44

1.3

36.69

36.40

iu/l

0.08

795

6822

Hypertrophic scar

213

1735

1.25

2.43

1.4

22.85

24.47

iu/l

0.33

181

1473

Failed attempted abortion

705

1.43

2.43

1.5

1.4

18.82

23.56

iu/l

0.88

621

Follicular adenocarcinoma of thyroid gland, including Hilmo

161

1.86

2.42

1.1

1.3

31.77

24.12

iu/l

0.49

142

Benign neoplasm: Pancreas

258

1.65

2.42

1.4

37.71

30.41

iu/l

0.63

219

Monoplegia

213

1.73

2.42

1.6

1.3

39.17

23.49

iu/l

1.40

186

Contact with heat and hot substances

149

1162

1.30

2.42

1.4

1.5

20.25

21.39

iu/l

0.16

116

952

Inflammatory disorders of breast

320

2716

1.20

2.41

1.3

21.88

22.60

iu/l

0.17

270

2323

Dermatitis due to substances taken internally

151

1180

1.30

2.41

1.6

1.4

25.12

25.09

iu/l

0.00

133

990

Torsion of testis

205

1.74

2.41

1.5

2.0

8.49

6.83

iu/l

0.45

155

Personal history of certain other diseases

699

1.41

2.41

1.6

1.3

18.32

16.15

iu/l

0.34

590

Dementia, including avohilmo

170

1466

0.79

2.41

1.6

1.4

35.16

32.44

iu/l

0.41

144

1229

Parkinson's disease, strict definition, excluding more controls

425

1.48

2.41

1.6

1.4

32.40

35.72

iu/l

0.32

371

Gout

211

1462

1.24

2.40

1.5

1.4

24.09

29.02

iu/l

1.17

163

1196

Effects of foreign body entering through natural orifice

567

4999

1.14

2.40

1.4

1.5

20.46

22.59

iu/l

1.01

473

4138

Benign neoplasm: Tongue

346

1.56

2.39

1.3

1.4

33.78

30.07

iu/l

0.33

290

Infective dermatitis

258

2139

1.22

2.39

1.3

1.4

25.79

27.50

iu/l

0.35

215

1836

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.21

2.39

1.2

1.4

24.39

24.03

iu/l

0.02

Chronic conjunctivitis

688

1.40

2.39

1.4

1.5

28.91

26.95

iu/l

0.20

581

Macular pucker

117

880

1.34

2.38

1.3

1.4

42.03

36.06

iu/l

0.91

738

Infections of breast associated with childbirth

221

1820

1.25

2.38

1.3

26.94

22.65

iu/l

1.07

192

1552

Gout, idiopatic and unspecified

171

1353

1.27

2.38

1.5

1.4

23.70

25.80

iu/l

0.32

131

1114

Benign neoplasm: Peripheral nerves and autonomic nervous system

245

1.68

2.37

1.5

1.3

27.31

25.80

iu/l

0.09

214

Other congenital malformations of brain

120

2.04

2.37

2.3

1.9

13.90

16.78

iu/l

0.18

Entropion and trichiasis of eyelid

337

1.55

2.37

1.4

1.3

36.79

31.33

iu/l

0.47

285

Peritonsillar abscess

827

7472

1.12

2.36

1.4

22.44

23.76

iu/l

0.63

713

6398

Other specified disorders of kidney and ureter

478

1.47

2.36

1.4

1.3

33.13

27.18

iu/l

0.66

405

Other disorders of conjunctiva

237

1950

1.22

2.36

1.4

30.69

31.64

iu/l

0.16

213

1672

Other diseases of oesophagus

148

1154

1.29

2.35

1.5

1.4

28.34

28.48

iu/l

0.02

120

981

Other salmonella infections

612

1.41

2.35

1.6

1.4

27.22

25.95

iu/l

0.12

526

Ulcerative proctitis

210

1713

1.24

2.35

1.5

1.4

24.99

24.03

iu/l

0.15

178

1458

Polypectomy (DHB20)

110

824

1.35

2.35

1.3

1.4

27.65

26.09

iu/l

0.19

702

Autonomic disorders

488

1.47

2.34

1.6

1.4

22.28

24.99

iu/l

0.35

427

Other superficial mycoses

581

1.43

2.34

1.6

1.4

24.05

21.75

iu/l

0.29

492

Slow fetal growth and fetal malnutrition

186

1.83

2.34

3.3

2.6

8.51

6.28

iu/l

0.34

117

DVT of lower extremities

326

2765

1.19

2.33

1.4

33.15

30.91

iu/l

0.55

286

2380

Chronic viral hepatitis

175

1401

1.27

2.33

1.3

1.4

18.49

21.25

iu/l

0.71

119

1187

Contusion of toe(s) with damage to nail

279

1.64

2.33

1.5

20.37

20.14

iu/l

0.02

238

Benign neoplasm: Skin of eyelid, including canthus

287

2409

1.20

2.32

1.4

32.22

32.37

iu/l

0.02

240

2076

Ectopic testis

121

2.02

2.32

2.1

2.7

6.69

5.46

iu/l

0.23

Implicit bacterial Sepsis

528

3971

1.14

2.32

1.5

1.4

26.12

29.22

iu/l

1.33

425

3329

Fracture of lumbar spine and pelvis

319

2693

1.19

2.32

1.4

25.31

27.16

iu/l

0.50

263

2277

Presbyopia

285

2399

1.20

2.32

1.3

1.4

32.60

34.78

iu/l

0.46

250

2085

L04AD Calcineurin inhibitors

286

2404

1.20

2.32

1.7

1.5

29.46

25.47

iu/l

0.87

232

1987

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

505

4305

1.15

2.32

1.8

1.5

23.94

21.99

iu/l

0.60

419

3507

Desensitization to allergens

269

2258

1.21

2.32

1.4

1.5

19.97

20.56

iu/l

0.11

228

1888

Carcinoma in situ, bladder

112

1.98

2.31

1.4

1.3

27.03

23.62

iu/l

0.22

Papilloedema, unspecified

549

1.44

2.31

1.8

1.4

18.10

20.90

iu/l

0.38

463

Bacterial pneumonia, not elsewhere classified

787

6218

1.11

2.30

1.5

1.4

24.78

26.86

iu/l

1.09

672

5274

Localized skin eruption due to drugs and medicaments

225

1.70

2.29

1.3

1.4

16.64

24.34

iu/l

0.80

191

Disorders of orbit

120

917

1.33

2.29

1.5

1.4

27.01

29.22

iu/l

0.33

788

Other disorders of binocular movement

713

1.39

2.29

1.5

1.4

29.83

22.06

iu/l

1.03

595

Mental retardation, excluding more controls

111

809

1.35

2.29

2.7

1.6

15.66

20.21

iu/l

0.93

634

Disorders of speech understanding and production

115

856

1.34

2.28

2.3

1.8

13.88

12.34

iu/l

0.18

603

Other infestations, including avohilmo

232

1.68

2.28

1.4

1.3

33.59

25.68

iu/l

0.65

192

Superficial injury of ankle and foot, unspecified

129

1.97

2.28

1.3

1.5

17.22

19.35

iu/l

0.14

110

Diseases caused by chlamydiae

515

1.48

2.28

1.3

1.4

32.49

32.45

iu/l

0.00

458

Paralytic strabismus

121

924

1.32

2.28

1.9

1.4

26.55

27.74

iu/l

0.13

786

Schizophrenia

318

3733

0.85

2.28

1.5

1.4

21.32

25.91

iu/l

2.14

247

3184

Hydrocele

446

1.46

2.27

1.8

1.7

12.83

9.29

iu/l

0.83

353

Failure and rejection of transplanted organs and tissues

202

1.73

2.27

1.8

1.5

31.54

23.15

iu/l

0.43

162

Hyperlipidaemia, other/unspecified

414

3216

1.16

2.27

1.4

30.07

33.42

iu/l

1.18

333

2745

Impetigo

171

1371

1.27

2.27

1.7

1.5

18.59

21.93

iu/l

0.79

138

1107

Diseases of the myoneural junction and muscle

207

1688

1.24

2.26

1.7

1.4

24.74

27.31

iu/l

0.55

161

1418

Carrier of infectious disease

585

1.42

2.26

1.4

17.26

21.95

iu/l

0.90

493

Intentional self-harm by unspecified means

395

1.52

2.26

1.5

19.71

17.93

iu/l

0.15

332

Acute hepatitis A

2.37

2.25

1.5

1.3

48.80

22.34

iu/l

—

Obstructive hydrocephalus

218

1.69

2.24

2.9

1.6

16.39

22.62

iu/l

0.65

172

Congenital malformations of the respiratory system

345

1.55

2.24

1.6

1.8

37.33

23.33

iu/l

1.73

264

Disorders of vitreous body and globe

943

8113

1.10

2.24

1.4

1.3

36.48

36.26

iu/l

0.07

813

7004

Dermatitis due to ingested food

148

1118

1.29

2.23

1.9

10.15

11.73

iu/l

0.42

116

820

Protozoal diseases

401

1.50

2.23

1.6

1.4

34.94

27.62

iu/l

0.69

337

Explicit bacterial Sepsis, including avohilmo

186

1502

1.25

2.23

1.5

1.4

22.99

23.99

iu/l

0.17

144

1237

Degenerative diseases of the nervous system

880

0.73

2.22

1.4

45.76

33.76

iu/l

1.70

735

Other and unspecified hydrocephalus

226

1.67

2.22

1.6

1.5

31.02

25.33

iu/l

0.39

186

Behavioural disorders, excluding more controls

518

1.44

2.22

1.5

15.78

16.23

iu/l

0.05

414

Injury of nerves and spinal cord at neck level

265

1.61

2.22

1.5

30.79

24.34

iu/l

0.57

220

Follicular lymphoma, hilmo

296

1.57

2.21

1.5

1.3

28.82

28.72

iu/l

0.01

253

Disorder of the sleep-wake schedule

412

1.50

2.21

1.4

1.6

20.29

20.66

iu/l

0.03

349

All chronic kidney diseases

953

8328

0.91

2.20

1.5

1.4

29.95

26.34

iu/l

2.12

799

7040

Transient global amnesia

635

1.38

2.19

1.3

1.4

41.42

36.32

iu/l

0.63

535

Disorders of eyelid in diseases classified elsewhere

690

1.37

2.19

1.4

27.89

28.53

iu/l

0.07

595

Non-allergic asthma

189

1533

1.24

2.19

1.5

22.95

26.37

iu/l

0.85

156

1245

Recurrent dislocation of patella

277

2346

1.20

2.19

1.4

22.46

21.86

iu/l

0.12

239

1974

Superficial injury of forearm

331

2835

1.18

2.18

1.5

1.4

23.55

22.50

iu/l

0.25

292

2380

Haemorrhage, not elsewhere classified

321

1.54

2.18

1.7

1.5

26.32

25.31

iu/l

0.06

267

Type 2 diabetes, definitions combined, including avohilmo

3163

19229

0.95

2.18

1.4

21.90

28.83

iu/l

36.81

2676

16684

Benign lipomatous neoplasm of other sites/unspecified

131

1018

1.30

2.17

1.3

1.4

28.65

31.73

iu/l

0.48

111

876

Other and unspecified injuries of shoulder and upper arm

640

1.38

2.16

1.4

23.50

25.47

iu/l

0.24

547

Poisoning by medicine, drug-induced

317

1.57

2.16

1.3

21.00

27.27

iu/l

0.90

275

Cardiovascular disorders originating in the perinatal period

118

2.03

2.16

2.1

2.6

21.55

8.83

iu/l

0.69

Congenital deformities of hip, including avohilmo

634

1.39

2.15

1.7

21.90

19.95

iu/l

0.22

497

Other and unspecified disorders of adult personality and behaviour

162

1.83

2.14

1.7

1.4

14.27

19.61

iu/l

0.54

133

Type 1 diabetes, strict (exclude DM2)

277

3253

0.84

2.14

1.5

1.6

17.32

18.98

iu/l

0.45

226

2633

Benign neoplasm: Transverse colon

123

950

1.30

2.13

1.3

1.4

26.37

31.78

iu/l

0.98

100

811

Hyperkinetic disorders (excl. ADHD)

618

1.40

2.13

1.6

1.9

16.18

14.17

iu/l

0.29

456

Simple and mucopurulent chronic bronchitis

339

1.52

2.13

1.6

1.5

33.23

28.13

iu/l

0.42

286

Malignant neoplasm of head and neck

478

1.43

2.13

1.5

1.3

25.95

26.81

iu/l

0.09

411

Toxic effect of other and unspecified substances

310

1.57

2.12

1.6

1.4

22.89

19.61

iu/l

0.36

263

Allergic urticaria

307

2624

1.19

2.12

1.4

26.45

24.06

iu/l

0.60

255

2201

Schizoaffective disorder

251

2108

1.21

2.12

1.4

21.37

24.50

iu/l

0.86

176

1796

Dislocation, sprain and strain of joint and ligaments of hip

397

1.48

2.12

1.6

1.4

24.02

24.98

iu/l

0.08

330

ILD medications: azathioprine

459

4036

1.15

2.11

1.6

1.4

24.70

24.64

iu/l

0.01

399

3410

Flat foot [pes planus] (acquired)

253

2124

1.20

2.11

1.4

32.55

34.83

iu/l

0.54

230

1810

Tubulo-interstitial nephritis, not specified as acute or chronic

166

1336

1.26

2.10

1.4

26.87

27.02

iu/l

0.02

134

1139

Benign neoplasm: Colon

752

6370

1.11

2.10

1.4

30.39

33.98

iu/l

2.14

631

5466

Gout, unspecified

132

1030

1.29

2.10

1.5

1.4

24.94

25.43

iu/l

0.05

104

846

Suggestive for eosinophilic asthma

177

1434

1.25

2.10

1.4

26.63

28.80

iu/l

0.40

145

1247

Viral agents as the cause of diseases classified to other chapters, including avohilmo

654

1.38

2.09

1.4

1.5

24.76

22.92

iu/l

0.21

553

Benign neoplasm: Adrenal gland

136

1069

1.28

2.09

1.5

1.4

32.67

33.46

iu/l

0.10

113

923

Abnormality of red blood cells

2.20

2.08

2.0

1.6

18.00

22.12

iu/l

0.25

Synovial cyst of popliteal space [Baker]

131

1025

1.29

2.08

1.3

1.4

29.63

31.54

iu/l

0.28

117

886

Wide developmental disorders

148

1177

1.28

2.08

1.9

1.8

11.24

12.41

iu/l

0.28

115

890

Atopic conjunctivitis

166

1342

1.26

2.08

1.5

25.53

24.19

iu/l

0.18

140

1119

Other and unspecified myopathies

108

823

1.32

2.08

1.7

1.4

19.97

26.79

iu/l

1.53

690

Mental and behavioural disorders due to use of other stimulants, including caffeine

107

820

1.33

2.07

1.4

13.67

17.19

iu/l

0.90

698

Unspecified chronic bronchitis

293

1.55

2.07

1.6

1.4

32.58

29.57

iu/l

0.23

244

Periodontal disease, other/unspecified

509

1.42

2.07

1.6

1.3

31.93

27.20

iu/l

0.47

430

Carcinoma in situ of cervix uteri

627

5648

1.13

2.06

1.3

19.90

21.84

iu/l

0.98

559

4856

Benign neoplasm: Parotid gland

141

1116

1.28

2.06

1.3

1.4

34.87

30.64

iu/l

0.69

120

966

Heart failure and bmi 25plus

209

1689

0.82

2.05

1.4

21.91

29.35

iu/l

3.18

166

1429

Benign neoplasm: Spinal meninges

111

1.94

2.05

1.5

1.4

28.54

27.41

iu/l

0.05

Asthma and opportunity respiratory infection

408

1.46

2.05

1.4

1.3

34.86

32.51

iu/l

0.18

350

Sacroiliitis, not elsewhere classified

202

1671

1.23

2.05

1.5

1.4

18.82

23.05

iu/l

1.44

182

1422

Pneumonia due to Streptococcus pneumoniae

568

1.39

2.05

1.4

26.43

23.85

iu/l

0.27

477

Rotator cuff syndrome

1630

10476

1.07

2.04

1.4

1.3

30.90

32.49

iu/l

1.11

1422

9067

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

553

4960

1.14

2.04

1.3

1.4

24.71

28.93

iu/l

2.70

486

4335

Other diseases of pancreas

116

896

1.30

2.03

1.4

35.88

29.92

iu/l

0.98

751

Bronchiectasis

593

1.38

2.03

1.3

1.4

37.52

33.89

iu/l

0.35

502

Inflammatory disease of cervix uteri

167

1353

1.25

2.03

1.3

33.16

33.05

iu/l

0.02

153

1191

Streptococcal septicaemia

134

1055

1.28

2.03

1.6

1.5

24.09

26.09

iu/l

0.32

105

872

Other cataract

571

4756

0.89

2.03

1.5

1.4

33.10

34.75

iu/l

0.54

475

4075

Melanoma in situ

409

1.46

2.03

1.1

1.3

23.18

30.02

iu/l

1.04

354

Gonarthrosis [arthrosis of knee](FG)

1943

11894

0.94

2.03

1.4

1.3

31.89

33.90

iu/l

1.90

1703

10369

Lichen planus, including avohilmo

364

3157

1.16

2.02

1.4

30.14

33.35

iu/l

1.17

323

2705

Bursitis of shoulder

461

1.44

2.02

1.3

1.4

31.53

28.69

iu/l

0.28

400

Other protozoal intestinal diseases, including avohilmo

633

1.38

2.02

1.7

1.4

17.40

22.93

iu/l

1.20

537

Enterobiasis

106

2.01

1.2

1.9

21.57

17.62

iu/l

0.18

Sequelae of other external causes

141

1121

1.27

2.01

1.3

1.4

29.78

27.37

iu/l

0.34

110

957

Other symptoms and signs involving general sensations and perceptions

536

1.40

2.01

1.6

1.5

18.60

20.97

iu/l

0.27

438

Malignant neoplasm of bone and articular cartilage of limbs

2.46

2.00

2.7

2.2

8.43

18.10

iu/l

—

Crohn's disease NAS

204

1691

1.22

2.00

1.5

1.4

21.40

23.85

iu/l

0.63

184

1409

Other diseases caused by chlamydiae, including avohilmo

646

1.38

2.00

1.4

29.80

29.23

iu/l

0.05

568

Seropositive rheumatoid arthritis, strict definition

256

3020

0.84

1.99

1.4

1.3

33.08

31.25

iu/l

0.37

220

2619

Viral conjunctivitis

609

1.38

1.99

1.4

24.47

25.91

iu/l

0.18

517

Multiple gestation

645

5839

1.12

1.98

1.3

1.4

28.06

27.96

iu/l

0.02

568

5044

Monosomies and deletions from the autosomes, not elsewhere classified

2.17

1.98

3.4

2.5

16.86

9.52

iu/l

0.37

Other diseases of gallbladder

580

1.38

1.98

1.2

1.3

30.52

30.73

iu/l

0.02

493

Other secondary coxarthrosis

462

1.43

1.98

1.6

1.3

29.08

30.49

iu/l

0.12

388

Maternal care for known or suspected disproportion

356

3121

1.17

1.98

1.3

1.4

31.67

30.31

iu/l

0.30

327

2724

Diabetes, varying definitions

3584

21720

0.95

1.97

1.4

21.69

26.85

iu/l

22.52

3018

18640

Gonococcal infection, including avohilmo

547

1.39

1.97

1.6

1.4

30.69

26.30

iu/l

0.44

458

Toxic effect of alcohol

298

1.54

1.97

1.6

1.4

28.94

25.32

iu/l

0.20

253

Varicella [chickenpox], including avohilmo

144

1151

1.27

1.97

1.8

1.7

12.83

18.08

iu/l

1.75

111

892

Acute tubulo-interstitial nephritis

1742

15649

0.94

1.96

1.4

25.54

25.79

iu/l

0.11

1439

13438

Benign neoplasm: Sigmoid colon

219

1825

1.21

1.96

1.4

33.29

33.77

iu/l

0.07

181

1567

Other and unspecified intracranial injuries

438

1.44

1.96

1.4

24.62

23.56

iu/l

0.09

365

Other congenital malformations of limb(s)

229

1.65

1.95

1.6

1.9

13.98

15.12

iu/l

0.10

177

Fracture of rib(s), sternum and thoracic spine

465

4109

1.14

1.95

1.4

28.35

28.53

iu/l

0.04

384

3476

Retinal breaks without detachment

295

2526

1.17

1.95

1.4

1.3

35.70

36.05

iu/l

0.06

256

2184

Fasciculation

276

1.57

1.95

1.5

1.3

26.27

23.25

iu/l

0.20

233

2.50

1.95

1.6

18.11

25.09

iu/l

0.42

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

503

1.40

1.95

1.3

27.50

30.70

iu/l

0.37

427

Torticollis

407

1.46

1.95

1.4

1.5

20.52

23.14

iu/l

0.32

346

Foreign body in respiratory tract

139

1109

1.27

1.95

1.6

1.5

19.53

24.30

iu/l

1.30

117

911

Allergic contact dermatitis

538

4812

1.13

1.94

1.3

1.4

26.67

28.44

iu/l

0.62

480

4140

Unequal limb length (acquired)

197

1.68

1.94

1.7

1.6

8.34

13.98

iu/l

1.61

153

Pilonidal cyst

280

2395

1.18

1.93

1.5

1.4

16.19

20.58

iu/l

2.51

241

2001

Diastasis of muscle

319

1.54

1.93

1.3

22.05

21.97

iu/l

0.01

289

Congenital malformations of eye, ear, face and neck

226

1900

1.21

1.93

1.6

1.5

18.69

19.28

iu/l

0.11

177

1536

Benign neoplasm of breast

368

3214

1.16

1.92

1.5

1.4

29.60

30.72

iu/l

0.24

314

2783

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

253

1.60

1.92

2.0

1.9

14.91

15.24

iu/l

0.03

191

Presence of other functional implants

717

5419

0.90

1.92

1.4

31.78

35.22

iu/l

1.97

610

4665

Use of disulfiram, acamprosate or naltrexone

198

1642

1.22

1.91

1.5

1.4

22.64

26.27

iu/l

0.95

152

1392

Diseases caused by chlamydiae, including avohilmo

634

1.38

1.91

1.4

29.53

29.25

iu/l

0.02

557

Azathioprine

459

4067

1.14

1.91

1.6

1.4

24.70

24.73

iu/l

0.00

399

3434

Gonococcal infection

457

1.42

1.91

1.6

1.4

33.54

28.35

iu/l

0.49

387

Type 1 diabetes, definitions combined

282

3271

0.85

1.91

1.5

1.6

17.24

19.09

iu/l

0.53

230

2647

Atrial fibrillation and flutter

535

3868

0.89

1.90

1.4

29.84

36.10

iu/l

3.88

443

3323

Haemolytic anaemias

534

1.39

1.90

1.5

23.99

23.62

iu/l

0.03

449

Hypercalcemia

474

1.41

1.90

1.8

1.4

37.59

30.60

iu/l

0.64

406

Other orthopaedic follow-up care

126

996

1.28

1.90

1.6

1.4

30.14

27.83

iu/l

0.29

102

852

Other chondrocalcinosis

0.00

1.89

0.0

1.2

—

28.00

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

117

916

1.29

1.89

1.4

32.67

28.86

iu/l

0.56

104

782

Other diseases of spinal cord

501

1.40

1.89

1.4

26.33

26.58

iu/l

0.02

436

Prurigo nodularis

309

1.51

1.89

1.4

1.3

25.83

29.34

iu/l

0.34

269

Carcinoma in situ of skin

576

1.36

1.88

1.1

1.3

33.70

32.63

iu/l

0.09

490

Other and unspecified tonsillitis

1470

11426

1.07

1.88

1.5

1.4

16.97

19.21

iu/l

2.54

1233

9577

Implicit Sepsis, including avohilmo

2021

15282

0.94

1.88

1.5

1.4

26.67

27.09

iu/l

0.21

1655

13057

Acute hepatitis A, including avohilmo

2.15

1.87

1.5

1.3

48.80

23.31

iu/l

—

Retention of urine

411

2917

1.14

1.86

1.5

1.4

24.77

25.56

iu/l

0.18

346

2461

Urethral discharge

4.47

1.86

1.2

1.1

30.18

28.83

iu/l

—

Other congenital malformations of intestine, including avohilmo

199

1.66

1.86

1.8

21.79

20.31

iu/l

0.09

159

Myocarditis

102

786

1.31

1.86

1.5

1.4

25.65

27.27

iu/l

0.20

671

Macular cyst

182

1.66

1.86

1.3

46.53

29.98

iu/l

1.11

151

Unspecified visual impairment (binocular)

238

1.59

1.86

2.3

1.6

20.30

24.35

iu/l

0.31

197

Nephropathy related operations

184

1518

1.22

1.86

1.6

1.5

28.75

24.72

iu/l

0.58

141

1247

Type 2 diabetes

3362

20339

0.95

1.86

1.4

21.83

27.90

iu/l

29.29

2838

17628

Hypoplasia of dental enamel, prenatal

2.39

1.85

4.2

2.6

4.91

8.11

iu/l

—

Other disorders of the genitourinary system

234

1976

1.19

1.85

1.4

1.3

34.75

35.32

iu/l

0.08

206

1717

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

182

1.66

1.85

1.3

1.4

25.54

26.04

iu/l

0.02

147

Other and unspecified injuries of lower leg

265

2267

1.18

1.85

1.4

20.90

25.35

iu/l

1.64

228

1895

Nonpyogenic thrombosis of intracranial venous system

240

1.60

1.84

1.9

1.4

31.22

23.31

iu/l

0.61

206

Malignant neoplasm of small intestine, including Hilmo

206

1.62

1.84

1.5

1.3

55.33

30.53

iu/l

1.64

173

Gout, strict definition

103

794

1.30

1.84

1.3

1.4

22.36

24.40

iu/l

0.27

659

Puerperal sepsis

385

3385

1.15

1.84

1.3

30.68

32.20

iu/l

0.37

330

2946

Malignant neoplasm of oral cavity, including Hilmo

318

1.49

1.84

1.5

1.3

34.61

27.55

iu/l

0.51

275

Cholelithiasis, broad definition with cholecystitis

2700

18860

0.95

1.83

1.4

28.35

28.83

iu/l

0.33

2339

16391

Skin changes due to chronic exposure to nonionizing radiation

257

1976

1.18

1.83

1.4

34.29

37.74

iu/l

0.93

222

1690

Congenital ovarian cysts

263

2262

1.19

1.83

1.4

21.66

25.24

iu/l

1.22

221

1960

Chalazion

307

2656

1.17

1.83

1.5

1.4

26.35

26.93

iu/l

0.11

261

2268

Atherosclerosis, excluding cerebral and coronary sclerosis

175

1670

0.82

1.83

1.3

1.4

30.91

31.97

iu/l

0.14

138

1403

Leiomyoma of uterus

2974

15915

1.05

1.82

1.4

1.3

31.49

31.52

iu/l

0.01

2633

13958

Sub-endpoint used in defining T1D endpoints

642

6970

0.90

1.82

1.4

1.5

19.86

21.86

iu/l

0.92

530

5792

Unspecific neurodegenerative disorder

104

918

0.77

1.82

1.5

1.4

37.86

34.23

iu/l

0.41

767

Other specified disorders of external ear

303

1.50

1.82

1.9

1.5

27.11

26.18

iu/l

0.07

253

Graves ophthalmopathy

601

1.36

1.81

1.4

1.3

25.34

29.58

iu/l

0.60

521

Hordeolum and other deep inflammation of eyelid

178

1472

1.22

1.81

1.5

1.4

28.79

24.57

iu/l

0.73

136

1230

Malignant neoplasm of stomach, including Hilmo

270

1.53

1.81

1.3

47.22

27.81

iu/l

2.05

229

Symptoms and signs involving the urinary system

1830

12994

1.06

1.81

1.5

1.4

25.92

27.53

iu/l

1.21

1544

11073

Vertical strabismus

713

1.33

1.81

1.4

24.63

25.61

iu/l

0.11

599

Optic atrophy

313

1.50

1.81

2.9

1.5

19.45

24.70

iu/l

0.53

255

Early lumbar disc prolapse operation

497

4451

1.13

1.81

1.4

22.79

24.03

iu/l

0.39

433

3806

Organic, including symptomatic, mental disorders

332

2688

0.87

1.81

1.5

1.4

30.74

30.47

iu/l

0.05

273

2274

Chronic iridocyclitis

127

1013

1.27

1.81

1.3

1.4

28.83

26.14

iu/l

0.38

109

852

Other appendicitis

242

2059

1.19

1.80

1.5

1.4

23.22

29.24

iu/l

2.35

206

1757

Congenital malformations of anterior segment of eye

194

1.66

1.80

1.8

1.5

16.65

21.81

iu/l

0.50

159

Cholecystitis

214

1798

1.20

1.79

1.4

26.31

29.37

iu/l

0.74

175

1541

Dipeptidyl peptidase 4 (DPP-4) inhibitors

622

5394

0.90

1.79

1.4

25.76

35.31

iu/l

12.37

507

4633

Other respiratory diseases principally affecting the interstitium

174

1433

1.22

1.78

1.5

1.4

32.67

30.39

iu/l

0.36

138

1218

Parkinson's disease, excluding more controls

494

1.36

1.78

1.5

1.4

32.17

37.13

iu/l

0.58

430

Congenital deformities of feet, including avohilmo

139

1125

1.26

1.77

1.5

22.94

23.17

iu/l

0.03

114

938

Other disorders of the musculoskeletal system and connective tissue

280

2410

1.17

1.77

1.5

1.4

29.71

30.87

iu/l

0.25

246

2077

Extreme obesity with alveolar hypoventilation

636

1.34

1.77

1.3

20.71

31.85

iu/l

3.23

550

Other inflammatory liver diseases

141

1140

1.25

1.77

1.6

1.4

23.03

27.03

iu/l

0.93

123

966

Oral lichen planus

372

1.45

1.77

1.5

1.3

37.72

32.03

iu/l

0.52

320

Other arrhythmias

1967

15519

0.94

1.76

1.4

26.11

28.44

iu/l

2.61

1724

13371

Erectile dysfunction

208

1.59

1.76

1.2

1.5

11.53

12.50

iu/l

0.18

160

Struck by thrown, projected or falling objec

133

1070

1.26

1.76

1.3

1.4

14.68

19.95

iu/l

1.96

116

891

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

283

1.53

1.75

1.9

17.05

iu/l

0.00

218

Respiratory and cardiovascular disorders specific to the perinatal period

626

1.33

1.75

2.5

2.4

10.38

7.25

iu/l

0.59

399

ILD medications: immunosuppressive drugs

2211

18999

1.06

1.75

1.5

1.4

27.33

26.23

iu/l

0.80

1880

16203

Benign neoplasm: Connective and other soft tissue of head, face and neck

291

1.51

1.74

1.6

1.4

30.32

25.72

iu/l

0.35

250

Seborrhoeic dermatitis

204

1714

1.20

1.74

1.5

1.4

23.47

26.10

iu/l

0.55

184

1443

Osteonecrosis

733

1.31

1.74

1.7

1.3

28.25

31.40

iu/l

0.42

635

Spasmodic torticollis

745

1.31

1.73

1.5

1.4

31.31

29.53

iu/l

0.20

640

Shigellosis, including avohilmo

149

1.74

1.73

1.4

21.87

21.23

iu/l

0.04

123

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

463

4006

1.13

1.73

1.9

1.5

23.49

21.62

iu/l

0.54

383

3249

Benign neoplasm: Conjunctiva

518

1.37

1.73

1.4

30.29

27.99

iu/l

0.20

449

Additional codes for the location of defect, injury or illness

142

1154

1.24

1.72

1.4

32.57

25.86

iu/l

1.65

133

988

Explicit bacterial Sepsis

177

1468

1.21

1.72

1.6

1.5

22.28

24.01

iu/l

0.34

139

1208

Other Crohn's disease

229

1950

1.19

1.72

1.5

1.4

22.32

23.18

iu/l

0.18

204

1646

Social disorders starting during childhood or adolescence

237

1.58

1.72

2.2

1.9

4.76

10.90

iu/l

4.37

171

Other disorders of cornea

210

1772

1.19

1.71

1.4

34.44

29.02

iu/l

1.43

183

1515

Other lesions of median nerve

283

1.50

1.71

1.4

37.66

29.52

iu/l

0.58

243

Mesial bite

261

1.55

1.71

1.7

21.86

14.47

iu/l

0.92

214

Disorders of porphyrin and bilirubin metabolism

180

1.65

1.71

1.8

1.5

35.81

22.27

iu/l

0.77

155

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

115

914

1.28

1.71

1.3

1.4

22.86

29.63

iu/l

1.90

108

783

Implicit bacterial Sepsis, including avohilmo

620

4666

1.11

1.71

1.5

1.4

26.48

28.62

iu/l

0.86

501

3925

Blepharospasm

119

1.81

1.70

1.6

1.3

46.44

22.56

iu/l

1.39

106

Ethmoidectomy

356

3132

1.15

1.70

1.3

1.4

24.79

27.52

iu/l

0.96

310

2693

Personal history of allergy to analgesic agent

174

1.69

1.70

1.4

1.3

16.17

21.81

iu/l

0.63

150

Congenital malformations of uterus and cervix

126

1021

1.27

1.70

1.2

1.4

19.08

21.58

iu/l

0.38

103

873

Melanocytic naevi, other sites/unspecified

268

2313

1.17

1.70

1.4

25.52

26.89

iu/l

0.31

236

1985

Lichen sclerosus et atrophicus

269

2320

1.17

1.69

1.4

29.56

33.84

iu/l

1.30

231

2025

Mumps, including avohilmo

547

1.36

1.69

1.4

25.77

30.17

iu/l

0.47

472

324

2539

1.15

1.69

1.4

31.48

36.70

iu/l

2.16

280

2179

Other mycoses, not elsewhere classified/unspecified, including avohilmo

318

1.48

1.69

1.6

1.5

15.67

22.48

iu/l

1.15

265

Impacted cerumen

162

1335

1.22

1.69

1.5

30.47

27.90

iu/l

0.40

135

1106

Peripheral artery disease

231

2143

0.85

1.68

1.3

1.4

26.96

31.26

iu/l

1.06

183

1810

Mixed disorders of conduct and emotions

732

1.31

1.68

1.5

1.7

7.28

8.84

iu/l

0.77

568

Other disorders of bone density and structure

601

1.34

1.66

1.6

1.4

31.90

25.23

iu/l

0.81

515

Psoriatic and enteropathic arthropathies

324

2838

1.15

1.66

1.4

29.54

29.61

iu/l

0.01

288

2457

Erythema multiforme

412

1.41

1.65

1.3

1.4

24.25

24.98

iu/l

0.06

352

Inflammation of lacrimal passages (acute and unspecified)

320

1.47

1.64

1.3

25.16

26.63

iu/l

0.10

277

Vitamin B12 deficiency anaemia

130

1050

1.24

1.64

1.4

1.3

35.04

31.73

iu/l

0.40

108

907

Other disorders of skin and subcutaneous tissue

1836

16362

0.94

1.64

1.4

28.05

29.18

iu/l

0.74

1571

14079

Mixed conductive and sensorineural hearing loss

174

1449

1.21

1.64

1.5

1.4

30.75

30.34

iu/l

0.06

148

1235

Any dementia, excluding more controls

110

952

0.79

1.64

1.5

1.4

39.02

33.47

iu/l

0.78

800

Optic atrophy, wide definition

329

1.46

1.63

2.9

1.5

19.45

24.75

iu/l

0.54

268

577

1.34

1.62

2.6

2.4

8.31

6.74

iu/l

0.48

370

Idiopathic urticaria

746

1.31

1.62

1.4

28.33

23.84

iu/l

0.62

635

Anxious personality disorder

561

1.35

1.62

1.6

1.4

14.33

19.31

iu/l

1.03

476

Malignant neoplasm of eye and adnexa, including Hilmo

113

1.80

1.62

1.8

1.3

35.45

26.43

iu/l

0.51

Congenital musculoskeletal deformities of head, face, spine and chest

256

1.53

1.61

1.9

1.8

16.73

17.08

iu/l

0.03

196

Schizoid personality disorder

280

1.49

1.61

1.7

1.4

24.23

26.84

iu/l

0.18

232

Congenital varicose veins

154

1.72

1.60

1.4

1.6

16.46

19.79

iu/l

0.21

126

Malignant neoplasm of digestive organs

296

2597

0.87

1.60

1.3

37.87

32.81

iu/l

1.38

241

2235

Schizophrenia or delusion

961

8920

1.08

1.60

1.4

20.45

24.69

iu/l

4.27

721

7591

Sequelae of cerebrovascular disease

275

2707

0.87

1.60

1.5

1.4

35.97

32.17

iu/l

0.90

225

2310

Congenital deformities of feet

720

1.30

1.60

1.6

1.5

23.51

22.23

iu/l

0.15

598

Other and unspecified primary disorders of muscles

153

1.70

1.59

1.3

1.6

21.05

24.02

iu/l

0.17

122

LeFortI or BSSO operation

181

1526

1.21

1.59

1.3

1.4

24.84

25.21

iu/l

0.05

159

1310

Other congenital malformations of the digestive system, including avohilmo

140

1139

1.23

1.59

1.8

20.24

18.67

iu/l

0.22

116

863

Patent foramen ovale

545

1.35

1.59

2.0

1.8

21.68

22.45

iu/l

0.08

423

Benign neoplasm of major salivary glands

160

1327

1.21

1.59

1.3

1.4

34.92

31.10

iu/l

0.65

137

1142

Disorder of thyroid, unspecified

232

1.55

1.59

1.6

1.4

23.16

27.79

iu/l

0.41

201

Sequelae of injuries of lower limb

250

2158

1.17

1.59

1.4

25.69

27.29

iu/l

0.33

211

1855

Spondylopathies (FG)

461

4142

1.12

1.58

1.4

23.33

26.12

iu/l

1.14

394

3562

169

1.66

1.58

1.2

1.3

21.19

29.31

iu/l

0.84

142

Status post-ami

808

0.77

1.58

1.3

1.4

27.00

27.73

iu/l

0.05

653

Drug-induced headache, not elsewhere classified

170

1.67

1.58

1.7

1.4

30.20

24.47

iu/l

0.37

149

Contusion of toe(s) without damage to nail

103

819

1.28

1.58

1.3

1.4

24.67

22.00

iu/l

0.38

687

Other and unspecified paralytic syndromes

290

1.48

1.58

1.4

25.62

23.63

iu/l

0.16

250

Cholelithiasis

2614

18656

0.95

1.58

1.4

28.38

29.04

iu/l

0.48

2272

16224

Complications of genitourinary prosthetic devices, implants and grafts

554

1.34

1.57

1.3

1.4

25.39

27.96

iu/l

0.30

480

Complications following abortion and ectopic and molar pregnancy

694

1.30

1.57

1.3

1.4

37.70

35.00

iu/l

0.25

609

Olecranon bursitis

448

1.37

1.57

1.2

1.4

19.08

23.97

iu/l

0.77

368

Twin gestation

619

5670

1.11

1.57

1.3

1.4

28.04

27.88

iu/l

0.04

546

4902

Benign neoplasm: Retina

1.90

1.57

1.4

1.3

36.68

29.08

iu/l

0.33

Lesion of plantar nerve

120

969

1.25

1.56

1.3

1.4

33.25

35.71

iu/l

0.35

109

841

Divergent concomitant strabismus

254

2201

1.17

1.56

1.4

31.07

27.62

iu/l

0.88

205

1876

Toxic liver disease

274

1.49

1.56

1.5

1.3

23.69

24.68

iu/l

0.08

235

Diabetic neuropathy

1197

0.79

1.56

1.3

1.4

23.35

22.65

iu/l

0.09

1012

Intentional self-harm by jumping from a high place

139

1.73

1.55

1.3

1.4

21.84

18.34

iu/l

0.23

112

Urticaria due to cold and heat

235

1.55

1.4

22.40

22.17

iu/l

0.01

197

Epiphora

324

1.44

1.54

1.6

1.4

26.59

28.24

iu/l

0.12

278

Birth trauma

171

1.65

1.54

1.9

12.16

16.25

iu/l

0.38

130

Other disorders of optic disc

292

1.47

1.54

1.4

25.00

20.64

iu/l

0.38

241

Papulosquamous disorders

948

8808

1.08

1.53

1.4

28.09

29.51

iu/l

0.68

801

7521

Essential (haemorrhagic) thrombocythaemia

391

1.40

1.53

1.3

1.2

30.61

29.12

iu/l

0.14

337

Open wound of wrist and hand

1362

12375

1.07

1.53

1.4

21.55

23.21

iu/l

1.28

1145

10424

Diseases of arteries, arterioles and capillaries (FINNGEN)

307

2415

0.87

1.53

1.4

29.12

34.38

iu/l

1.79

254

2056

Other meningitis

359

1.43

1.53

1.7

1.4

28.37

23.67

iu/l

0.38

303

Contact with other and unspecified heat and hot substances

101

1.84

1.53

1.5

1.4

17.87

22.56

iu/l

0.19

Colectomy operation

215

1837

1.18

1.53

1.5

1.4

27.81

29.18

iu/l

0.23

185

1566

Benign neoplasm: Vertebral column

2.58

1.52

1.6

1.5

20.71

23.49

iu/l

—

Dialysis, with operation codes

181

1525

1.19

1.52

1.7

1.5

29.20

24.62

iu/l

0.68

139

1253

Continuous positive airway pressure

314

2295

1.14

1.52

1.5

1.4

25.43

34.56

iu/l

5.38

254

1932

Presence of other devices

355

3093

1.13

1.52

1.3

1.4

27.00

30.73

iu/l

1.44

331

2665

Congenital malformations of the urinary system, including avohilmo

163

1364

1.21

1.52

1.6

29.22

22.08

iu/l

1.25

136

1106

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

412

3684

1.12

1.52

1.5

1.4

23.59

25.84

iu/l

0.73

337

3100

Burns and corrosions of external body surface, specified by site

285

2493

1.15

1.52

1.4

1.5

19.66

21.63

iu/l

0.53

233

2051

Corneal degeneration

218

1.54

1.52

1.3

1.4

39.53

29.89

iu/l

0.75

180

Palmar fascial fibromatosis [Dupuytren]

105

836

1.26

1.51

1.5

1.4

26.87

30.87

iu/l

0.61

699

Covid-19 suspected case

759

8218

0.92

1.51

1.4

22.51

24.25

iu/l

0.83

606

7039

Other disorders originating in the perinatal period

363

1.44

1.51

1.7

2.2

17.49

14.23

iu/l

0.31

242

Myocardial infarction, unclassifiable

720

0.74

1.51

1.3

1.4

37.37

29.13

iu/l

0.64

601

Congenital malformations of ovaries, fallopian tubes and broad ligaments

314

2779

1.15

1.50

1.3

1.4

23.54

25.42

iu/l

0.52

265

2409

Occupant of pick-up truck or van injured in other and unspecified transport accidents

1.91

1.50

1.1

1.4

19.69

19.95

iu/l

0.02

Use of antiglaucoma preparations and miotics

443

1.36

1.50

1.4

31.69

30.02

iu/l

0.14

375

Patellar tendinitis

386

1.40

1.50

1.3

1.4

20.15

20.66

iu/l

0.04

328

Focal epilepsy, strict definition

436

3915

1.12

1.49

1.5

27.43

24.92

iu/l

0.77

351

3233

Schizophrenia, schizotypal and delusional disorders

959

8929

1.08

1.49

1.4

20.58

24.66

iu/l

3.96

719

7599

Other malignant neoplasms of skin (=non-melanoma skin cancer)

452

3413

0.90

1.49

1.4

1.3

35.88

35.51

iu/l

0.08

391

2970

Glaucoma-related operations

342

1.41

1.49

1.2

1.4

33.16

27.93

iu/l

0.43

285

Myeloproliferative diseases (CML excluded)

102

813

1.26

1.48

1.4

1.3

26.22

29.82

iu/l

0.64

693

Localized scleroderma [morphea]

269

1.48

1.2

1.3

19.50

27.46

iu/l

1.21

229

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

311

1.45

1.48

1.6

1.5

19.46

18.38

iu/l

0.10

269

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

435

4835

0.90

1.48

1.4

33.67

32.10

iu/l

0.41

373

4189

Abnormal findings in nipple discharge synovial fluid wound secretions

286

1.47

1.48

1.3

1.4

28.99

23.21

iu/l

0.36

242

Lactose intolerance, other/unspecified

648

1.30

1.47

1.4

1.5

25.15

23.82

iu/l

0.13

545

Other infectious diseases, including avohilmo

180

1523

1.19

1.47

1.4

23.86

25.64

iu/l

0.33

158

1297

Benign neoplasm: Other/unspecified site

220

1.53

1.47

1.7

1.3

22.57

26.57

iu/l

0.28

185

Hereditary retinal dystrophy

245

1.50

1.46

1.6

1.5

30.50

24.35

iu/l

0.48

208

Pneumothorax

708

1.28

1.46

1.4

22.20

24.02

iu/l

0.24

601

Mumps

526

1.33

1.46

1.4

26.02

30.46

iu/l

0.45

456

Von Willebrand disease

416

1.39

1.46

1.6

1.4

21.54

25.60

iu/l

0.53

352

Burn and corrosion of trunk

517

1.33

1.45

1.4

1.5

17.69

22.57

iu/l

0.72

432

Vestibular neuronitis

172

1452

1.19

1.45

1.5

1.4

28.06

30.21

iu/l

0.38

140

1250

280

1.48

1.45

1.6

1.4

20.18

18.29

iu/l

0.16

233

Benign neoplasm of thyroid gland

614

1.31

1.45

1.4

28.30

30.18

iu/l

0.21

534

Mental and behavioural disorders due to hallucinogens

111

1.78

1.45

1.3

1.4

13.16

14.94

iu/l

0.15

Other congenital malformations of the digestive system

122

991

1.24

1.45

1.8

19.47

17.42

iu/l

0.28

102

748

Bilateral sagittal split ramus osteotomy operation

154

1294

1.21

1.45

1.4

26.43

26.59

iu/l

0.02

136

1110

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

458

1.36

1.44

1.9

1.6

37.99

18.31

iu/l

1.86

358

Benign neoplasm: salivary glands, exclude unknown (D119)

150

1251

1.21

1.44

1.3

1.4

35.43

30.70

iu/l

0.82

128

1081

Calculus of lower urinary tract

336

1.41

1.44

1.4

30.90

22.54

iu/l

0.85

282

Dementia in Alzheimer disease

234

0.57

1.44

1.1

1.5

51.55

34.36

iu/l

0.94

196

Tic and related disorders

304

1.45

1.44

1.8

14.03

13.51

iu/l

0.05

222

Hepatocellular carcinoma, including Hilmo

1.98

1.43

1.2

1.4

15.17

19.98

iu/l

—

Arthropathic psoriasis

278

2439

1.15

1.43

1.4

30.30

29.99

iu/l

0.05

237

2104

Hypertrophy of (infrapatellar) fat pad

214

1.54

1.43

1.3

1.4

23.34

25.41

iu/l

0.14

197

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

456

1.36

1.43

1.8

1.9

16.09

11.92

iu/l

0.46

319

Mandibular prognathia

373

1.40

1.43

2.2

1.8

15.63

15.85

iu/l

0.02

293

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1047

9810

1.07

1.43

1.4

20.62

20.64

iu/l

0.01

872

8420

Superficial injury of shoulder and upper arm

311

2749

1.14

1.43

1.5

1.4

22.35

25.69

iu/l

1.21

271

2318

Oesophagitis

649

1.29

1.43

1.4

29.19

27.16

iu/l

0.24

554

Other benign neoplasm of uterus: Corpus uteri

150

1.65

1.43

1.3

1.4

21.49

27.96

iu/l

0.61

126

Adjustment and management of implanted device

147

1223

1.21

1.42

1.5

28.35

27.01

iu/l

0.16

113

1012

Basal cell carcinoma, including Hilmo

471

3530

0.90

1.42

1.4

1.3

35.51

35.72

iu/l

0.04

402

3075

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

503

3744

0.90

1.42

1.4

1.3

35.97

35.49

iu/l

0.11

438

3258

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

306

1.45

1.42

1.5

1.4

17.11

26.66

iu/l

1.90

269

Diabetes mellitus

3633

21742

0.96

1.42

1.4

21.59

26.81

iu/l

23.38

3061

18654

Hirsprung

2.87

1.42

2.3

20.63

10.94

iu/l

—

Type 1 diabetes, wide definition

571

6235

0.91

1.42

1.4

1.5

20.41

22.46

iu/l

0.84

471

5185

Fracture of neck

553

1.31

1.41

1.5

1.4

20.65

23.86

iu/l

0.44

458

Maltreatment syndromes

208

1794

1.17

1.41

1.5

1.4

17.85

21.09

iu/l

1.08

170

1506

Benign neoplasm: Other and unspecified parts of mouth

476

1.34

1.41

1.3

1.4

30.39

28.02

iu/l

0.26

404

Malignant neoplasm of prostate, including Hilmo

384

1.29

1.41

1.7

1.3

11.10

10.02

iu/l

0.31

298

Other/unspecified seropositive rheumatoid arthritis

439

4861

0.90

1.41

1.4

33.84

32.23

iu/l

0.42

377

4212

Graves ophthalmopathy, strict

539

1.33

1.40

1.3

1.4

25.94

29.30

iu/l

0.39

466

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2942

19336

0.96

1.40

1.4

30.64

28.05

iu/l

3.79

2543

16722

Injuries to the thorax

899

8363

1.08

1.39

1.4

25.82

26.74

iu/l

0.39

740

7087

Use of rotigotine

127

1.69

1.39

1.7

1.3

32.22

29.35

iu/l

0.16

103

Spondyloarthritis

492

4469

1.11

1.39

1.4

23.98

26.02

iu/l

0.74

422

3831

IBD patients in KELA-register

770

7139

1.08

1.38

1.4

24.70

24.51

iu/l

0.06

675

6044

Feeding problems of newborn

153

1.66

1.38

1.6

2.3

8.25

7.31

iu/l

0.10

Mental and behavioural disorders due to alcohol, excluding acute intoxication

911

8414

1.08

1.38

1.4

21.52

25.12

iu/l

3.25

693

7118

Deficiency of other B group vitamins

298

1.43

1.38

1.5

1.3

25.50

27.77

iu/l

0.17

256

Other specified/unspecified systemic involvement of connective tissue

173

1472

1.19

1.38

1.4

30.05

29.46

iu/l

0.08

148

1272

Open wound of lower leg

331

2944

1.13

1.38

1.5

21.67

23.53

iu/l

0.55

280

2426

FESS (DNB20)

343

3060

1.13

1.38

1.3

1.4

24.33

27.26

iu/l

1.05

300

2631

Malignant neoplasm of digestive organs, including Hilmo

368

3026

0.89

1.37

1.3

37.67

32.67

iu/l

1.62

296

2618

Disorders of gallbladder, biliary tract and pancreas

3072

19853

0.96

1.37

1.4

28.01

27.92

iu/l

0.05

2650

17161

Transport accidents

1744

13795

1.05

1.37

1.4

20.99

25.48

iu/l

8.79

1518

11818

Tuberculosis, IBD comorbidity

442

1.34

1.37

1.5

1.3

23.82

28.32

iu/l

0.52

375

Bitten or struck by other mammals

479

4357

1.11

1.37

1.4

23.99

24.91

iu/l

0.26

414

3723

Other congenital malformations of peripheral vascular system

403

1.38

1.36

1.3

1.5

23.89

21.61

iu/l

0.20

334

Other secondary gonarthrosis

672

1.28

1.36

1.4

1.3

30.34

32.25

iu/l

0.25

572

Crushed, pushed or stepped on by crowd or human stampede

241

2106

1.15

1.35

1.5

17.07

18.75

iu/l

0.41

191

1723

Focal brain injury

645

1.28

1.35

1.4

20.11

25.68

iu/l

1.07

537

Respiratory tuberculosis

290

1.42

1.35

1.5

1.3

23.87

25.85

iu/l

0.15

242

Respiratory tuberculosis, confirmed and not-confirmed

290

1.42

1.35

1.5

1.3

23.87

25.85

iu/l

0.15

242

Lung diseases due to external agents

137

1140

1.21

1.34

1.6

1.4

31.65

27.02

iu/l

0.81

114

972

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

146

1224

1.20

1.34

1.4

27.48

30.80

iu/l

0.76

126

1045

Corneal ulcer

540

4939

1.10

1.34

1.4

25.90

25.74

iu/l

0.04

461

4195

Chronic tubulo-interstitial nephritis

674

1.28

1.34

1.5

1.4

39.27

30.95

iu/l

1.22

586

Crohn's disease of large intestine

158

1338

1.19

1.34

1.5

1.4

24.85

23.41

iu/l

0.25

143

1127

Hereditary spherocytosis

2.06

1.34

1.4

1.5

9.98

25.20

iu/l

—

Habit and impulse disorders

395

1.37

1.34

1.5

1.4

17.59

20.25

iu/l

0.33

338

Childhood allergy (age < 16)

636

4831

1.09

1.33

1.7

1.5

7.85

8.26

iu/l

0.39

516

3817

Acute generalized exanthematous pustulosis

114

936

1.23

1.33

1.6

1.4

26.64

26.41

iu/l

0.03

102

802

Other infective otitis externa

155

1310

1.19

1.33

1.4

21.69

26.36

iu/l

1.14

129

1113

Major anomalies of jaw size

641

1.29

1.33

1.5

19.32

25.49

iu/l

0.93

536

Benign neoplasm: Other parts of oropharynx

153

1.61

1.33

1.3

27.32

22.10

iu/l

0.27

131

Coeliac disease

351

3145

1.12

1.32

1.5

26.32

25.78

iu/l

0.11

300

2634

Benign neoplasm: Short bones of upper limb

379

1.38

1.32

1.2

1.4

34.40

27.01

iu/l

0.62

322

Burns and corrosions

370

3324

1.12

1.32

1.4

1.5

21.34

22.29

iu/l

0.24

296

2760

Angina pectoris

499

3637

0.91

1.32

1.3

1.4

31.41

35.48

iu/l

1.76

419

3067

Systemic lupus erythematosus, unspecified

795

1.25

1.31

1.4

37.12

27.64

iu/l

1.66

684

Melanocytic naevi of scalp and neck

598

1.29

1.31

1.4

26.23

24.05

iu/l

0.23

515

Other localized connective tissue disorders

353

1.38

1.31

1.4

1.3

21.19

27.58

iu/l

0.68

296

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

145

1.61

1.30

1.6

1.2

56.43

25.33

iu/l

1.83

125

Autoimmune diseases excluding thyroid diseases

3532

18468

1.04

1.30

1.4

26.59

24.87

iu/l

2.24

3021

15636

Nonalcoholic steatohepatitis

178

1.56

1.30

1.3

16.79

27.32

iu/l

1.57

152

Assault by sharp object

302

1.42

1.30

1.5

1.4

24.80

19.24

iu/l

0.59

250

Premature rupture of membranes

1562

10571

1.06

1.30

1.3

1.4

20.15

25.60

iu/l

11.06

1393

9042

Actinic keratosis

218

1719

1.15

1.30

1.4

35.04

38.18

iu/l

0.74

185

1462

Primary coxarthrosis, bilateral

250

2192

1.14

1.29

1.4

35.98

38.50

iu/l

0.61

224

1880

Other or ill-defined heart diseases

784

1.25

1.29

1.3

1.5

29.61

24.60

iu/l

0.65

667

Unspecified kidney failure

640

1.27

1.29

2.1

1.4

28.90

25.72

iu/l

0.31

534

Other disorders of thyroid

244

1.47

1.29

1.6

1.4

23.16

25.58

iu/l

0.19

207

Asymmetry of jaw

451

1.34

1.29

1.2

1.5

22.28

22.63

iu/l

0.03

388

Other hereditary haemolytic anaemias

123

1.68

1.29

1.3

1.5

22.28

23.45

iu/l

0.05

102

Seropositive rheumatoid arthritis, wide

449

4936

0.91

1.28

1.4

33.92

32.09

iu/l

0.51

385

4271

Tuberculosis, wide

448

1.32

1.27

1.5

1.3

23.82

28.71

iu/l

0.58

380

Aspergillosis, including avohilmo

1.78

1.27

1.2

1.3

30.84

25.96

iu/l

—

Nonsuppurative otitis media, including avohilmo

1267

10354

1.06

1.27

1.5

1.4

18.15

19.68

iu/l

1.20

1024

8646

Serous carcinoma of ovary, including Hilmo

340

0.64

1.27

1.3

48.44

33.71

iu/l

0.72

299

Eosinophilic disease (BM)

228

1.47

1.27

1.6

1.4

24.50

28.62

iu/l

0.24

194

Other noninfective disorders of lymphatic vessels and lymph nodes

761

1.25

1.27

1.5

1.3

28.53

29.07

iu/l

0.06

643

Open wound of ankle and foot

245

2153

1.15

1.27

1.4

1.5

18.84

21.66

iu/l

0.97

207

1763

Intracerebral haemorrhage

749

1.25

1.26

1.5

1.4

32.12

28.49

iu/l

0.41

629

Typhoid and paratyphoid fevers, including avohilmo

108

1.72

1.26

1.4

1.3

22.62

26.23

iu/l

0.20

Coronary artery bypass grafting

647

0.78

1.25

1.3

1.5

21.05

24.34

iu/l

0.36

521

malignant neoplasm of female genital organs

262

2261

1.14

1.25

1.5

1.3

39.21

33.62

iu/l

1.58

218

1992

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

269

1.42

1.25

1.3

1.4

29.77

29.01

iu/l

0.04

222

Erythema nodosum

691

1.26

1.25

1.5

1.3

24.98

27.40

iu/l

0.28

600

Injury of muscle and tendon at ankle and foot level

575

1.29

1.25

1.2

1.4

22.21

26.21

iu/l

0.44

492

Residual foreign body in soft tissue

120

997

1.21

1.25

1.4

26.01

23.90

iu/l

0.26

838

Biomechanical lesions, not elsewhere classified

106

870

1.23

1.25

1.4

1.3

27.18

27.74

iu/l

0.07

749

Hypocalcemia

426

1.34

1.24

1.5

1.4

23.24

25.47

iu/l

0.21

367

Cardiodefibrillation

221

1922

1.15

1.24

1.4

22.35

29.98

iu/l

3.44

187

1595

Other disorders of pigmentation

763

1.24

1.23

1.4

32.50

29.03

iu/l

0.41

649

Other and unspecified nail disorders

435

1.33

1.23

1.3

1.4

24.90

28.91

iu/l

0.43

374

Acute gastritis

121

1007

1.21

1.23

1.3

1.4

30.11

29.22

iu/l

0.11

102

862

Basal cell carcinoma

434

3258

0.91

1.23

1.4

1.3

35.44

35.74

iu/l

0.06

371

2831

MS-disease / Multiple Sclerosis

257

2894

0.88

1.22

1.3

1.4

29.52

25.45

iu/l

1.13

228

2493

Injury of unspecified body region

171

1469

1.17

1.22

1.4

1.5

25.75

23.90

iu/l

0.30

141

1222

Gastric ulcer

184

1587

1.16

1.22

1.4

32.43

30.89

iu/l

0.24

152

1347

Focal epilepsy

500

4579

1.10

1.21

1.5

27.38

24.72

iu/l

0.95

406

3808

Hypoplasia of dental enamel, prenatal , including avohilmo

142

1.63

1.21

3.0

2.6

13.87

8.52

iu/l

0.25

Localized hypertrichosis

2.28

1.21

1.9

1.7

5.02

24.65

iu/l

—

Enteritis due to Yersinia enterocolitica

1.76

1.21

1.2

1.5

22.69

20.47

iu/l

0.08

Other and unspecified injuries of forearm

190

1.52

1.21

1.7

1.5

18.62

20.45

iu/l

0.11

160

Foreign body in alimentary tract

108

892

1.22

1.20

1.4

1.5

19.88

23.31

iu/l

0.71

735

Melanocytic naevi of upper limb, including shoulder

579

1.28

1.20

1.5

1.4

22.47

24.68

iu/l

0.27

490

Pedestrian injured in collision with pedal cycle

498

1.30

1.20

1.6

1.4

23.52

26.29

iu/l

0.29

429

Other ulcerative colitis

175

1511

1.17

1.20

1.4

25.75

24.10

iu/l

0.27

161

1277

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

364

3286

1.11

1.20

1.5

1.4

22.35

25.42

iu/l

1.11

293

2761

Malignant neoplasm of thymus, including Hilmo

2.07

1.19

1.8

1.1

44.01

24.61

iu/l

—

Infectious mononucleosis, including avohilmo

361

3267

1.12

1.19

1.4

18.00

17.27

iu/l

0.20

294

2708

Infectious mononucleosis

361

3267

1.12

1.19

1.4

18.00

17.27

iu/l

0.20

294

2708

Delivery, wide proxy

1108

5538

1.07

1.19

1.3

1.4

22.77

23.01

iu/l

0.09

957

4554

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

206

1.47

1.18

1.2

1.3

39.56

34.59

iu/l

0.45

186

Nystagmus and other irregular eye movements

326

1.38

1.18

2.1

1.6

23.32

22.25

iu/l

0.06

263

Viral infections of the central nervous system

196

1708

1.16

1.18

1.4

22.87

24.90

iu/l

0.41

166

1451

Retinal detachments and breaks

494

4528

1.09

1.18

1.4

34.54

34.21

iu/l

0.07

429

3896

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

110

1.67

1.17

2.2

1.7

28.18

21.66

iu/l

0.30

Other and unspecified glaucoma

402

1.32

1.17

1.3

28.72

31.56

iu/l

0.26

336

Corneal scars and opacities

421

1.32

1.17

1.7

1.4

24.99

25.67

iu/l

0.06

350

Glomerular disorders in diseases classified elsewhere

137

1613

0.85

1.17

1.4

29.96

23.77

iu/l

0.96

121

1365

Alcohol use disorder, ICD-based

847

7935

1.07

1.16

1.4

21.53

25.28

iu/l

3.28

649

6709

Other and unspecified vasculitis limited to skin

326

1.37

1.16

1.7

1.4

24.25

27.05

iu/l

0.22

270

Other abnormal auditory perceptions

302

1.39

1.16

1.4

29.27

25.20

iu/l

0.32

261

Insulin, intermediate and long-acting

983

10066

0.94

1.16

1.4

20.89

25.39

iu/l

5.00

802

8480

Mixed hyperlipidaemia

317

1.37

1.15

1.4

1.3

17.25

27.22

iu/l

2.03

263

Tuberculosis, wide, including avohilmo

456

1.30

1.15

1.5

1.3

23.82

28.78

iu/l

0.59

387

Inflammatory bowel disease, strict (require KELA)

770

7202

1.07

1.14

1.4

24.70

24.30

iu/l

0.13

675

6108

Dislocation, sprain and strain of joints and ligaments of knee

2378

20685

1.04

1.14

1.4

24.16

25.89

iu/l

1.99

2073

17681

Cholangitis (primary sclerosing, PSC)

806

1.22

1.14

1.3

1.5

26.55

25.56

iu/l

0.09

662

Substance abuse

1478

13071

1.05

1.14

1.4

20.76

24.32

iu/l

4.87

1137

11127

Drug-induced cataract

388

1.33

1.14

1.6

1.4

29.85

27.75

iu/l

0.11

334

Alcohol dependence

441

4030

1.10

1.14

1.4

22.71

26.26

iu/l

1.71

329

3432

Other diseases of pericardium

466

1.30

1.14

1.4

1.5

28.84

28.20

iu/l

0.05

397

Primary gonarthrosis, bilateral

704

5483

1.08

1.14

1.4

1.3

31.65

39.30

iu/l

9.28

616

4712

Ulcerative colitis (strict definition, all Crohn cases excluded)

435

3979

1.10

1.14

1.4

26.56

23.98

iu/l

0.83

375

3377

Type 1 diabetes, wide definition, subgroup 1

558

6026

0.92

1.14

1.4

1.5

20.66

22.37

iu/l

0.63

460

5008

Superficial injury of thorax

324

2919

1.11

1.13

1.4

23.43

26.00

iu/l

0.86

272

2474

Psoriasis

703

6555

1.08

1.13

1.4

27.92

29.09

iu/l

0.43

585

5589

Other and unspecified vaccines and biological substances

194

1.50

1.13

1.5

1.4

18.20

22.22

iu/l

0.36

170

Mental and behavioural disorders due to psychoactive substance use

1554

13573

1.05

1.12

1.4

21.24

24.51

iu/l

4.26

1194

11564

Open wound of abdomen, lower back and pelvis

611

1.26

1.12

1.3

1.5

18.48

20.12

iu/l

0.17

512

Ankylosing spondylitis

219

1932

1.14

1.11

1.4

24.94

27.07

iu/l

0.43

187

1664

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

120

1414

0.84

1.11

1.3

1.4

29.45

29.75

iu/l

0.03

105

1227

Tuberculosis

302

1.36

1.11

1.5

1.3

23.87

26.35

iu/l

0.19

254

Other acquired deformities of musculoskeletal system and connective tissue

756

1.23

1.10

1.4

31.48

27.83

iu/l

0.47

642

Contact with sharp object, undetermined intent

488

1.29

1.10

1.3

1.5

19.71

19.81

iu/l

0.01

418

Motorcycle rider injured in other and unspecified transport accidents

132

1123

1.18

1.09

1.4

1.5

12.00

17.80

iu/l

2.77

114

909

Aspergillosis

1.72

1.09

1.2

1.3

33.79

26.46

iu/l

—

Other and unspecified mononeuropathies, also in other diseases

417

1.31

1.09

1.4

35.90

29.56

iu/l

0.61

369

Prolapse and hernia of ovary and fallopian tube

1.88

1.09

2.0

1.5

51.03

50.39

iu/l

0.02

Fall involving playground equipment

238

1.44

1.09

1.9

2.3

17.75

13.45

iu/l

0.33

159

malignant neoplasm of female genital organs, including Hilmo

320

2751

1.11

1.09

1.4

1.3

40.21

33.71

iu/l

2.38

267

2420

Viral infections of the central nervous system, including avohilmo

215

1900

1.14

1.08

1.5

1.4

22.78

24.85

iu/l

0.46

182

1609

Onycholysis

154

1.54

1.08

1.4

1.3

32.74

25.84

iu/l

0.34

127

Injuries involving multiple body regions

100

832

1.22

1.08

1.6

1.4

20.89

23.53

iu/l

0.39

702

Retinal detachment with retinal break

161

1392

1.16

1.07

1.4

33.94

31.26

iu/l

0.43

145

1191

Benign neoplasm: Skin of ear and external auricular canal

453

1.29

1.07

1.2

1.3

19.78

28.00

iu/l

1.91

384

Alzheimer disease, including avohilmo

667

0.81

1.07

1.4

44.05

35.61

iu/l

1.06

558

Open bite that required surgery (Lefort1 or BSSO)

360

1.35

1.07

1.2

1.3

21.80

20.80

iu/l

0.07

311

Noonan syndrome

2.05

1.07

2.1

17.48

13.74

iu/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

210

2377

0.88

1.07

1.4

25.65

28.57

iu/l

0.60

176

2046

Other congenital malformations of tongue, mouth and pharynx

348

1.34

1.07

1.7

2.0

15.54

10.75

iu/l

0.46

244

Psoriatic arthropathies

246

2193

1.13

1.06

1.4

31.50

31.05

iu/l

0.08

217

1887

Viral meningitis, including avohilmo

135

1157

1.18

1.06

1.5

1.4

22.79

iu/l

0.00

112

993

Respiratory insufficiency

487

1.27

1.06

1.8

1.5

26.39

33.08

iu/l

0.91

406

Abscess of Bartholin gland

134

1151

1.19

1.06

1.4

29.14

24.14

iu/l

0.88

124

1013

Failed induction of labour

339

3716

0.90

1.06

1.3

1.4

17.98

19.48

iu/l

0.49

295

3161

Peripheral retinal degeneration

580

1.26

1.06

1.6

1.3

23.71

31.03

iu/l

1.01

501

Injury of nerves at lower leg level

196

1.46

1.05

1.4

29.39

28.03

iu/l

0.06

169

Family history of other specific disorders

413

1.31

1.05

1.4

1.3

17.34

20.37

iu/l

0.46

352

Acute suppurative otitis media

1216

10782

1.06

1.04

1.5

1.4

18.18

17.82

iu/l

0.17

999

9035

Exposure to other specified electric current

630

0.77

1.04

1.3

1.4

14.58

20.56

iu/l

1.27

530

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

144

864

1.17

1.04

1.4

33.95

37.01

iu/l

0.43

112

723

Fitting and adjustment of other devices

383

3692

0.91

1.04

1.5

1.4

28.62

32.05

iu/l

1.39

354

3156

Other diseases of biliary tract

114

962

1.19

1.03

1.3

1.4

34.47

30.02

iu/l

0.67

806

Chronic Coagulation defects

802

1.22

1.03

1.5

19.93

24.22

iu/l

0.96

676

Biological medicines for asthma

592

1.25

1.03

1.2

1.3

25.01

25.24

iu/l

0.02

512

Cellulitis of external ear

265

1.39

1.03

1.6

1.5

22.83

22.60

iu/l

0.01

226

Type 1 diabetes

639

6832

0.93

1.03

1.4

1.5

19.87

22.94

iu/l

1.74

528

5697

Conductive hearing loss, unspecified

189

1662

1.14

1.03

1.4

28.84

27.08

iu/l

0.29

160

1397

Eosinophilia

239

1.40

1.03

1.6

1.5

24.50

24.48

iu/l

0.00

202

Crohn disease (strict definition, require KELA)

208

1843

1.14

1.02

1.5

1.4

20.12

22.03

iu/l

0.47

184

1552

Other and unspecified aplastic anaemias

147

1.52

1.02

2.1

1.6

32.68

21.96

iu/l

0.52

121

Embedded and impacted teeth

1301

10064

1.05

1.02

1.5

1.4

13.74

15.87

iu/l

2.61

1100

8353

Marasmic kwashiorkor

2.09

1.02

3.4

2.4

5.46

19.73

iu/l

—

Golimumab

132

1134

1.18

1.02

1.4

1.5

20.92

24.44

iu/l

0.68

120

966

Carcinoma in situ of skin, other sites/unspecified

1.93

1.02

1.1

1.2

23.61

29.91

iu/l

—

Juvenile osteochondrosis

104

875

1.20

1.02

1.6

1.5

15.18

18.91

iu/l

1.03

719

Acute alcohol intoxication, ICD10

438

4030

1.09

1.02

1.5

1.4

20.46

23.20

iu/l

1.15

334

3358

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

387

1.31

1.02

1.3

1.4

27.42

27.88

iu/l

0.03

330

Burn and corrosion of hip and lower limb, except ankle and foot

458

1.28

1.02

1.3

1.5

20.81

20.46

iu/l

0.02

386

Symptoms and signs involving appearance and behaviour

181

1.47

1.02

1.6

1.3

25.92

19.85

iu/l

0.31

153

Other renal tubulo-interstitial diseases

721

1.23

1.01

1.3

1.4

30.69

28.32

iu/l

0.22

620

Plasmodium falciparum malaria

1.96

1.01

1.3

1.4

24.01

22.29

iu/l

—

Delirium, not induced by alcohol and other psychoactive substances

679

1.22

1.01

1.3

30.07

26.95

iu/l

0.32

572

Plasmodium falciparum malaria, including avohilmo

1.95

1.01

1.3

1.4

24.01

22.29

iu/l

—

Conduct disorder

585

1.25

1.01

1.5

1.7

15.78

15.16

iu/l

0.08

452

Polyp of middle ear

0.00

1.00

0.0

1.6

—

26.88

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

504

4671

1.08

1.00

1.4

25.80

23.99

iu/l

0.59

435

3955

Congenital dislocation of hip, unilateral

157

1.51

1.00

1.5

2.2

7.57

15.63

iu/l

3.23

124

Other assisted single delivery

130

1126

1.19

1.00

1.4

25.92

25.65

iu/l

0.03

122

950

Valvular operations

929

0.82

1.00

1.6

28.74

23.52

iu/l

0.55

756

Other and unspecified disorders of binocular movement

149

1.53

1.00

1.5

1.4

21.09

22.74

iu/l

0.09

117

Other neurological diseases

1583

11745

1.05

1.00

1.5

1.4

28.06

28.99

iu/l

0.51

1355

10071

Spirochaetal infections, other/unspecified

181

1591

1.14

0.99

1.6

1.4

29.34

30.00

iu/l

0.09

157

1370

Bacterial Sepsis

672

5192

1.07

0.99

1.5

1.4

25.20

28.27

iu/l

1.68

541

4353

Iridocyclitis

571

5318

1.08

0.99

1.4

28.27

27.74

iu/l

0.13

491

4541

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

2.01

0.99

1.4

1.7

35.59

21.30

iu/l

—

Peripheral artery operations in Hilmo

651

0.78

0.99

1.2

1.4

15.91

27.16

iu/l

3.67

540

Other and unspecified neuropathies

1.85

0.98

2.8

1.4

25.09

16.49

iu/l

—

Other disorders of Eustachian tube

677

1.23

0.98

1.3

1.4

22.16

26.42

iu/l

0.65

583

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

317

2836

1.11

0.98

1.6

1.5

17.71

17.08

iu/l

0.15

264

2270

Autoimmune hepatitis

174

1.47

0.98

1.4

1.6

26.45

23.45

iu/l

0.20

141

Assault by unspecified means

524

1.26

0.98

1.3

1.5

15.48

19.51

iu/l

0.67

446

Ulcerative colitis (strict definition, require KELA)

517

4802

1.08

0.98

1.4

26.01

24.10

iu/l

0.64

447

4065

Other infectious diseases

134

1154

1.17

0.98

1.5

1.4

25.06

25.43

iu/l

0.05

121

986

Dependent personality disorder

390

1.30

0.98

1.6

1.3

21.04

28.25

iu/l

0.94

332

Speech disturbances, not elsewhere classified

128

1098

1.17

0.97

1.5

1.4

25.39

28.89

iu/l

0.63

112

942

Maxillary retrognathism

507

1.27

0.97

1.8

1.7

15.44

15.77

iu/l

0.04

403

Melanocytic naevi of lip

183

1.46

0.97

1.2

1.3

27.57

26.46

iu/l

0.05

154

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

460

4265

1.09

0.97

1.3

26.47

25.96

iu/l

0.12

405

3691

528

1.24

0.97

1.3

1.4

42.54

39.29

iu/l

0.28

443

Degenerative macular diseases

100

840

1.19

0.97

1.4

37.54

30.68

iu/l

1.08

714

SLE (Finngen)

107

908

1.19

0.97

1.4

36.50

29.50

iu/l

1.12

787

Malignant neoplasm of rectum, including Hilmo

721

1.21

0.96

1.3

37.25

31.38

iu/l

0.83

622

Phakomatoses, not elsewhere classified

295

1.35

0.96

2.2

1.6

7.64

20.13

iu/l

7.69

238

Seropositive rheumatoid arthritis

449

4831

0.92

0.96

1.4

1.3

33.92

32.41

iu/l

0.39

385

4183

Mental and behavioural disorders due to alcohol

1158

10495

1.05

0.96

1.4

21.42

24.54

iu/l

3.13

894

8924

Generalized skin eruption due to drugs and medicaments

834

1.20

0.96

1.6

1.5

28.50

25.46

iu/l

0.41

715

Pleural effusion

133

1145

1.16

0.96

1.5

1.4

25.96

29.81

iu/l

0.81

109

981

Benign neoplasm: Skin of trunk

100

843

1.20

0.96

1.6

1.4

29.83

27.09

iu/l

0.34

723

Pure hypercholesterolaemia

1453

9641

0.95

0.96

1.4

30.76

33.56

iu/l

2.23

1166

8357

Paralytic ileus

337

1.31

0.96

1.3

39.55

29.51

iu/l

0.58

294

Other infections specific to the perinatal period

159

1.50

0.96

2.2

2.5

4.76

7.36

iu/l

1.62

105

Dislocation, sprain and strain of joints and ligaments of thorax

697

1.22

0.96

1.3

1.4

27.57

25.14

iu/l

0.29

587

Intrahepatic Cholestasis of Pregnancy (ICP)

452

4195

1.09

0.95

1.3

26.18

25.48

iu/l

0.17

399

3630

Other and unspecified iridocyclitis

119

1019

1.18

0.95

1.3

1.4

28.74

25.41

iu/l

0.47

102

870

Respiratory distress of newborn

397

1.29

0.95

2.8

2.6

6.81

6.37

iu/l

0.12

225

Postpartum haemorrhage due to retained placenta

829

7849

1.07

0.95

1.3

25.71

26.37

iu/l

0.25

746

6900

Keratoconus

463

1.27

0.94

1.3

1.4

28.03

23.27

iu/l

0.51

399

SLE, ICD10

105

892

1.19

0.94

1.4

36.27

28.23

iu/l

1.38

768

SLE, strict definition

105

892

1.19

0.94

1.4

36.27

28.23

iu/l

1.38

768

Unspecified jaundice

435

1.27

0.94

1.4

1.5

25.68

26.14

iu/l

0.04

356

Viral agents as the cause of diseases classified to other chapters

545

1.25

0.94

1.5

27.32

22.12

iu/l

0.61

459

Laparoscopic right hemicolectomy

329

1.31

0.94

1.4

1.3

37.94

31.65

iu/l

0.51

277

Benign neoplasm: Skin of other and unspecified parts of face

191

1692

1.13

0.94

1.4

1.3

26.90

30.05

iu/l

0.65

166

1460

Other specified and unspecified retinal disorders

427

1.27

0.94

1.6

1.4

31.08

28.82

iu/l

0.18

355

Preparatory care for dialysis

454

0.74

0.94

1.1

1.4

43.96

25.48

iu/l

0.79

380

Disorder of external ear, unspecified

617

1.23

0.93

1.7

1.4

29.74

28.65

iu/l

0.10

527

Peroneal tendinitis

474

1.27

0.93

1.6

1.4

30.39

30.63

iu/l

0.02

415

Gastroduodenal ulcer

257

2308

1.11

0.93

1.4

30.22

30.82

iu/l

0.10

213

1960

Congenital malformations of the urinary system

146

1273

1.16

0.93

1.7

1.6

29.57

21.57

iu/l

1.36

121

1028

Bruxism

721

1.22

0.93

1.5

1.3

23.85

25.96

iu/l

0.25

623

Spinal stenosis

681

4704

1.07

0.93

1.4

34.85

36.87

iu/l

0.83

583

4034

Generalized epilepsy, strict definition

619

1.23

0.93

1.5

21.47

21.21

iu/l

0.03

507

Other and specified injuries of hip and thigh

287

1.34

0.92

1.3

1.4

19.50

22.01

iu/l

0.25

243

Coxarthrosis, primary

645

5710

0.94

0.92

1.4

34.94

37.67

iu/l

1.27

562

4899

Dermatophytosis

238

2139

1.12

0.92

1.5

1.4

23.35

27.17

iu/l

1.15

195

1802

Cytomegaloviral disease, including avohilmo

447

1.27

0.92

2.1

1.5

27.71

25.96

iu/l

0.11

377

Glaucoma secondary to other eye disorders

491

1.25

0.92

1.3

1.4

29.43

25.59

iu/l

0.36

420

Postpartum hemorraghe, parous women as controls

1838

14826

1.04

0.91

1.3

24.54

26.39

iu/l

1.70

1658

12994

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

546

5098

1.08

0.91

1.4

26.49

24.42

iu/l

0.75

475

4306

Diseases of peritoneum

188

1668

1.13

0.91

1.4

26.88

29.76

iu/l

0.60

165

1430

Other cranial nerve disorders in other disorders

1.98

0.91

3.0

1.4

15.57

30.13

iu/l

—

Atrial fibrillation and flutter with reimbursement

259

1809

0.90

0.91

1.3

29.54

38.89

iu/l

4.13

211

1530

Osteomalacia

169

1.45

0.90

1.6

1.3

28.69

24.30

iu/l

0.30

150

Other sexually transmitted chlamydial diseases

306

2797

1.10

0.90

1.4

16.76

14.93

iu/l

0.52

232

2350

Other congenital malformations of heart

195

1.43

0.90

2.4

2.1

14.88

16.53

iu/l

0.18

152

Alcoholic liver disease

862

0.82

0.90

1.3

1.4

32.99

28.17

iu/l

0.59

722

Acute and subacute iridocyclitis

480

4463

1.08

0.90

1.4

28.93

27.82

iu/l

0.28

411

3828

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

841

1.19

0.90

1.6

1.5

24.38

25.28

iu/l

0.10

706

Rubella [German measles], including avohilmo

202

1.39

0.89

1.3

1.4

17.43

16.56

iu/l

0.06

170

Benign neoplasm: Long bones of lower limb

823

1.19

0.89

1.6

1.5

21.16

24.51

iu/l

0.49

694

Demyelinating diseases of the central nervous system

305

3333

0.91

0.89

1.3

1.4

28.11

25.49

iu/l

0.69

269

2878

Otosclerosis

127

1099

1.16

0.89

1.4

39.21

32.55

iu/l

1.22

116

946

Other respiratory disorders and diseases

214

1915

1.12

0.89

1.7

1.5

30.26

28.42

iu/l

0.32

167

1622

Other diseases of the respiratory system

214

1915

1.12

0.89

1.7

1.5

30.26

28.42

iu/l

0.32

167

1622

Pedal cyclist injured in other and unspecified transport accidents

277

2517

1.11

0.89

1.5

1.4

23.53

24.25

iu/l

0.14

230

2096

Reactive arthropathies

211

1890

1.12

0.89

1.4

23.49

28.19

iu/l

1.55

189

1612

Carcinoma in situ of skin of other and unspecified parts of face

202

1.39

0.89

1.2

1.3

34.63

33.36

iu/l

0.06

166

Malignant neoplasm of prostate

374

1.22

0.89

1.7

1.3

11.27

10.07

iu/l

0.35

290

Behavioural disorders

604

1.23

0.89

1.5

1.6

15.78

14.82

iu/l

0.13

475

Generalized epilepsy, mode (most common among epilepsy diagnosis)

103

880

1.19

0.88

1.4

1.5

21.20

23.09

iu/l

0.29

734

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

300

1.33

0.88

1.7

1.9

20.14

15.20

iu/l

0.40

234

Other and unspecified psoriasis

124

1073

1.16

0.88

1.5

1.4

27.57

29.19

iu/l

0.23

100

916

Paroxysmal tachycardia

681

5324

1.07

0.87

1.4

24.14

28.74

iu/l

3.08

574

4549

Suppurative and unspecified otitis media

1573

13395

1.04

0.87

1.5

1.4

17.54

19.25

iu/l

1.75

1315

11278

Acute epiglottitis

344

1.30

0.87

1.5

1.4

23.54

25.20

iu/l

0.13

290

Toxic effects of substances chiefly nonmedicinal as to source

299

2731

1.10

0.87

1.5

1.4

22.36

22.51

iu/l

0.03

238

2271

Foreign body on external eye

249

2252

1.11

0.87

1.4

19.73

19.78

iu/l

0.01

206

1854

Use of interferon beta-1a

1013

0.83

0.87

1.3

1.4

31.84

25.91

iu/l

0.81

880

Fall on and from ladder

667

1.20

0.87

1.5

1.4

21.22

22.21

iu/l

0.10

558

Other epidermal thickening

723

1.20

0.87

1.7

1.4

29.14

26.18

iu/l

0.35

603

Squamous cell neoplasms and carcinoma of cervix

214

1.39

0.86

1.4

1.3

37.53

24.18

iu/l

1.13

185

Drug-induced obesity

275

1.34

0.86

1.7

1.3

22.12

23.32

iu/l

0.08

235

Acute inflammation of orbit

1.60

0.86

1.6

1.5

22.38

24.12

iu/l

—

Contact with lifting and transmission devices, not elsewhere classified

230

1.36

0.86

1.3

1.4

20.81

21.43

iu/l

0.03

188

Disorder of carbohydrate metabolism, other/unspecified

1.83

0.86

2.1

1.5

42.39

27.21

iu/l

—

Burn and corrosion, body region unspecified

121

1.53

0.86

1.2

1.3

20.28

20.70

iu/l

0.02

108

Other arterial embolism and thrombosis

204

1.38

0.85

1.5

1.4

30.06

20.06

iu/l

0.84

165

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

222

2002

1.12

0.85

1.5

1.4

20.52

22.51

iu/l

0.51

198

1685

Vasculitis limited to skin, not elsewhere classified

362

1.28

0.85

1.7

1.4

23.27

27.63

iu/l

0.39

305

Other bursitis of hip

327

1.30

0.85

1.5

1.3

27.72

31.20

iu/l

0.28

286

Septal defects

189

1654

1.13

0.85

2.0

1.7

19.69

21.24

iu/l

0.29

147

1266

Ankyloglossia

443

1.26

0.85

1.8

1.9

15.36

9.62

iu/l

0.73

312

Premature separation of placenta [abruptio placentae]

137

1206

1.16

0.85

1.3

22.52

27.78

iu/l

1.20

110

1021

Guillain-Barre syndrome

231

1.36

0.84

1.3

1.4

38.11

24.63

iu/l

0.77

196

Other protozoal intestinal diseases

382

1.28

0.84

1.9

1.4

15.61

22.12

iu/l

1.13

316

Placental disorders

484

1.26

0.84

1.6

1.3

19.26

22.51

iu/l

0.34

410

Paraplegia, diplegia of upper limbs

310

1.30

0.84

1.4

25.66

25.41

iu/l

0.02

256

Acute alcohol intoxication

476

4439

1.07

0.83

1.5

1.4

21.37

24.15

iu/l

1.24

364

3748

Reactive arthropathies, FINNGEN

186

1663

1.13

0.83

1.4

22.10

27.21

iu/l

1.79

167

1418

Neovascular glaucoma

498

1.23

0.83

1.3

1.4

29.43

25.45

iu/l

0.38

422

Other conjunctival vascular disorders and cysts

355

1.28

0.83

1.3

1.4

32.43

29.94

iu/l

0.21

298

Persistent delusional disorders

143

1257

1.14

0.83

1.4

25.18

28.23

iu/l

0.54

115

1075

Lesion of lateral popliteal nerve

736

1.19

0.83

1.3

1.4

21.82

26.49

iu/l

0.95

631

Cytomegaloviral disease

436

1.25

0.83

2.2

1.5

27.93

25.97

iu/l

0.13

366

Malignant neoplasm of thymus

1.75

0.82

1.4

1.1

46.34

25.27

iu/l

—

Suppurative otitis media, unspecified

472

1.24

0.82

1.6

1.5

15.35

14.99

iu/l

0.04

376

Systemic sclerosis

531

0.78

0.82

1.7

1.4

37.21

30.43

iu/l

0.55

456

Hyperkalaemia

346

1.28

0.81

1.5

1.4

32.19

27.93

iu/l

0.22

285

Thiazolidinediones

838

1.17

0.81

1.4

23.08

31.78

iu/l

2.90

703

Other osteochondropathies

185

1657

1.12

0.81

1.6

1.4

25.43

24.99

iu/l

0.07

163

1405

Anterior Iridocyclitis

500

4679

1.07

0.81

1.4

28.99

27.77

iu/l

0.33

429

4005

Later onset COPD

428

1.22

0.81

1.3

1.5

29.09

29.77

iu/l

0.06

348

Anomalies of pupillary function

547

1.22

0.81

1.3

1.4

42.82

23.50

iu/l

1.95

469

Other and unspecified mononeuropathies of lower limb

410

1.26

0.81

1.4

1.3

25.84

29.85

iu/l

0.45

351

Need for immunization against other single viral diseases

268

1.32

0.81

1.7

1.4

24.01

22.05

iu/l

0.13

219

Other benign neoplasm of uterus: Cervix uteri

200

1.39

0.80

1.2

1.3

22.29

28.00

iu/l

0.44

172

Pre-eclampsia

1058

10128

1.05

0.80

1.3

25.30

27.70

iu/l

1.75

941

8809

Other contact dermatitis

235

2134

1.11

0.80

1.3

1.4

24.73

27.86

iu/l

0.87

212

1830

Other congenital malformations of integument

2.37

0.80

1.4

2.3

25.58

20.94

iu/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

274

2504

1.10

0.80

1.4

23.61

29.49

iu/l

2.67

239

2158

Calcific aortic valvular stenosis, operated

103

1150

0.86

0.80

1.4

27.94

28.98

iu/l

0.12

957

Calcific aortic valvular stenosis

103

1150

0.86

0.80

1.4

27.94

28.98

iu/l

0.12

957

Overjet

101

867

1.18

0.80

2.1

2.0

15.06

14.81

iu/l

0.03

652

Ingrowing nail

124

1084

1.15

0.79

1.6

1.5

21.79

22.34

iu/l

0.07

101

905

Diseases of spleen

260

1.32

0.79

1.4

31.94

21.53

iu/l

0.87

222

Malignant neoplasm of ovary

703

1.19

0.79

1.8

1.4

30.67

32.62

iu/l

0.23

622

Crohn disease (strict definition, require KELA, min 2 HDR)

201

1813

1.12

0.79

1.5

1.4

20.19

22.02

iu/l

0.43

177

1527

Staphylococcal scalded skin syndrome

2.32

0.79

1.2

1.4

8.06

11.77

iu/l

—

Chondromalacia

622

1.20

0.78

1.5

1.3

24.91

28.99

iu/l

0.64

536

Other misadventures during surgical and medical care

385

1.26

0.78

1.4

1.3

18.46

26.08

iu/l

1.20

325

Other and unspecified mental retardation

445

1.25

0.78

2.7

2.0

21.14

15.79

iu/l

0.46

307

Emphysema

384

1.25

0.78

1.3

1.4

31.47

29.38

iu/l

0.17

319

Retrobulbar neuritis in diseases classified elsewhere

131

0.59

0.78

1.4

1.3

31.09

21.15

iu/l

—

106

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

287

2636

1.10

0.78

1.4

24.73

27.40

iu/l

0.78

258

2246

Motor neuron disease (with DMD)

123

1.47

0.78

2.3

1.3

38.73

34.24

iu/l

0.12

107

Alzheimer disease

553

0.83

0.78

1.4

45.18

36.13

iu/l

0.92

464

Insulin, fast-acting or short human

767

8072

0.95

0.78

1.4

1.5

21.09

23.66

iu/l

1.49

630

6779

Other otitis externa (chronic)

164

1463

1.13

0.78

1.6

1.4

22.67

26.63

iu/l

1.21

144

1246

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

182

1.38

0.78

1.4

1.3

27.68

27.58

iu/l

0.00

146

Other factor of the environment

244

1.33

0.77

1.3

15.84

23.98

iu/l

1.05

205

Dysplastic lesion of the vagina of unknown severity

2.22

0.77

2.0

1.5

44.76

29.34

iu/l

—

Systemic sclerosis, icd10

526

0.79

0.77

1.7

1.4

37.21

30.11

iu/l

0.59

451

Cardiac arrhythmias

2544

16766

0.97

0.77

1.4

25.92

27.42

iu/l

1.48

2198

14486

Dyspnoea

2755

20417

0.97

0.76

1.4

26.46

27.21

iu/l

0.57

2369

17538

Rubella [German measles]

200

1.36

0.76

1.3

1.4

17.40

16.45

iu/l

0.06

168

Deep bite that required surgery

452

1.24

0.76

1.3

27.31

26.22

iu/l

0.08

392

Kissing spine

2.16

0.76

1.8

1.4

24.30

21.85

iu/l

—

Other specified/unspecified deforming dorsopathies

515

1.22

0.76

1.6

1.4

27.93

30.55

iu/l

0.24

452

Pneumococcal septicemia

477

1.23

0.76

1.6

1.5

22.40

21.35

iu/l

0.09

398

Unspecified acute lower respiratory infection

358

3320

1.08

0.76

1.4

23.31

22.64

iu/l

0.15

299

2810

Pregnancy, childbirth and the puerperium

898

4464

1.05

0.75

1.3

1.4

22.63

22.22

iu/l

0.14

771

3679

Congenital malformations of larynx

1.62

0.75

1.8

2.8

24.14

15.13

iu/l

—

Other, unspecified and serous retinal detachments

324

1.27

0.75

1.3

1.4

20.78

28.60

iu/l

0.95

274

Injury of muscle and tendon at forearm level

289

1.29

0.75

1.3

1.5

22.01

21.91

iu/l

0.01

246

Other diseases of peritoneum

856

1.17

0.75

1.4

1.3

28.97

30.85

iu/l

0.25

739

Systemic sclerosis (FG)

524

0.79

0.75

1.7

1.4

37.21

31.20

iu/l

0.47

453

Mental retardation, wide definition

116

1007

1.15

0.75

2.6

1.8

15.72

18.68

iu/l

0.54

758

Other obstructed labour

340

3156

1.09

0.75

1.3

1.4

27.32

28.82

iu/l

0.39

298

2719

Allergic purpura

718

1.18

0.75

1.4

1.5

18.83

23.74

iu/l

0.95

604

Aneurysms, operations, SAH

268

2457

1.09

0.74

1.4

31.61

33.55

iu/l

0.40

225

2127

Ankle and foot

159

1.41

0.74

1.4

34.31

25.01

iu/l

0.63

137

Effects of other external causes

709

1.18

0.74

1.4

18.02

19.58

iu/l

0.22

593

Ulcerative enterocolitis

765

1.18

0.74

1.5

1.4

19.28

23.91

iu/l

0.80

656

Systemic lupus erythematosus

107

933

1.16

0.74

1.4

36.50

28.40

iu/l

1.40

798

Adrenomedullary hyperfunction

1.85

0.74

1.6

1.3

19.30

31.99

iu/l

—

Congenital malformations of cardiac septa

199

1745

1.11

0.74

2.0

1.7

19.67

21.38

iu/l

0.35

155

1342

Recurrent dislocation and subluxation of joint

259

2377

1.10

0.73

1.4

24.66

26.52

iu/l

0.45

233

2027

Ankylosis of joint

1.63

0.73

1.6

1.3

16.74

29.49

iu/l

—

Pedal cyclist injured in collision with motor vehicle

608

1.19

0.73

1.3

1.4

24.40

22.35

iu/l

0.21

518

Orthopaedic devices associated with adverse incidents

107

0.56

0.73

1.7

1.3

15.27

30.97

iu/l

—

Other and unspecified injuries of head

144

1280

1.13

0.73

1.6

1.5

23.18

25.68

iu/l

0.41

117

1048

UC patients in KELA-register (code 208), prior to 1994

608

1.19

0.73

1.3

1.4

38.46

33.60

iu/l

0.60

520

Femoral hernia

443

1.23

0.72

1.6

1.4

30.03

29.26

iu/l

0.06

380

Pyogenic granuloma

354

1.26

0.72

1.7

1.4

20.17

22.12

iu/l

0.15

299

Diseases of thymus

1.76

0.71

1.4

11.53

23.81

iu/l

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

1.59

0.71

1.3

1.4

41.60

23.22

iu/l

—

Allergic contact dermatitis due to drugs in contact with skin

473

1.22

0.71

1.6

1.4

27.04

27.29

iu/l

0.02

410

Haemorrhagic and haematological disorders of fetus and newborn

540

1.20

0.71

2.6

2.4

5.72

7.79

iu/l

0.86

335

Venous complications and haemorrhoids in the puerperium

311

1.28

0.71

1.4

1.3

33.25

28.69

iu/l

0.36

267

Oesophageal varices

318

1.26

0.71

1.6

1.4

27.79

23.95

iu/l

0.28

255

Insulin, fast-acting

765

8024

0.95

0.71

1.4

1.5

21.01

23.67

iu/l

1.58

628

6730

Viral meningitis

123

1088

1.14

0.70

1.5

1.4

22.75

22.91

iu/l

0.02

102

936

Other acute viral hepatitis

302

1.28

0.70

1.3

1.4

24.69

22.18

iu/l

0.18

257

Other pleural conditions

665

1.18

0.70

1.3

1.4

29.08

29.29

iu/l

0.02

571

Deaf mutism, not elsewhere classified

1.67

0.70

1.4

1.5

23.70

28.95

iu/l

—

Assault by blunt object

293

1.28

0.70

1.5

1.4

17.61

22.22

iu/l

0.53

242

Respiratory tuberculosis, not confirmed

169

1.37

0.69

1.7

1.3

25.10

28.08

iu/l

0.16

137

Carcinoma in situ of vulva

214

1.34

0.69

1.1

1.3

32.41

27.65

iu/l

0.25

186

Cerebral aneurysm, nonruptured

170

1532

1.11

0.69

1.4

30.98

33.46

iu/l

0.40

143

1324

Carcinoma in situ of cervix uteri, endocervix

635

1.20

0.69

1.3

28.92

25.27

iu/l

0.38

556

Loose body in joint

383

1.24

0.69

1.3

1.4

25.29

28.31

iu/l

0.26

326

Benign neoplasm: Caecum

921

0.86

0.69

1.4

32.38

33.41

iu/l

0.10

795

Aortic arch syndrome [Takayasu]

1.69

0.69

1.6

1.4

38.93

25.10

iu/l

—

L04AC Interleukin inhibitors

203

1849

1.11

0.69

1.3

1.4

22.93

25.47

iu/l

0.60

173

1576

Malignant neoplasm of oral cavity

204

1.33

0.69

1.3

28.27

27.04

iu/l

0.07

175

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

139

1242

1.13

0.69

1.6

1.5

16.64

17.29

iu/l

0.10

116

981

Acute myringitis

162

1.39

0.68

1.9

1.5

18.53

19.59

iu/l

0.08

133

Sequelae of infectious and parasitic diseases

179

1620

1.11

0.68

1.3

1.4

23.71

26.28

iu/l

0.56

155

1387

Acute alcohol intoxication ICD-9

311

1.26

0.68

1.3

34.20

28.76

iu/l

0.50

263

Open wound of thorax

205

1.33

0.68

1.5

19.01

20.57

iu/l

0.09

171

Cytomegalovirus infection, IBD co-morbidity

393

1.23

0.68

2.3

1.4

29.13

24.75

iu/l

0.29

329

Prominent ears

304

1.28

0.68

1.3

1.6

17.31

13.17

iu/l

0.35

241

Congenital malformations of pulmonary and tricuspid valves

213

0.69

0.68

4.5

2.0

14.69

13.51

iu/l

0.06

150

Other chronic obstructive pulmonary disease

367

2798

1.07

0.67

1.4

28.95

32.55

iu/l

1.39

293

2369

Sleepwalking [somnambulism]

1.54

0.67

1.4

28.80

20.56

iu/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

102

1.48

0.67

1.5

1.4

18.31

24.71

iu/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

460

4338

1.07

0.67

1.3

26.47

26.31

iu/l

0.04

405

3787

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

1.84

0.67

1.8

1.6

6.32

18.96

iu/l

—

Erythema intertrigo

330

1.25

0.67

1.6

1.3

24.11

27.14

iu/l

0.27

284

Glomerular diseases

268

2903

0.92

0.67

1.4

29.30

24.89

iu/l

1.06

233

2434

Myositis

312

1.26

0.67

1.7

1.4

23.55

27.15

iu/l

0.28

262

Operations 2 for CAVS

103

1131

0.88

0.67

1.4

27.94

29.16

iu/l

0.14

946

Calcific aortic valvular stenosis, diagnosis (helper)

103

1131

0.88

0.67

1.4

27.94

29.16

iu/l

0.14

946

Pre-eclampsia or eclampsia

1091

10507

1.04

0.66

1.3

25.31

27.74

iu/l

1.85

973

9132

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

452

4266

1.07

0.66

1.3

26.18

25.90

iu/l

0.06

399

3723

Sequelae of infectious and parasitic diseases, including avohilmo

180

1633

1.11

0.66

1.3

1.4

24.08

26.35

iu/l

0.47

156

1400

Nonischemic cardiomyopathy

884

0.86

0.66

1.6

1.4

29.05

27.98

iu/l

0.09

742

Contusion of ankle

120

1065

1.14

0.66

1.6

1.5

23.31

21.89

iu/l

0.19

103

873

Fracture at wrist and hand level

917

8762

1.05

0.66

1.4

23.14

24.51

iu/l

0.66

777

7304

Pedestrian injured in transport accident

150

1348

1.12

0.66

1.6

1.4

21.29

24.05

iu/l

0.56

131

1152

Malignant neoplasm of ovary, including Hilmo

115

1017

1.14

0.65

1.7

1.3

35.99

34.41

iu/l

0.20

901

Amputation

538

0.82

0.65

1.1

1.4

17.17

26.58

iu/l

2.19

444

Corns and callosities

120

1064

1.13

0.65

1.4

24.90

28.84

iu/l

0.58

104

915

Peripheral arterial reconstruction

582

0.82

0.65

1.2

1.4

20.80

28.39

iu/l

1.05

479

Gangrene, not elsewhere classified

1.60

0.65

1.7

1.3

24.04

22.63

iu/l

—

Sixth [abducent] nerve palsy

422

1.22

0.65

2.3

1.4

25.26

25.79

iu/l

0.04

353

Idiopathic gout

476

1.20

0.65

1.6

1.4

20.23

24.01

iu/l

0.44

394

Inflammatory disorders of male genital organs, not elsewhere classified

1.62

0.65

1.5

13.42

7.59

iu/l

—

Acute and transient psychotic disorders

324

3019

1.08

0.65

1.4

24.89

26.75

iu/l

0.43

235

2591

Superficial injuries involving multiple body regions

589

1.18

0.65

1.6

1.3

19.73

23.28

iu/l

0.40

493

Lesion of radial nerve

607

1.18

0.64

1.4

30.69

27.93

iu/l

0.29

522

Other early complications of trauma

0.00

0.64

0.0

1.7

—

17.68

—

Intrauterine hypoxia

0.00

0.64

0.0

3.0

—

16.20

—

Nontraumatic intracranial haemmorrhage

194

1767

1.10

0.64

1.5

1.4

32.66

31.96

iu/l

0.10

155

1510

Sequelae of injuries of neck and trunk

497

1.20

0.64

1.5

1.4

22.15

25.65

iu/l

0.39

422

Thyrotoxicosis with toxic multinodular goitre

803

1.15

0.64

1.4

1.3

39.45

33.64

iu/l

0.84

695

Severe combined immunodeficiency [SCID] with reticular dysgenesis

1.68

0.64

1.4

1.5

7.51

24.64

iu/l

—

Secondary parkinsonism, excluding more controls

112

1.43

0.63

1.4

1.3

20.70

32.54

iu/l

0.93

Benign neoplasm of colon, rectum, anus and anal canal

966

7836

1.04

0.63

1.4

31.17

33.80

iu/l

1.56

808

6726

Other congenital malformations of skull and face bones

1.53

0.63

2.6

2.8

6.64

9.45

iu/l

—

Defect, injury or illness of chest

1.75

0.63

1.8

1.3

20.06

25.52

iu/l

—

Fracture of shoulder and upper arm

654

6218

1.05

0.63

1.6

1.5

25.29

27.49

iu/l

1.00

543

5152

Adenocarcinoma and papilloma adenocarcinoma of rectum

561

1.18

0.63

1.2

1.3

40.51

30.08

iu/l

1.45

480

Alcohol abuse, main dg

340

3177

1.07

0.63

1.5

1.4

19.70

22.76

iu/l

1.22

264

2652

Use of glatiramer acetate

762

1.16

0.63

1.3

1.4

33.04

26.23

iu/l

0.91

656

Prophylactic surgery

327

1.26

0.62

1.4

1.3

39.82

26.17

iu/l

1.31

280

Single spontaneous delivery

1227

6715

0.96

0.62

1.3

1.4

26.20

25.19

iu/l

0.49

1054

5550

Right ventricular outflow tract obstruction

232

0.72

0.62

4.5

2.2

9.27

13.24

iu/l

0.47

168

Respiratory tuberculosis, not confirmed, including avohilmo

173

1.33

0.62

1.7

1.3

25.10

28.14

iu/l

0.17

140

Exophthalmic conditions

165

1.35

0.62

1.7

1.3

30.92

26.10

iu/l

0.27

141

Lifestyle-related condition

218

1.30

0.62

1.3

12.32

22.58

iu/l

2.78

183

Other acute skin changes due to ultraviolet radiation

499

1.19

0.61

1.4

1.3

21.42

29.47

iu/l

1.40

431

Mental retardation

112

987

1.13

0.61

2.7

1.8

15.66

18.48

iu/l

0.49

739

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

114

1.45

0.61

2.6

4.59

7.45

iu/l

—

Generalized epilepsy

139

1253

1.12

0.61

1.4

1.5

24.08

22.07

iu/l

0.34

118

1033

Chronic pancreatitis

137

1231

1.12

0.60

1.4

25.35

27.97

iu/l

0.47

114

1031

Viral encephalitis, not elsewhere classified/unspecified

299

1.25

0.60

1.4

24.52

23.37

iu/l

0.07

244

Tic disorders

336

1.24

0.60

1.9

2.1

12.09

13.10

iu/l

0.11

237

Other specified/unspecified disorders of ear

1.61

0.60

1.3

1.4

30.38

24.45

iu/l

—

Other spirochaetal diseases, including avohilmo

876

8412

1.04

0.60

1.4

30.86

29.73

iu/l

0.44

746

7188

Lyme disease, including avohilmo

851

8167

1.04

0.60

1.4

31.18

29.92

iu/l

0.49

724

6984

Lyme disease

851

8167

1.04

0.60

1.4

31.18

29.92

iu/l

0.49

724

6984

Acute disseminated encephalitis/encephalomyelitis

1.84

0.60

1.7

1.5

13.73

29.28

iu/l

—

Disorders of synovium and tendon in diseases classified elsewhere

299

1.25

0.60

1.6

1.4

28.16

26.28

iu/l

0.13

258

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

573

1.17

0.60

1.2

1.3

40.09

30.15

iu/l

1.38

491

L04AA Selective immunosuppressants

639

6095

1.05

0.60

1.5

1.4

30.71

28.19

iu/l

0.89

543

5199

Injury of intra-abdominal organs

436

1.20

0.60

1.3

1.4

13.20

20.15

iu/l

1.13

367

Other specific arthropathies

1.83

0.60

2.2

1.5

15.92

23.51

iu/l

—

Impacted teeth

929

7667

1.04

0.60

1.5

1.4

12.19

14.06

iu/l

1.98

781

6320

Other spirochaetal diseases

863

8287

1.04

0.60

1.4

30.97

29.83

iu/l

0.44

736

7081

Calcific aortic valvular stenosis, including rheumatic fever

105

1139

0.89

0.60

1.4

28.46

29.11

iu/l

0.07

953

Erectile dysfunction, exclusion

0.00

0.60

0.0

1.4

—

5.40

—

Injuries to the hip and thigh

876

7537

1.04

0.59

1.5

1.4

27.57

27.29

iu/l

0.09

748

6363

Retinal vascular occlusion

683

0.85

0.59

1.5

1.4

32.58

30.48

iu/l

0.16

577

Congenital absence, atresia and stenosis of small intestine

1.76

0.59

1.7

2.3

6.58

13.28

iu/l

—

!Aliquae complicationes praecoces traumatis

706

1.15

0.59

1.4

24.72

24.60

iu/l

0.01

599

Early complications of trauma

706

1.15

0.59

1.4

24.72

24.60

iu/l

0.01

599

Disorders resulting from impaired renal tubular function

446

1.20

0.59

1.8

1.5

31.32

28.10

iu/l

0.22

368

Lichen planus

196

1798

1.09

0.58

1.4

29.22

33.57

iu/l

1.23

176

1551

COPD

397

3032

1.06

0.58

1.4

29.22

32.45

iu/l

1.25

321

2573

Other and unspecified acne

402

1.21

0.58

1.8

1.5

19.68

18.27

iu/l

0.11

330

Acute peritonitis

791

1.14

0.58

1.5

23.98

27.67

iu/l

0.46

678

Injury of blood vessels at neck level

1.51

0.58

1.1

1.3

23.24

22.08

iu/l

—

LSIL lesion of the vagina

537

0.83

0.58

1.4

1.3

30.40

27.93

iu/l

0.17

466

Unicornuate uterus

125

1.43

0.58

1.2

1.4

11.49

17.27

iu/l

0.67

104

Rheumatoid arthritis, including avohilmo

795

8284

0.96

0.58

1.4

31.01

30.36

iu/l

0.21

683

7151

Retinal vascular disorders

691

0.85

0.57

1.5

1.4

31.98

30.56

iu/l

0.10

584

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

534

1.19

0.57

1.4

1.3

17.55

22.08

iu/l

0.80

464

Cholangitis (primary sclerosing, PSC), with reimbursement 202

393

1.21

0.57

1.3

1.5

29.66

23.05

iu/l

0.51

328

Alzheimer’s disease, strict definition

454

0.83

0.57

1.2

1.4

53.09

36.35

iu/l

1.62

383

Unspecified organic or symptomatic mental disorder

1.69

0.57

1.2

26.95

24.54

iu/l

—

Use of levodopa decarboxylase inhibitor

567

1.17

0.57

1.7

1.4

30.89

31.12

iu/l

0.02

480

Foreign body or object entering through skin

137

1238

1.11

0.57

1.5

1.4

21.77

21.61

iu/l

0.02

112

1037

N06DA Anticholinesterases

674

0.87

0.57

1.4

46.92

34.50

iu/l

1.68

557

Use of anticholinesterases

674

0.87

0.57

1.4

46.92

34.50

iu/l

1.68

557

Benign neoplasm: Ascending colon

136

1227

1.11

0.57

1.3

1.4

32.38

33.22

iu/l

0.09

107

1049

Lesion of femoral nerve

124

1.39

0.57

1.4

26.16

30.05

iu/l

0.17

106

Use of biperiden

859

1.14

0.57

1.3

1.4

22.87

29.95

iu/l

1.43

734

Exposure to other and unspecified inanimate mechanical forces

196

1803

1.09

0.57

1.4

1.5

23.56

22.82

iu/l

0.13

159

1493

Disorders of plasma-protein metabolism, not elsewhere classified

0.55

0.57

2.6

1.3

30.36

22.87

iu/l

—

Psoriatic arthropathies, ICD10

246

2284

1.08

0.57

1.4

31.38

29.61

iu/l

0.38

218

1980

Other specific arthropathies, wide

421

1.20

0.57

1.5

1.4

21.24

30.32

iu/l

1.48

364

Contact with nonpowered hand tool

588

1.16

0.56

1.3

1.4

22.18

20.62

iu/l

0.16

495

Seborrhoeic keratosis

375

3533

1.06

0.56

1.3

1.4

34.61

35.37

iu/l

0.16

339

3049

Juvenile rheumatoid arthirtis

834

0.86

0.55

1.4

29.09

24.55

iu/l

0.50

710

Multiple myeloma, including Hilmo

212

1.28

0.55

1.9

1.3

28.93

32.22

iu/l

0.19

184

Dislocation, sprain and strain of joints and ligaments of head

135

1223

1.11

0.55

1.4

1.5

25.74

23.21

iu/l

0.39

122

1012

Ulcer of lower limb, not elsewhere classified

107

1197

0.89

0.55

1.3

1.4

25.18

28.85

iu/l

0.46

1018

Dislocation, sprain and strain of joints and ligaments of elbow

197

1817

1.09

0.55

1.5

22.30

23.57

iu/l

0.23

164

1511

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

171

1568

1.10

0.55

1.3

1.4

23.91

26.24

iu/l

0.48

149

1344

Other/unspecified cytomegaloviral diseases

340

1.22

0.55

2.4

1.4

28.66

25.04

iu/l

0.22

285

Benign neoplasm: Duodenum

186

1.30

0.55

1.5

1.3

27.03

27.84

iu/l

0.04

154

Chronic laryngitis and laryngotracheitis

317

2975

1.07

0.54

1.4

1.3

30.31

31.98

iu/l

0.36

278

2592

Sequelae of other and unspecified infectious and parasitic diseases

170

1559

1.10

0.54

1.3

1.4

23.52

26.23

iu/l

0.60

148

1335

Edwards' syndrome and Patau's syndrome

1.59

0.54

1.7

16.38

23.50

iu/l

—

Pre-eclampsia or poor fetal growth

1827

17739

1.03

0.54

1.3

24.28

25.52

iu/l

0.99

1614

15387

Guttate psoriasis

332

1.22

0.54

1.3

36.83

24.55

iu/l

1.04

287

Other and unspecified corneal deformities and disorders

666

1.15

0.54

1.3

1.4

37.05

29.96

iu/l

0.91

569

Other/unspecified reactive arthropathies

162

1483

1.10

0.53

1.4

20.91

25.78

iu/l

1.64

145

1266

Glucosamine medication

333

2495

1.07

0.53

1.4

1.3

38.74

40.65

iu/l

0.54

287

2132

1367

12243

0.97

0.53

1.4

22.03

24.73

iu/l

2.67

1070

10396

Car occupant injured in noncollision transport accident

855

1.13

0.53

1.4

25.18

20.92

iu/l

0.66

730

Contact with other sharp object(s)

197

1820

1.09

0.53

1.4

20.85

20.47

iu/l

0.07

165

1497

Toxic effect of ethanol

102

912

1.13

0.53

1.5

1.4

23.24

20.67

iu/l

0.29

760

Other/unspecified rheumatoid arthritis

147

1612

0.91

0.53

1.3

1.4

32.16

31.67

iu/l

0.06

121

1392

Disorders of optic nerve, not elsewhere classified

214

1.27

0.53

1.4

36.35

26.86

iu/l

0.54

180

Convergent concomitant strabismus

204

1890

1.09

0.52

1.6

1.5

25.28

23.19

iu/l

0.43

165

1557

Other condition

364

3438

1.06

0.52

1.4

27.16

25.92

iu/l

0.32

332

2894

Benign neoplasm: Lower jaw bone

1.45

0.52

1.2

1.5

5.22

22.03

iu/l

—

Other fall from one level to another

575

5493

1.05

0.52

1.5

20.90

21.23

iu/l

0.10

475

4515

Family history of certain disabilities and chronic diseases leading to disablement

209

1940

1.09

0.52

1.4

20.47

22.33

iu/l

0.43

193

1652

Pneumonia derived septicemia

499

1.17

0.52

1.6

1.5

22.40

22.16

iu/l

0.02

409

Arterial embolism and thrombosis

387

1.19

0.52

1.5

1.4

30.39

26.23

iu/l

0.34

325

Chronic periodontitis, complicated

1143

10785

1.03

0.52

1.4

33.45

31.38

iu/l

1.22

923

9320

Caught, crushed, jammed or pinched in or between objects

133

1209

1.11

0.51

1.4

1.5

19.35

21.49

iu/l

0.39

120

1002

severe traumatic brain injury, does not include concussion

225

2090

1.08

0.51

1.4

22.11

25.31

iu/l

0.87

183

1753

Enduring personality changes

101

1.42

0.51

2.1

1.7

20.79

24.89

iu/l

—

COPD-related respiratory insufficiency

592

1.15

0.51

1.3

30.59

30.15

iu/l

0.04

503

Nonspecific lymphadenitis

187

1728

1.09

0.51

1.4

34.15

30.75

iu/l

0.57

161

1478

Malignant neoplasm of tongue, including Hilmo

188

1.28

0.51

1.3

1.2

34.67

25.13

iu/l

0.38

160

Measles

484

1.18

0.51

1.4

28.00

31.47

iu/l

0.33

433

Other and unspecified mononeuropathies of upper limb

575

1.16

0.51

1.3

1.4

31.03

27.58

iu/l

0.32

497

Tic and related disorders

362

1.20

0.51

1.8

2.0

14.03

13.30

iu/l

0.07

267

Thalassaemia

1.47

0.51

3.0

1.4

11.18

16.33

iu/l

0.34

3058

17519

1.02

0.50

1.5

1.4

25.11

26.63

iu/l

1.72

2548

14929

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3058

17519

1.02

0.50

1.5

1.4

25.11

26.63

iu/l

1.72

2548

14929

Fall on same level

4266

22356

1.02

0.50

1.4

25.71

25.02

iu/l

0.68

3537

19112

All dysplastic lesions of the vulva

173

1597

1.09

0.50

1.3

1.4

31.22

32.09

iu/l

0.11

142

1391

Parkinson's disease, including avohilmo

687

1.14

0.50

1.5

1.4

31.37

32.41

iu/l

0.09

576

Psoriasis vulgaris

407

3862

1.06

0.50

1.5

1.4

26.39

28.07

iu/l

0.48

338

3294

Spirochaetal infections, other/unspecified, including avohilmo

855

8250

1.04

0.50

1.4

31.11

29.83

iu/l

0.50

727

7054

Other congenital malformations of ear

419

1.19

0.50

1.3

1.6

19.74

14.00

iu/l

0.66

328

Osteomyelitis

712

0.87

0.50

1.8

1.5

22.67

22.77

iu/l

0.01

592

Alcohol-induced acute pancreatitis

316

1.21

0.49

1.2

1.4

18.11

20.94

iu/l

0.28

254

Tobacco use

108

1196

0.90

0.49

1.4

23.10

23.30

iu/l

0.02

1025

Other obstructive and reflux uropathy

117

1060

1.11

0.49

1.4

23.01

21.53

iu/l

0.15

899

Congenital malformations of heart and great arteries

344

3154

1.06

0.49

1.9

1.6

20.54

21.95

iu/l

0.39

285

2535

Foreign body entering into or through eye or natural orifice

158

1452

1.09

0.49

1.4

1.5

20.71

21.48

iu/l

0.12

130

1196

Lower leg

128

1.35

0.49

1.2

1.4

36.22

24.19

iu/l

0.73

109

Aggressive periodontitis

317

1.21

0.49

1.3

34.22

28.22

iu/l

0.44

268

COPD (mode)

240

1745

1.07

0.49

1.3

1.4

28.08

34.26

iu/l

2.23

187

1475

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

308

1.21

0.49

1.4

24.52

22.92

iu/l

0.10

253

Pericarditis

400

1.18

0.48

1.3

1.6

27.68

24.33

iu/l

0.26

346

Abdominal aortic aneurysm (AAA)

179

1.28

0.48

1.6

1.4

11.89

21.41

iu/l

2.41

147

Acute renal failure

197

1827

1.08

0.48

1.5

1.4

31.29

27.58

iu/l

0.66

159

1537

COPD, hospital admissions

366

2916

1.06

0.48

1.4

28.71

32.86

iu/l

1.73

292

2459

LSIL lesion of the vulva

130

1189

1.11

0.48

1.3

1.4

29.30

32.93

iu/l

0.54

107

1041

Left bundle-branch block

662

1.14

0.48

1.3

1.4

37.47

33.09

iu/l

0.54

573

Mandibular retrognathia

246

2299

1.07

0.48

1.5

1.6

23.67

22.64

iu/l

0.21

213

1912

Hypertrophy of tongue papillae

254

1.23

0.48

1.4

1.3

35.90

26.63

iu/l

0.64

221

Benign neoplasm: Oesophagus

146

1.31

0.47

1.4

1.3

31.41

26.20

iu/l

0.27

125

Acute thyroiditis

1.42

0.47

1.5

1.4

30.26

26.66

iu/l

0.16

Polyhydramnios

292

2758

1.07

0.47

1.3

1.4

22.74

22.45

iu/l

0.05

259

2347

Carcinoma in situ of other and unspecified digestive organs

281

1.21

0.47

1.5

1.3

32.08

32.62

iu/l

0.03

230

Injury of nerves at wrist and hand level

759

1.13

0.47

1.5

1.4

24.60

23.52

iu/l

0.10

644

Endocarditis

299

0.80

0.47

1.6

1.5

28.42

21.00

iu/l

0.35

251

Mandibular retrognathia AND surgery (BSSO)

106

961

1.11

0.47

1.3

1.4

25.39

26.57

iu/l

0.15

819

All dysplastic lesions of the vagina

958

0.89

0.46

1.4

1.3

29.76

28.80

iu/l

0.09

830

Background retinopathy and retinal vascular changes

273

1.22

0.46

1.6

1.4

22.00

26.94

iu/l

0.31

230

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

175

1621

1.08

0.46

1.3

1.4

27.77

28.09

iu/l

0.04

154

1392

Muscular dystrophy

147

1.31

0.46

2.4

1.7

18.36

24.84

iu/l

—

117

Intentional self-harm by sharp object

723

1.13

0.46

1.3

1.4

10.88

16.86

iu/l

1.57

588

Dementia in other diseases classified elsewhere

319

1.20

0.46

1.6

1.4

31.11

26.57

iu/l

0.33

274

Polyarthrosis

274

2320

1.06

0.46

1.3

38.45

42.14

iu/l

1.10

247

1986

Use of teriflunomide

452

1.17

0.46

1.4

34.71

25.65

iu/l

0.88

395

COPD, early/later onset

368

2928

1.06

0.46

1.4

28.86

32.96

iu/l

1.72

294

2466

Colorectal cancer, including Hilmo

212

1842

1.07

0.45

1.3

38.23

33.24

iu/l

1.14

168

1593

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

129

1181

1.10

0.45

1.4

20.73

26.62

iu/l

1.47

110

1019

Measles, including avohilmo

490

1.16

0.45

1.4

28.00

31.37

iu/l

0.32

439

Retained placenta and membranes, without haemorrhage

482

4616

1.05

0.45

1.3

1.4

28.15

28.91

iu/l

0.20

427

3985

Transient ischemic attack

621

4751

1.04

0.45

1.3

1.4

34.81

33.83

iu/l

0.28

522

4093

Accidental poisoning by and exposure to alcohol

340

0.82

0.45

1.5

1.4

9.32

13.87

iu/l

0.66

282

Pyoderma

330

1.19

0.45

1.5

1.3

34.85

26.09

iu/l

0.77

276

Thyroiditis, unspecified

405

1.17

0.44

1.3

1.4

31.16

28.94

iu/l

0.14

350

Colorectal adenocarcinoma

125

1127

1.10

0.44

1.3

38.91

33.10

iu/l

1.01

103

962

Benign neoplasm: Skin, unspecified

810

1.12

0.44

1.4

32.23

29.53

iu/l

0.29

696

Other specified/unspecified disorders of bone/cartilage

423

1.17

0.44

1.6

1.3

24.93

26.12

iu/l

0.09

354

Lordosis

1.49

0.44

1.1

1.4

43.65

20.92

iu/l

—

Parkinson's disease, strict definition

591

1.14

0.44

1.6

1.4

32.40

31.79

iu/l

0.05

499

Burn and corrosion of wrist and hand

887

1.11

0.44

1.4

1.5

19.89

21.87

iu/l

0.31

721

Other hyperalimentation

1.49

0.44

1.5

1.3

21.44

22.35

iu/l

—

Benign neoplasm: Kidney

470

1.15

0.44

1.5

1.4

41.63

32.10

iu/l

0.99

399

Malignant neoplasm of colon, including Hilmo

134

1224

1.09

0.44

1.2

1.3

39.22

31.83

iu/l

1.34

105

1057

Contact with sharp glass

115

1050

1.10

0.44

1.2

1.4

23.94

19.67

iu/l

0.73

883

Pseudopolyposis of colon

1.46

0.44

1.8

1.2

29.69

22.58

iu/l

—

Cleft lip

1.40

0.44

1.6

1.4

43.35

23.75

iu/l

1.17

Vitreous prolapse

1.46

0.43

1.1

1.4

39.70

27.95

iu/l

—

Respiratory disorders in diseases classified elsewhere

196

0.76

0.43

1.4

1.3

41.42

25.69

iu/l

1.03

166

Problems related to social environment

612

1.13

0.43

1.4

1.3

19.45

22.95

iu/l

0.45

527

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.45

0.43

1.3

1.4

14.26

25.30

iu/l

—

Bicuspidal aortic valve syndrome

564

0.86

0.43

1.6

1.5

30.50

21.80

iu/l

0.96

456

Perforation of tympanic membrane

210

1966

1.07

0.43

1.4

25.57

23.87

iu/l

0.35

183

1647

Cirrhosis of liver, NAS

424

1.16

0.43

1.6

1.4

29.94

28.22

iu/l

0.13

356

Paranoid personality disorder

444

1.16

0.43

1.4

1.3

15.93

24.82

iu/l

1.66

383

Histoplasmosis

0.00

0.42

0.0

2.4

—

38.49

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

401

3825

1.05

0.42

1.5

28.91

24.98

iu/l

1.41

330

3170

Dizziness and giddiness

2278

17363

1.02

0.42

1.4

27.18

28.21

iu/l

0.77

1932

15019

Labour and delivery complicated by fetal stress [distress]

1989

12677

1.02

0.42

1.3

1.4

21.87

24.37

iu/l

3.11

1729

10881

Histoplasmosis, including avohilmo

0.00

0.42

0.0

2.4

—

38.49

—

Other predominantly sexually transmitted diseases, not elsewhere classified

826

8006

1.04

0.42

1.4

22.17

22.02

iu/l

0.05

691

6895

Ascites

754

0.89

0.42

1.4

34.21

32.30

iu/l

0.18

640

Other nutritional anaemias

1.39

0.41

1.4

1.8

8.54

27.35

iu/l

—

Acute posthaemorrhagic anaemia

323

1.18

0.41

1.3

18.15

27.31

iu/l

1.12

272

Other bursitis of elbow

1.36

0.41

1.1

1.3

15.01

22.77

iu/l

—

Other specified disorders of muscle

483

1.15

0.41

1.2

1.4

36.31

26.64

iu/l

0.96

421

Cardiac arrest

441

0.86

0.41

1.4

27.58

26.30

iu/l

0.10

362

Complications of anaesthesia during pregnancy

107

1.37

0.40

1.4

10.74

19.91

iu/l

0.97

Pyogenic arthritis

853

1.11

0.40

1.3

1.4

26.41

27.70

iu/l

0.14

719

Epidermolysis bullosa

1.47

0.40

1.4

2.1

23.64

25.99

iu/l

—

Gonarthrosis, primary, with knee surgery

656

5287

0.96

0.40

1.3

33.12

40.38

iu/l

7.42

591

4526

Hereditary deficiency of other clotting factors

326

1.19

0.40

1.3

1.4

21.15

21.51

iu/l

0.03

283

Left ventricular outflow tract obstruction, narrow definition

907

0.90

0.40

2.0

1.7

24.26

19.57

iu/l

0.68

717

Unspecified urinary incontinence

128

1387

0.92

0.40

1.5

1.4

24.79

31.81

iu/l

1.62

109

1181

Extracorporeal dialysis

687

0.89

0.40

1.8

1.5

23.69

24.21

iu/l

0.03

562

Viral haemorrhagic fevers, not elsewhere classified/unspecified

131

1417

0.92

0.39

1.5

1.4

24.16

27.16

iu/l

0.55

124

1219

Superficial injury of neck

599

1.13

0.39

1.4

22.23

20.27

iu/l

0.20

509

Congenital malformations of nose, including avohilmo

1.36

0.39

1.0

2.2

32.43

23.31

iu/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

608

1.12

0.39

1.4

33.87

29.85

iu/l

0.42

518

Crohn disease (strict definition, all UC cases excluded)

146

1357

1.08

0.39

1.4

21.71

22.53

iu/l

0.13

127

1144

Myocardial infarction, with ST-elevation

749

0.89

0.38

1.4

28.47

26.00

iu/l

0.22

611

Other abortion

403

1.16

0.38

1.3

1.4

25.63

25.09

iu/l

0.03

360

Metabolic disorders

3053

18592

0.98

0.38

1.5

1.4

29.03

28.65

iu/l

0.23

2465

16101

Carcinoma in situ of oral cavity, oesophagus and stomach

1.40

0.38

1.0

1.2

49.16

24.01

iu/l

—

Other bullous disorders

420

1.15

0.38

1.5

1.4

30.12

28.42

iu/l

0.11

351

Other encephalitis

524

1.13

0.38

1.4

28.41

24.46

iu/l

0.36

438

Schizotypal disorder

629

1.12

0.38

1.5

1.4

21.28

23.15

iu/l

0.24

539

Idiopathic thrombocytopenic purpura

505

1.14

0.38

1.5

1.4

27.57

24.52

iu/l

0.26

416

Preterm labour and delivery

1139

11111

1.03

0.38

1.3

1.4

30.40

30.20

iu/l

0.07

1014

9602

Aortic valve malfunction, age under 60 years

178

1667

1.07

0.38

1.5

29.20

28.68

iu/l

0.07

148

1393

Colon adenocarcinoma

561

1.12

0.38

1.3

37.41

30.78

iu/l

0.77

478

Other deformities of toe(s)

619

1.12

0.38

1.4

24.69

32.44

iu/l

1.25

532

Malignant neoplasm of colon

104

952

1.09

0.38

1.3

36.94

32.05

iu/l

0.60

817

Other ill-defined and unspecified causes of mortality

448

1.14

0.38

1.4

30.32

26.76

iu/l

0.33

375

therapeutic use

290

0.82

0.38

1.3

25.59

31.27

iu/l

0.37

238

Psoriasis (vulgaris), strict definition

648

1.12

0.37

1.3

1.4

24.36

25.07

iu/l

0.07

551

Severe visual impairment, monocular

107

1.32

0.37

1.3

1.5

38.74

25.39

iu/l

—

Unstable angina pectoris

245

1818

1.06

0.37

1.3

1.4

30.01

33.06

iu/l

0.72

212

1532

IgA nephropathy (IgA glomerulonephritis)

393

1.15

0.37

1.6

1.4

24.70

22.08

iu/l

0.21

326

Allergic colitis

677

1.12

0.37

1.9

2.0

11.55

12.71

iu/l

0.21

474

Neonatal jaundice from other and unspecified causes

427

1.15

0.37

2.9

2.5

4.87

6.50

iu/l

0.95

255

Internuclear ophthalmoplegia

0.65

0.37

1.2

6.40

23.47

iu/l

—

Clubfoot

282

1.19

0.37

1.8

1.5

22.66

20.70

iu/l

0.11

237

Seronegative juvenile rheumatoid arthritis

670

1.12

0.36

1.3

1.6

22.67

17.86

iu/l

0.54

550

Benign neoplasm: Small intestine

337

1.16

0.36

1.5

1.3

26.36

31.80

iu/l

0.48

286

753

1.10

0.36

1.3

1.4

37.59

38.29

iu/l

0.06

630

Other specified and unspecified disorders of choroid

1.48

0.36

1.0

1.3

39.02

21.65

iu/l

—

Benign neoplasm: Rectosigmoid junction

309

1.17

0.36

1.4

30.90

32.12

iu/l

0.05

260

CR(E)ST syndrome

331

0.84

0.36

1.7

1.3

39.52

31.19

iu/l

0.50

290

Parkinson's disease

658

1.11

0.36

1.5

1.3

32.17

32.35

iu/l

0.01

549

Asymptomatic human immunodeficiency virus [HIV] infection status

0.65

0.36

1.2

1.5

21.65

15.69

iu/l

—

Isolated patent ductus arteriosus

288

1.18

0.36

2.4

2.2

11.51

13.12

iu/l

0.21

189

Use of dimethyl fumarate

372

0.85

0.36

1.3

13.58

23.63

iu/l

2.16

319

Other psoriatic arthropathies

235

2226

1.06

0.36

1.4

31.98

29.49

iu/l

0.56

208

1924

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

0.62

0.36

1.8

1.4

10.12

25.71

iu/l

—

Use of other anti-dementia drugs

456

0.88

0.36

1.3

1.4

36.25

32.27

iu/l

0.30

387

Use of memantine

456

0.88

0.36

1.3

1.4

36.25

32.27

iu/l

0.30

387

Colorectal neuroendocrine tumor and carcinoma

208

1.21

0.36

1.2

1.3

36.64

24.92

iu/l

0.63

174

Human immunodeficiency virus [HIV] disease resulting in other conditions

273

1.18

0.35

1.2

1.4

17.50

19.52

iu/l

0.17

224

Follow-up care involving plastic surgery

1024

0.91

0.35

1.6

1.4

29.23

30.03

iu/l

0.09

888

Other (seronegative) rheumatoid arthritis, wide

320

3349

0.95

0.35

1.4

33.04

31.10

iu/l

0.42

269

2892

Unknown and unspecified causes of morbidity

152

1421

1.07

0.35

1.5

1.4

26.91

26.24

iu/l

0.09

131

1226

Abscess of external ear

311

1.17

0.35

1.8

1.4

23.11

21.28

iu/l

0.16

267

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

279

2926

0.95

0.35

1.3

1.4

25.56

27.46

iu/l

0.50

258

2540

Airway disease due to specific organic dust

1.39

0.35

1.2

21.18

26.37

iu/l

—

Cholesteatoma of middle ear

499

1.13

0.35

1.3

1.4

27.15

26.46

iu/l

0.06

417

Colitis, primary sclerosing, strict definition

209

1.21

0.35

1.5

1.4

32.20

19.70

iu/l

0.64

173

Autoimmune diseases excluding thyroid diseases, strict definition

3313

17759

1.01

0.35

1.4

26.48

24.89

iu/l

1.88

2833

15041

Type of accident

750

7287

1.03

0.34

1.4

24.84

25.09

iu/l

0.07

672

6159

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

274

1.18

0.34

1.2

1.4

17.50

19.52

iu/l

0.17

225

Traumatic subdural haemorrhage

618

1.11

0.34

1.3

1.4

28.29

29.45

iu/l

0.10

525

Sequelae of hyperalimentation

1.33

0.34

1.0

1.3

12.50

25.28

iu/l

—

Vitiligo

303

1.17

0.34

1.3

1.4

25.67

24.42

iu/l

0.08

261

Other corneal oedema

1.34

0.34

2.0

1.4

45.07

28.51

iu/l

—

Unspecified human immunodeficiency virus [HIV] disease

155

0.77

0.34

1.2

1.5

19.97

18.99

iu/l

—

125

Pedestrian injured in collision with car, pick-up truck or van

425

1.14

0.34

1.3

1.4

18.99

23.18

iu/l

0.51

366

Familial hypercholesterolemia

863

1.09

0.34

1.4

23.41

28.32

iu/l

0.89

726

Bacterial sepsis of newborn

176

0.78

0.33

1.9

2.7

4.16

6.80

iu/l

—

107

Inflammatory diseases of the central nervous system

186

1755

1.06

0.33

1.5

1.4

25.44

25.91

iu/l

0.07

157

1477

COPD, hospital admission 2, with asthma infections

237

1936

1.05

0.33

1.3

1.4

27.11

31.32

iu/l

1.30

193

1642

COPD related to multimorbidity

263

2115

1.05

0.33

1.3

1.4

29.22

32.90

iu/l

1.10

206

1787

Sequelae of injuries of head

103

952

1.09

0.33

1.4

23.03

24.65

iu/l

0.18

809

Colon adenocarcinoma, helper endpoint

698

0.90

0.33

1.3

1.4

37.41

32.23

iu/l

0.55

582

Cardiomyopathy, other and unspecified

817

1.09

0.33

1.5

29.89

28.96

iu/l

0.09

692

Viral pneumonia (known virus, not influenza)

341

1.15

0.32

1.6

1.5

19.85

21.52

iu/l

0.11

280

Hydatidiform mole

619

1.11

0.32

1.4

28.92

28.82

iu/l

0.01

553

Alopecia areata

800

1.09

0.32

1.4

20.34

25.07

iu/l

0.85

677

Other bursitis, not elsewhere classified

128

1.26

0.32

1.1

1.3

21.78

29.34

iu/l

0.36

114

Adhesive middle ear disease

284

0.84

0.32

1.6

1.4

19.58

18.12

iu/l

0.09

237

Renal tubulo-interstitial disorders in diseases classified elsewhere

119

1.27

0.32

1.4

1.3

20.58

26.10

iu/l

0.33

102

Other lack of coordination

248

1.18

0.32

2.2

1.4

37.10

23.56

iu/l

0.96

197

Benign neoplasm: Lip

248

1.18

0.32

1.8

1.3

25.54

28.06

iu/l

0.15

210

Second line medication for Crohn's disease

1816

17828

1.02

0.32

1.5

1.4

27.51

27.09

iu/l

0.20

1553

15225

Multiple delivery

390

3761

1.04

0.31

1.3

1.4

28.84

29.20

iu/l

0.07

344

3169

Absence of one kidney

1.32

0.31

1.1

1.7

24.34

19.74

iu/l

—

Chronic hepatitis, not elsewhere classified

638

1.10

0.31

1.4

32.64

28.95

iu/l

0.33

540

Pulmonary eosinophilia, not elsewhere classified

100

0.70

0.31

1.0

1.3

36.23

26.10

iu/l

—

Subarachnoid haemorrhage

121

1129

1.07

0.31

1.6

1.4

34.21

33.51

iu/l

0.08

970

Congenital malformations of posterior segment of eye

1.31

0.30

2.3

2.0

12.30

20.82

iu/l

—

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

1.30

0.30

1.3

21.69

27.20

iu/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

821

1.09

0.30

1.7

1.3

31.20

34.02

iu/l

0.38

701

Other and unspecified disorders of psychological development

324

1.15

0.30

2.1

13.33

11.83

iu/l

0.14

214

Colitis, primary sclerosing

278

1.16

0.30

1.4

1.5

27.84

19.96

iu/l

0.49

232

Implicit Sepsis

1673

12533

0.98

0.30

1.5

1.4

26.64

27.14

iu/l

0.24

1365

10675

Dilated cardiomyopathy

860

0.92

0.30

1.5

1.4

31.47

26.10

iu/l

0.56

717

Other and unspecified haemorrhagic conditions

278

1.16

0.30

1.3

1.4

34.90

23.83

iu/l

0.78

233

AV-block

131

1047

1.07

0.30

1.4

1.5

25.98

27.89

iu/l

0.28

107

876

Other and unspecified vascular occlusions

494

0.89

0.30

1.5

1.3

30.70

30.54

iu/l

0.01

409

Encephalitis

573

1.11

0.29

1.4

27.58

24.56

iu/l

0.28

481

Burn and corrosion of ankle and foot

213

1.18

0.29

1.4

17.66

20.93

iu/l

0.27

178

Pediculosis, acariasis and other infestations

141

1327

1.07

0.29

1.5

1.4

23.18

22.25

iu/l

0.14

124

1111

Late syphilis, including avohilmo

232

1.17

0.29

1.2

1.3

15.65

24.03

iu/l

0.74

193

Burn and corrosion confined to eye and adnexa

536

1.11

0.29

1.3

1.4

31.22

23.30

iu/l

1.02

457

Embolic stroke

176

1.19

0.28

1.6

1.3

42.39

24.59

iu/l

0.80

146

Mild mental retardation

604

1.10

0.28

2.8

1.8

11.19

17.43

iu/l

2.24

469

Cardiomyopathy

180

1707

1.05

0.28

1.5

30.00

27.78

iu/l

0.35

140

1433

Post-traumatic wound infection, not elsewhere classified

422

1.12

0.28

1.5

1.4

24.91

24.57

iu/l

0.02

354

Infections of genitourinary tract in pregnancy

340

3524

0.96

0.28

1.3

1.4

20.85

21.48

iu/l

0.15

294

3022

Examination and encounter for administrative purposes

854

1.08

0.28

1.5

1.4

20.09

26.22

iu/l

1.51

715

Open wound of head

1069

10239

0.98

0.27

1.5

1.4

22.18

25.53

iu/l

3.17

863

8530

Traction detachment of retina

128

0.77

0.27

1.1

1.4

27.53

19.18

iu/l

—

109

Polymyalgia rheumatica

691

1.09

0.27

1.6

1.3

30.99

36.51

iu/l

0.80

588

Polyarthritis, unspecified

663

1.09

0.27

1.3

1.4

28.11

30.05

iu/l

0.18

555

Scarlet fever

197

1.18

0.27

1.6

1.4

34.26

24.56

iu/l

0.45

164

Colour vision deficiencies

0.68

0.26

1.6

1.7

50.96

13.83

iu/l

—

HSIL lesion of the vulva

444

1.11

0.26

1.2

1.3

33.44

28.73

iu/l

0.35

395

Benign neoplasm: Skin of lower limb, including hip

530

1.10

0.26

1.2

1.4

25.02

28.40

iu/l

0.36

449

Primary open-angle glaucoma, strict

156

1475

1.06

0.26

1.4

35.84

37.15

iu/l

0.18

136

1259

Glaucoma

742

6446

0.98

0.25

1.4

32.94

33.63

iu/l

0.22

648

5533

Reimbursement for rheumatic diseases

1606

16200

0.98

0.25

1.4

29.96

28.43

iu/l

1.02

1384

13896

Excessive and redundant skin and subcutaneous tissue

0.73

0.25

1.0

1.4

9.95

24.35

iu/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

156

1642

0.95

0.25

1.5

1.4

25.51

27.81

iu/l

0.40

148

1412

Secondary right heart disease

277

0.86

0.25

1.3

1.4

38.62

24.14

iu/l

1.18

228

Primary biliary cholangitis, wide definition

445

1.11

0.25

1.3

1.5

29.93

31.13

iu/l

0.09

383

Other chronic obstructive pulmonary disease, including avohilmo

568

4540

1.03

0.25

1.4

29.48

33.35

iu/l

2.16

461

3857

Infliximab

609

1.09

0.25

1.4

19.01

19.88

iu/l

0.08

513

Other hammer toe(s) (acquired)

190

1649

1.05

0.25

1.4

1.3

38.02

41.21

iu/l

0.65

164

1406

Meningitis

113

1064

1.07

0.25

1.6

1.4

25.34

25.46

iu/l

0.01

910

Sulfasalazine

793

7763

1.02

0.24

1.4

26.95

27.74

iu/l

0.28

679

6670

Scabies

116

1094

1.06

0.24

1.5

22.10

21.79

iu/l

0.04

101

916

Cerebral palsy

475

1.10

0.24

2.3

1.6

17.15

18.77

iu/l

0.13

377

Brain glioblastoma

1.27

0.24

1.4

1.3

24.05

24.57

iu/l

0.02

Fibrosis and cirrhosis of liver

909

1.07

0.24

1.5

1.4

30.90

31.25

iu/l

0.03

772

Small cell lung cancer, helper endpoint

0.74

0.24

1.5

1.3

68.22

29.57

iu/l

—

Periapical abscess

1284

12632

1.02

0.24

1.4

27.01

28.77

iu/l

1.16

1036

10806

Acute mastoiditis

218

1.16

0.24

1.2

1.4

15.69

25.15

iu/l

1.25

183

Special screening examination for neoplasms

735

1.08

0.24

1.4

1.3

33.24

36.44

iu/l

0.31

622

Other obstetric trauma

308

3182

0.96

0.24

1.3

1.4

22.36

25.05

iu/l

0.83

269

2730

Chronic suppurative otitis media

120

1269

0.94

0.24

1.4

1.5

16.33

21.46

iu/l

1.30

1045

Ankylosing spondylitis, strict definition

126

1193

1.06

0.24

1.4

23.98

24.95

iu/l

0.12

109

1018

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

544

1.10

0.24

1.2

1.3

30.01

26.15

iu/l

0.41

479

Other arthrosis

1363

8982

1.02

0.24

1.4

1.3

31.93

34.04

iu/l

1.45

1183

7777

Pneumonitis due to solids and liquids

579

0.91

0.24

1.5

1.4

29.46

25.02

iu/l

0.35

487

Other conditions related to polyarteritis nodosa

1.33

0.23

1.4

1.3

27.30

24.35

iu/l

—

Endovascular or surgical operations to intracerebral aneurysms

823

1.07

0.23

1.4

36.89

34.59

iu/l

0.22

712

Multiple myeloma and malignant plasma cell neoplasms

265

1.13

0.23

2.1

1.3

26.28

32.12

iu/l

0.44

223

Contusion of other and unspecified parts of foot

175

1673

1.05

0.23

1.6

1.5

20.16

21.76

iu/l

0.32

144

1384

Other diseases of appendix

190

1.17

0.23

1.5

1.3

30.02

31.42

iu/l

0.05

164

Benign neoplasm of urinary organs

601

1.08

0.23

1.5

1.4

37.44

30.88

iu/l

0.72

518

Acne tropica

0.00

0.23

0.0

1.3

—

28.59

—

Open wound of forearm

185

1771

1.05

0.23

1.4

20.21

20.18

iu/l

0.00

147

1462

Conduction disorders

372

2889

1.03

0.23

1.4

29.06

28.92

iu/l

0.03

305

2417

Congenital malformations of aortic and mitral valves

722

0.93

0.23

1.9

1.7

24.31

19.92

iu/l

0.53

567

Optic neuritis

163

1558

1.05

0.23

1.5

1.4

24.52

25.46

iu/l

0.14

144

1346

Birth asphyxia

144

1.20

0.23

2.4

2.5

14.86

7.88

iu/l

—

Malignant neoplasm of rectum

582

1.08

0.23

1.2

1.3

39.03

31.11

iu/l

0.97

499

Discharge from other and unspecified firearms

1.26

0.22

3.2

1.6

9.90

9.69

iu/l

—

Osteitis due to dental implant

1.28

0.22

1.5

1.3

38.10

21.72

iu/l

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.22

0.0

1.1

—

26.56

—

Diabetic maculopathy, excluding more controls

170

1777

0.96

0.22

1.3

1.4

20.06

22.41

iu/l

0.45

146

1491

Anhidrosis

0.00

0.22

0.0

1.7

—

20.55

—

Exposure to smoke, fire and flames

343

1.11

0.22

1.2

1.5

15.08

21.14

iu/l

0.86

284

Normotensive glaucoma

429

1.10

0.22

1.3

1.4

41.20

37.41

iu/l

0.26

362

Spontaneous rupture of synovium and tendon

121

1147

1.06

0.22

1.5

1.4

30.08

33.90

iu/l

0.68

110

985

Other specified transport accidents

135

1.20

0.22

1.4

36.17

18.61

iu/l

0.65

103

Nephrotic syndrome

497

1.09

0.22

1.7

1.6

17.01

21.78

iu/l

0.54

399

Fetus and newborn affected by complications of placenta, cord and membranes

1.20

0.22

3.2

2.6

15.24

7.30

iu/l

—

Bacterial agents resistant to antibiotics

0.00

0.22

0.0

1.3

—

26.60

—

Disorders of aromatic amino-acid metabolism

1.20

0.22

2.6

2.4

10.72

19.20

iu/l

—

Hypertension, portal

1.20

0.21

1.8

1.5

4.28

24.32

iu/l

—

Abnormal findings on diagnostic imaging of breast

325

0.89

0.21

1.5

1.3

33.20

29.89

iu/l

0.19

279

Familial hypercholesterolemia, with ischemic heart disease

286

1.12

0.21

1.3

1.4

23.74

26.87

iu/l

0.20

228

Coxarthrosis, primary, with hip surgery

403

3840

0.97

0.21

1.5

1.4

36.64

38.91

iu/l

0.68

353

3278

L01XX Other antineoplastic agents

334

1.11

0.21

1.4

1.3

38.96

31.35

iu/l

0.79

283

Bacterial meningitis

657

0.93

0.21

1.6

1.4

24.74

26.49

iu/l

0.16

563

Iliotibial band syndrome

251

0.87

0.21

1.4

1.5

39.53

29.28

iu/l

0.60

214

Other injuries involving multiple body regions, not elsewhere classified

1.31

0.21

1.5

1.3

27.07

21.90

iu/l

—

Primary angle-closure glaucoma

239

1.13

0.21

1.3

42.58

31.03

iu/l

0.71

202

Vitreous haemorrhage

142

1355

1.05

0.21

1.4

29.87

27.23

iu/l

0.41

123

1154

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

166

0.84

0.21

1.1

1.5

19.97

18.50

iu/l

—

133

Atrial septal defect

101

949

1.06

0.21

1.8

22.57

20.89

iu/l

0.19

717

Foreign body granuloma of skin and subcutaneous tissue

1.26

0.20

2.0

1.7

10.50

29.64

iu/l

—

Cardiomyopathies, Primary/intrinsic

975

0.94

0.20

1.6

1.5

29.51

25.97

iu/l

0.39

813

Infections specific to the perinatal period

336

1.11

0.20

2.1

2.4

4.45

7.43

iu/l

3.08

216

Anuria and oliguria

1.26

0.20

3.2

1.4

40.72

28.80

iu/l

—

Poor fetal growth

850

8359

1.02

0.20

1.3

22.54

22.47

iu/l

0.02

742

7254

Placenta praevia

289

2806

1.03

0.20

1.4

23.37

24.51

iu/l

0.26

252

2401

Other infiltrative disorders of skin and subcutaneous tissue

1.23

0.20

1.2

1.4

43.88

28.63

iu/l

—

Systemic atrophies primarily affecting the central nervous system

417

0.91

0.20

1.4

42.01

27.41

iu/l

1.23

342

Toxic colitis

1.18

0.19

1.5

31.15

23.21

iu/l

—

Cleft lip, lip and palate or palate

519

0.92

0.19

1.2

1.4

30.69

20.81

iu/l

1.22

431

Otorrhoea

1.16

0.19

2.3

17.55

19.01

iu/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

154

1264

1.04

0.19

1.3

1.4

25.43

29.74

iu/l

0.99

122

1058

Wet age-related macular degeneration

352

1.10

0.19

1.4

32.53

37.60

iu/l

0.40

292

Other demyelinating diseases of the central nervous system

136

1420

0.95

0.19

1.4

27.13

24.80

iu/l

0.37

124

1235

Benign neoplasm: Skin of scalp and neck

482

1.08

0.19

1.5

1.4

19.33

26.07

iu/l

1.11

406

Fracture of lower leg, including ankle

1443

13981

1.01

0.19

1.4

27.37

28.45

iu/l

0.63

1219

11883

Supplementary factors related to causes of morbidity and mortality classified elsewhere

815

8013

1.02

0.19

1.4

24.46

24.94

iu/l

0.16

725

6764

Abnormal findings on antenatal screening of mother

539

5499

0.98

0.19

1.3

1.4

17.21

19.88

iu/l

1.67

495

4726

Tumor necrosis factor alpha inhibitors

555

5664

0.98

0.19

1.4

24.78

24.87

iu/l

0.02

483

4784

Primary Sclerosing Cholangitis, IBD and UDCA required

473

1.08

0.18

1.4

1.5

26.04

23.98

iu/l

0.14

388

Decubitus ulcer and pressure area

376

1.09

0.18

1.3

1.4

17.30

27.80

iu/l

2.12

312

Chorioretinal inflammation

541

1.08

0.18

1.4

34.34

27.61

iu/l

0.49

468

Benign neoplasm: Eye, unspecified

1.19

0.18

1.6

1.4

12.79

30.04

iu/l

—

Horner syndrome

185

1.14

0.18

1.5

1.3

18.33

25.28

iu/l

0.59

155

Cystic disease of liver

119

1.19

0.18

1.3

35.04

27.62

iu/l

0.24

Ill-defined and unknown causes of mortality

512

1.08

0.18

1.3

1.4

30.93

26.70

iu/l

0.42

425

Absence of one kidney, including avohilmo

1.16

0.18

1.1

1.6

24.34

20.53

iu/l

—

Etanercept

193

1997

0.96

0.18

1.3

1.4

25.13

26.17

iu/l

0.17

164

1696

Renal failure

447

3892

0.98

0.18

1.6

1.4

32.97

28.73

iu/l

1.27

367

3235

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

130

1357

0.96

0.17

1.4

31.86

29.70

iu/l

0.29

104

1145

Erysipelas

910

7960

0.98

0.17

1.4

27.30

30.05

iu/l

1.85

758

6827

Leisure time condition

409

3998

1.02

0.17

1.4

23.18

24.17

iu/l

0.25

365

3353

Juvenile arthritis (FINNGEN)

164

1700

0.96

0.17

1.4

1.6

22.74

20.32

iu/l

0.43

137

1394

Herpesviral keratitis and keratoconjunctivitis

728

1.06

0.17

1.6

1.4

26.42

27.60

iu/l

0.13

621

Primary open-angle glaucoma

187

1737

1.04

0.17

1.4

35.70

37.06

iu/l

0.21

166

1492

Hypertrophic cardiomyopathy

379

1.08

0.16

1.5

28.09

24.17

iu/l

0.27

310

Spondylopathies

2179

12758

1.01

0.16

1.4

30.41

30.08

iu/l

0.17

1865

11042

Labour and delivery complicated by umbilical cord complications

223

2294

0.97

0.16

1.3

1.4

28.46

27.98

iu/l

0.08

206

1978

Other degenerative diseases of the basal ganglia

1.11

0.16

1.5

1.3

40.50

29.43

iu/l

—

Prolonged pregnancy

1102

9290

1.01

0.16

1.3

1.4

21.31

24.00

iu/l

2.42

992

7918

Postpartum haemorrhage due to anatomy

707

6965

1.02

0.16

1.3

21.96

20.58

iu/l

0.59

638

6089

Fracture of femur

191

1777

0.97

0.16

1.6

1.5

27.24

28.43

iu/l

0.20

160

1494

Pedal cyclist injured in transport accident

607

5968

1.02

0.16

1.5

1.4

23.09

24.54

iu/l

0.55

512

5003

1260

11377

0.99

0.15

1.4

21.40

24.52

iu/l

3.36

977

9644

Granuloma annulare

361

1.09

0.15

1.4

30.37

25.56

iu/l

0.37

307

Gonarthrosis

1804

10088

1.01

0.15

1.4

1.3

31.08

33.24

iu/l

2.01

1582

8749

Pyothorax

351

1.08

0.15

1.4

25.90

24.05

iu/l

0.13

290

Chronic kidney disease

265

2482

1.03

0.15

1.5

34.31

26.70

iu/l

1.91

222

2053

Human immunodeficiency virus [HIV] disease

303

1.09

0.15

1.2

1.4

16.92

20.95

iu/l

0.41

252

Ankylosing spondylitis, ICD10

215

2089

1.03

0.15

1.4

24.99

26.18

iu/l

0.21

185

1788

Hypertrophy of bone

0.81

0.15

1.3

1.5

5.40

20.26

iu/l

—

Bullous disorders

677

0.94

0.15

1.5

1.4

27.81

27.74

iu/l

0.00

575

Cystic kidney disease, including avohilmo

605

1.06

0.15

1.6

1.5

27.57

24.34

iu/l

0.24

517

Intracranial trauma

2012

13463

1.01

0.15

1.4

23.20

25.12

iu/l

1.96

1678

11396

Biological medication for rheuma

608

6178

0.98

0.15

1.4

24.67

24.96

iu/l

0.08

526

5228

Hypertensive heart and/or renal disease

144

1090

0.96

0.15

1.4

26.57

33.60

iu/l

1.73

103

904

Open wound of hip and thigh

615

1.06

0.15

1.6

1.5

27.41

19.93

iu/l

0.92

500

Disorders of globe

275

1.09

0.14

1.6

1.3

27.00

26.41

iu/l

0.03

229

Chronic ulcer of skin, not elsewhere classified

713

1.05

0.14

1.3

1.4

21.90

29.09

iu/l

1.62

601

Dermatitis herpetiformis

256

1.10

0.14

1.4

1.3

24.09

27.99

iu/l

0.23

213

Certain zoonotic bacterial diseases, including avohilmo

499

1.06

0.14

1.3

1.4

33.39

24.81

iu/l

0.97

414

Volvulus

324

1.08

0.14

1.6

1.3

30.03

29.73

iu/l

0.01

280

Excessive earwax

1288

11786

0.99

0.14

1.5

1.4

26.20

27.58

iu/l

0.79

1075

10001

Syphilis

334

1.08

0.14

1.4

1.3

16.89

22.54

iu/l

0.56

278

Syphilis, including avohilmo

334

1.08

0.14

1.4

1.3

16.89

22.54

iu/l

0.56

278

Alcohol-induced chronic pancreatitis

558

1.06

0.13

1.3

1.4

21.85

24.98

iu/l

0.44

461

Other diseases of pleura

476

4063

1.02

0.13

1.5

1.4

27.80

29.95

iu/l

0.73

388

3438

Use of donepezil

374

1.07

0.13

1.4

50.73

34.80

iu/l

1.75

309

Atrioventricular septal defect

109

0.81

0.13

3.0

2.3

11.90

20.49

iu/l

—

Benign neoplasm: Larynx

286

1.09

0.13

1.4

1.5

34.34

26.94

iu/l

0.55

245

Spinal instabilities

569

1.06

0.13

1.4

25.89

30.54

iu/l

0.56

494

Nonsuppurative otitis media

779

6669

1.01

0.13

1.6

1.5

15.23

15.38

iu/l

0.06

636

5428

Other disorders of amniotic fluid and membranes

905

8833

0.99

0.13

1.3

1.4

21.29

24.56

iu/l

2.73

799

7552

Carcinoma in situ of skin of trunk

113

1.15

0.13

1.1

1.3

30.33

29.16

iu/l

0.04

Colorectal cancer

172

1602

1.03

0.13

1.2

1.3

37.55

32.87

iu/l

0.86

136

1385

Disorders of brain, other and unspecified

110

0.81

0.13

1.8

1.5

27.46

24.54

iu/l

—

Mixed connective tissue disease

386

0.93

0.13

1.2

1.3

37.00

28.67

iu/l

0.59

330

Cystic kidney disease

550

0.94

0.13

1.6

1.5

26.16

24.02

iu/l

0.14

469

Left ventricular outflow tract obstruction (LVOTO), broad definition

197

1919

1.03

0.12

1.6

1.5

28.33

27.06

iu/l

0.21

163

1590

Hand

104

1.16

0.12

1.8

1.3

35.50

24.12

iu/l

0.49

COPD, hospital admissions 1, only main diagnosis

218

1920

0.98

0.12

1.3

1.4

27.74

31.40

iu/l

1.07

179

1628

Distal bite

135

1298

1.03

0.12

2.1

1.9

15.79

16.75

iu/l

0.15

113

1000

L04AX Other immunosuppressants

1718

17027

1.01

0.12

1.5

1.4

27.71

27.36

iu/l

0.16

1470

14555

Impacted maxillary canine

239

1.09

0.12

3.3

2.2

6.56

9.90

iu/l

1.07

173

Seronegative rheumatoid arthritis

203

2081

0.97

0.12

1.4

35.31

32.20

iu/l

0.54

173

1797

Human immunodeficiency virus [HIV] disease, including avohilmo

307

1.08

0.12

1.2

1.4

16.92

21.08

iu/l

0.43

255

Other complications of labour and delivery, not elsewhere classified

815

7139

1.01

0.12

1.3

1.4

17.22

17.86

iu/l

0.28

693

6032

Scarlet fever, including avohilmo

259

1.09

0.12

1.6

1.5

28.44

21.38

iu/l

0.37

207

Delivery

1290

6733

1.01

0.12

1.3

1.4

24.87

25.14

iu/l

0.11

1116

5567

Malignant neoplasm of skin, including Hilmo

811

5367

1.01

0.11

1.4

1.3

32.97

33.75

iu/l

0.26

687

4670

Donors of organs and tissues

357

1.07

0.11

1.5

1.4

24.19

23.79

iu/l

0.03

311

Methotrexate

305

3107

0.98

0.11

1.5

1.4

29.65

30.07

iu/l

0.08

267

2670

Hepatic failure, not elsewhere classified

445

0.94

0.11

1.6

1.4

26.99

27.14

iu/l

0.01

382

Unspecified event, undetermined intent

553

1.05

0.11

1.5

1.4

19.10

22.24

iu/l

0.42

472

Burns and corrosions of multiple and unspecified body regions

377

1.06

0.11

1.2

1.5

16.97

19.79

iu/l

0.34

311

Malignant neoplasm of skin

706

4721

1.01

0.10

1.4

1.3

32.28

33.86

iu/l

0.62

594

4118

Burn and corrosion of head and neck

368

1.06

0.10

1.3

1.5

17.64

19.07

iu/l

0.12

304

Pacemaker

244

2222

1.02

0.10

1.5

27.59

28.96

iu/l

0.25

203

1852

Degeneration of macula and posterior pole

335

2541

1.02

0.10

1.3

1.4

39.93

35.98

iu/l

1.10

268

2186

Carcinoma in situ of other and unspecified genital organs

496

1.05

0.10

1.3

29.23

31.42

iu/l

0.17

438

Haematosalpinx/Haematoma of broad ligament

1.09

0.10

1.2

1.3

17.10

33.64

iu/l

—

Glaucoma secondary to eye trauma

1.11

0.10

1.0

1.3

25.18

23.33

iu/l

—

Other specified/unspecified disorders of tympanic membrane

1.09

0.09

2.8

1.4

28.40

22.91

iu/l

—

Other and unspecified syphilis, including avohilmo

1.09

0.09

1.6

1.5

5.96

23.07

iu/l

—

Arthropathies in other diseases classified elsewhere

664

1.04

0.09

1.2

1.4

32.93

28.23

iu/l

0.36

563

Benign neoplasm: Lymph nodes

1.04

0.09

1.4

40.62

27.68

iu/l

—

Missing teeth due to accident, extraction or parodontitis

1173

10390

1.01

0.09

1.4

31.23

31.09

iu/l

0.05

938

8942

Contact with machinery

101

1040

0.97

0.09

1.3

1.4

15.84

18.93

iu/l

0.71

856

Hypertensive Heart Disease

121

942

0.97

0.09

1.4

26.14

32.40

iu/l

1.22

783

Relapsing fevers

1.06

0.09

1.0

1.8

20.12

20.67

iu/l

—

Other abnormal immunological findings in serum

587

1.04

0.09

1.3

1.6

26.21

23.44

iu/l

0.28

489

Isolated proteinuria

512

0.96

0.09

1.4

1.5

20.36

20.99

iu/l

0.05

426

Other and unspecified thalassaemias

1.04

0.08

3.3

1.5

4.58

15.42

iu/l

—

Alzheimer’s disease (Late onset)

296

0.94

0.08

1.1

1.4

53.20

34.69

iu/l

1.50

251

Aortic aneurysm

124

1185

1.03

0.08

1.4

22.88

24.93

iu/l

0.33

977

Dialysis

522

0.96

0.08

1.7

1.6

18.93

24.17

iu/l

0.46

424

Tuberculosis of other organs

136

1.10

0.08

1.5

1.4

24.84

28.19

iu/l

—

107

Progressive systemic sclerosis

1.04

0.08

1.2

1.4

40.27

31.31

iu/l

—

Small cell lung cancer, including Hilmo

1.03

0.08

1.5

1.2

68.22

30.03

iu/l

—

Small cell lung cancer

1.03

0.08

1.5

1.2

68.22

30.03

iu/l

—

Pustulosis palmaris et plantaris

916

0.97

0.08

1.5

1.4

33.43

32.81

iu/l

0.06

788

Fourth [trochlear] nerve palsy

283

1.06

0.08

1.5

1.3

30.03

27.94

iu/l

0.10

241

Contact with other hot metals

246

0.93

0.08

1.4

1.5

36.99

19.92

iu/l

1.11

205

Atrial septal defect, secundum type

781

0.97

0.08

1.9

1.8

16.94

19.68

iu/l

0.40

592

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

205

1.08

0.08

2.0

1.6

22.31

22.62

iu/l

0.02

175

Amiodarone users

470

1.04

0.08

1.5

1.4

33.07

27.01

iu/l

0.53

384

Other infective (teno)synovitis

0.80

0.07

1.0

1.2

40.85

28.07

iu/l

—

Congenital vesicoureteral reflux

176

1.09

0.07

1.5

1.9

8.39

9.72

iu/l

0.19

135

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

407

1.05

0.07

2.3

6.93

6.77

iu/l

0.03

258

Pulmonary oedema

1.05

0.07

2.0

1.3

18.01

26.94

iu/l

—

Sudden idiopathic hearing loss

147

1441

1.02

0.07

1.4

25.51

29.34

iu/l

0.87

129

1234

Benign neoplasm of other and unspecified female genital organs

924

0.97

0.07

1.4

1.3

25.58

30.41

iu/l

0.77

807

Defect, injury or illness of lumbar spine

1.06

0.07

1.6

1.4

22.83

24.80

iu/l

—

Alcohol withdrawal state with delirium

570

0.96

0.07

1.3

1.4

23.13

23.67

iu/l

0.05

472

Unspecified parasitic disease

118

1.11

0.07

1.8

1.3

30.73

29.97

iu/l

0.03

100

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3233

21850

1.00

0.07

1.5

1.4

25.82

26.55

iu/l

0.60

2674

18785

Exposure to excessive heat of man-made origin

1.04

0.07

1.8

1.3

12.34

21.77

iu/l

—

Other congenital malformations of face and neck

789

1.03

0.06

1.3

1.4

19.37

22.09

iu/l

0.37

670

Burn and corrosion of shoulder and upper limb, except wrist and hand

354

1.05

0.06

1.3

1.6

22.57

21.75

iu/l

0.06

291

Other blood glucose lowering drugs, excl. Insulins

137

1344

1.02

0.06

1.2

1.4

29.23

34.54

iu/l

1.22

114

1144

Other pulmonary heart/vessel disease

325

0.95

0.06

1.3

1.5

42.89

24.02

iu/l

1.88

268

Cardiomyopathy (excluding other)

1012

0.98

0.06

1.6

1.4

27.97

26.23

iu/l

0.18

844

Injury of muscle and tendon at lower leg level

276

2728

1.01

0.06

1.3

1.4

28.25

27.04

iu/l

0.23

233

2293

Injury of urinary and pelvic organs

286

1.05

0.06

1.3

1.5

23.09

21.38

iu/l

0.12

241

Blood alcohol or alcohol intoxication level

476

0.96

0.05

1.3

1.5

21.71

18.40

iu/l

0.31

397

Glomerulonephritis

165

1675

0.98

0.05

1.5

29.83

25.17

iu/l

0.84

140

1401

Ventricular septal defect, a heart condition

615

0.97

0.05

2.4

1.9

12.26

15.54

iu/l

0.68

433

Palatinal maxillary canine

208

1.06

0.05

1.7

2.0

23.41

7.37

iu/l

0.42

160

Chronic suppurative otitis media, including avohilmo

166

1636

1.02

0.05

1.5

17.42

22.22

iu/l

1.59

138

1348

Other juvenile arthritis

149

1468

1.02

0.05

1.4

1.6

21.50

19.06

iu/l

0.41

124

1195

Duodenal ulcer

663

1.03

0.05

1.5

1.4

28.12

28.76

iu/l

0.05

553

Burns and corrosions confined to eye and internal organs

614

1.03

0.05

1.3

1.4

30.54

24.52

iu/l

0.76

524

Necrobiosis lipoidica, not elsewhere classified

189

1.06

0.05

1.3

34.19

18.61

iu/l

1.00

158

Pathological resorption of teeth

754

1.02

0.04

1.8

1.4

24.56

25.02

iu/l

0.04

645

Prepatellar bursitis

484

0.97

0.04

1.2

1.4

23.56

24.28

iu/l

0.05

410

Amputation of toe

383

0.97

0.04

1.2

1.4

18.30

26.34

iu/l

1.39

317

Venous complications and haemorrhoids in pregnancy

104

1057

0.98

0.04

1.2

1.4

21.46

24.98

iu/l

0.64

916

Motor- or nonmotor-vehicle accident in traffic area

150

0.93

0.04

1.3

1.5

10.61

17.88

iu/l

1.05

129

Palatinal maxillary operation

259

1.05

0.04

2.0

21.06

7.82

iu/l

0.43

196

Abnormalities of forces of labour

591

5940

0.99

0.04

1.3

1.4

30.34

31.66

iu/l

0.44

527

5136

Alcohol use disorder, Swedish definition

1152

10427

1.00

0.04

1.4

22.28

25.24

iu/l

2.68

897

8852

Myocardial infarction, without ST-elevation

227

2028

1.01

0.04

1.3

1.4

30.16

31.60

iu/l

0.23

181

1716

Smoking dependency

179

1808

0.99

0.03

1.5

1.4

26.40

27.49

iu/l

0.17

140

1553

Suppurative and necrotic conditions of lower respiratory tract

478

1.03

0.03

1.4

26.89

25.60

iu/l

0.10

390

Exclusion endpoint for supernumerary teeth

350

1.03

0.03

1.5

1.6

23.18

18.59

iu/l

0.37

267

Motorcycle rider injured in noncollision transport accidents

549

1.02

0.03

1.4

1.5

16.43

16.86

iu/l

0.05

447

Kidney transplant status

882

0.99

0.02

1.9

1.6

31.61

23.75

iu/l

0.72

723

Acute poliomyelitis

148

0.94

0.02

1.1

1.3

32.53

25.88

iu/l

—

122

Acute poliomyelitis, including avohilmo

148

0.94

0.02

1.1

1.3

32.53

25.88

iu/l

—

122

Granulomatous disorders of skin and subcutaneous tissue

670

1.02

0.02

1.4

27.77

25.52

iu/l

0.22

570

Congenital malformations of great arteries

550

1.02

0.02

2.7

2.1

15.83

13.38

iu/l

0.36

375

Gestational [pregnancy-induced] hypertension

1587

15810

1.00

0.02

1.3

24.30

25.46

iu/l

0.78

1414

13740

Malignant neoplasm of corpus uteri, including Hilmo

820

0.99

0.02

1.4

1.3

42.39

38.84

iu/l

0.39

728

Open wound of shoulder and upper arm

322

1.03

0.02

1.3

1.5

14.05

20.39

iu/l

0.56

267

Obstructed labour due to maternal pelvic abnormality

485

4865

1.00

0.02

1.3

1.4

35.08

36.16

iu/l

0.29

430

4213

Malignant neoplasm of corpus uteri

671

1.01

0.01

1.4

1.3

40.40

38.34

iu/l

0.21

597

Other bacterial agents as the cause of diseases classified to other chapters

143

1.05

0.01

2.5

1.6

20.45

22.58

iu/l

—

120

Injury of other and unspecified intrathoracic organs

738

0.99

0.01

1.6

1.4

20.88

23.34

iu/l

0.33

617

Acute appendicitis, with complications

414

4151

1.00

0.01

1.4

28.67

30.10

iu/l

0.39

353

3557

Pustular psoriasis

988

0.99

0.01

1.5

1.4

35.11

32.18

iu/l

0.38

845

Alzheimer’s disease (Late onset), excluding more controls

180

0.97

0.01

1.1

1.5

48.94

35.13

iu/l

0.91

149

Symptoms and signs involving cognition, perception, emotional state and behaviour

3229

21548

1.00

0.01

1.4

26.97

26.51

iu/l

0.33

2714

18526

Tuberculosis of other organs, strict

144

1.04

0.00

1.5

1.4

24.84

27.80

iu/l

—

113

Maternal care for (suspected) damage to fetus from alcohol

176

0.96

0.00

1.6

1.3

24.22

21.21

iu/l

—

159

Combinations of oral blood glucose lowering drugs

294

2947

1.00

0.00

1.5

1.4

24.49

33.34

iu/l

6.89

262

2498

Unspecified threat to breathing

256

0.97

0.00

1.5

1.4

21.16

21.33

iu/l

0.01

214

Alzheimer disease, excluding more controls

347

0.99

0.00

1.4

43.54

36.80

iu/l

0.54

296

Benign neoplasm: Vulva

426

0.99

0.00

1.5

1.3

19.31

28.77

iu/l

1.45

371

Exposure to other and unspecified man-made environmental factors

436

0.99

0.00

1.3

1.4

36.54

23.01

iu/l

1.39

375

Thoracic aortic aneurysm

936

0.99

0.00

1.4

25.10

25.90

iu/l

0.09

776

Mental and behavioural disorders due to tobacco

179

1784

1.00

0.00

1.5

1.4

26.40

27.68

iu/l

0.20

140

1536

Secondary parkinsonism

164

0.98

0.00

1.4

20.70

26.27

iu/l

0.38

139

HSIL lesion of the vagina

455

1.01

0.00

1.4

1.3

30.80

29.65

iu/l

0.08

399

Tuberculosis of other organs, strict, including avohilmo

152

0.99

0.00

1.5

1.4

24.84

27.65

iu/l

—

120

Crushing injury of wrist and hand

172

0.99

0.00

1.6

1.5

21.23

22.02

iu/l

0.04

141

Foreign body in ear

413

0.99

0.00

1.4

1.6

25.46

21.08

iu/l

0.23

341

Monoarthritis, not elsewhere classified

936

1.00

0.00

1.4

22.03

27.83

iu/l

1.12

799

Acne conglobata

121

0.99

0.00

1.6

13.46

13.22

iu/l

0.02

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

151

0.99

0.00

1.4

1.2

42.18

25.00

iu/l

—

127

Toxic effect of contact with venomous animals

932

1.00

0.00

1.5

23.02

25.58

iu/l

0.32

787

Dissocial personality disorder

229

1.00

0.00

1.3

1.4

21.97

19.05

iu/l

0.19

182

Evidence of alcohol involvement determined by blood alcohol level

269

1.00

0.00

1.3

1.4

20.50

19.73

iu/l

0.05

227

Adalimumab

332

3317

1.00

0.00

1.5

1.4

25.49

24.98

iu/l

0.11

299

2815

Pedal cyclist injured in noncollision transport accidents

284

2841

1.00

0.00

1.4

21.58

24.93

iu/l

1.12

241

2379

Liveborn infants according to place of birth

284

1.01

0.00

2.0

2.1

7.07

8.32

iu/l

0.23

191

Carcinoma in situ of colon

163

0.98

0.00

1.5

1.3

17.61

32.80

iu/l

0.95

131

Secondary parkinsonism+Parkinsonism in other disease

167

1.02

0.00

1.4

21.47

26.66

iu/l

0.38

143

Polycystic kidney disease

443

0.99

0.00

1.5

1.4

26.69

24.31

iu/l

0.13

376

Pyoderma gangrenosum

147

1.02

0.00

1.5

1.4

32.59

25.43

iu/l

—

125

Benign neoplasm: Descending colon

587

1.01

0.00

1.4

1.3

37.31

32.47

iu/l

0.43

497

Bronchitis, not specified as acute or chronic

147

1465

1.00

0.00

1.5

1.4

22.64

24.70

iu/l

0.34

127

1263

Inhalation and ingestion of other objects causing obstruction of respiratory tract

105

1.05

0.00

1.2

1.4

16.36

23.06

iu/l

0.52

Gangrene and necrosis of lung

0.00

0.0

1.0

—

16.86

—

Relapsing fevers, including avohilmo

1.00

0.00

1.0

1.7

22.86

19.34

iu/l

—

Traumatic shock

0.00

0.0

1.0

—

25.28

—

Malignant neoplasm of trachea, including Hilmo

0.00

0.0

1.8

—

22.10

—

Rheumatic fever with heart involvement

0.96

0.00

3.4

1.5

14.24

22.15

iu/l

—

Vascular dementia (sudden onset)

0.00

0.0

1.1

—

23.11

—

Deformity of orbit

0.00

-0.00

0.0

1.6

—

26.90

—

Chronic nephritic syndrome

550

1.00

-0.00

1.5

1.4

27.14

27.75

iu/l

0.04

464

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.6

—

8.04

—

Disorders of glycosaminoglycan metabolism

0.00

-0.00

0.0

1.0

—

8.43

—

Glaucoma secondary to drugs

1.02

-0.00

1.0

1.5

11.86

18.79

iu/l

—

Abnormal findings on examination of urine, without diagnosis

750

1.00

-0.00

1.4

1.5

20.23

23.36

iu/l

0.46

635

Alopecia mucinosa, drug-induced

0.00

-0.00

0.0

1.2

—

23.23

—

Care involving dialysis

910

1.00

-0.00

1.7

1.5

29.08

25.34

iu/l

0.28

744

Brain glioblastoma, helper endpoint

110

1.00

-0.00

1.4

24.05

26.28

iu/l

0.09

Papulosquamous disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

30.53

—

Heberden's nodes [with arthropathy]

0.93

-0.00

1.3

25.10

31.41

iu/l

—

Unspecified contracted kidney

0.92

-0.00

1.8

1.4

22.23

21.98

iu/l

—

Other and unspecified pemphigoid

0.94

-0.00

1.8

1.3

20.94

28.59

iu/l

—

Choroidal degeneration

0.00

-0.00

0.0

1.7

—

19.08

—

Benign neoplasm: Female genital organ, unspecified

0.95

-0.00

1.3

29.78

21.63

iu/l

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

1.00

-0.00

1.2

1.4

34.40

23.15

iu/l

—

Coccidioidomycosis

0.00

-0.00

0.0

1.4

—

9.04

—

Malignant neoplasm of uterus, part unspecified

0.00

-0.00

0.0

1.1

—

25.96

—

Mucopolysaccharidosis, other/unspecified

0.00

-0.00

0.0

1.0

—

9.28

—

Exposure to uncontrolled fire in building or structure

0.98

-0.00

1.4

19.52

20.72

iu/l

—

Other disorders of middle ear and mastoid in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

23.23

—

Acute necrotizing ulcerative gingivitis

0.00

-0.00

0.0

1.3

—

20.17

—

Pseudopelade

0.00

-0.00

0.0

1.6

—

24.97

—

Hyperalimentation, other specified

0.00

-0.00

0.0

1.2

—

9.68

—

Ischaemic infarction of muscle

0.00

-0.00

0.0

1.4

—

17.47

—

Congenital ichthyosis

0.93

-0.00

5.5

1.9

18.47

22.05

iu/l

—

Lipid storage disorder, other/unspecified

0.00

-0.00

0.0

1.4

—

30.83

—

Ectopic hormone secretion, not elsewhere classified

0.00

-0.00

0.0

2.3

—

35.25

—

Omphalitis of newborn with or without mild haemorrhage

0.00

-0.00

0.0

4.2

—

15.78

—

Heredofamilial amyloidosis, unspecified

0.00

-0.00

0.0

1.1

—

21.30

—

Chronic myringitis

0.97

-0.00

1.3

1.4

24.23

22.29

iu/l

—

Crushing injury of neck

0.00

-0.00

0.0

1.7

—

14.93

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Follitropin [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS